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ABSTRACT 
This project assessed the use of short chain peptide (F2/S) hydrogel biomaterial 
substrates as an instructional tool for driving stem cell differentiation through fine-tuning 
of the substrate mechanical properties (altered elasticity or stiffness) to mimic that of 
naturally occurring tissue types. By doing this, differentiation of mesenchymal stem cells 
(MSCs) into neuronal cells on a 2 kPa (soft) substrate, chondrocytes on 6 kPa (medium) 
substrate and osteoblasts on 38 kPa (rigid) substrates was achieved. 
This non-invasive procedure of influencing stem cell behaviour allows a means of 
exploring innate cell behaviour as they adopt different cell lineages on differentiation. As 
such, an LC-MS based metabolomics study was used to profile differences in cell 
behaviour. Stem cells were observed as having increased metabolic activity when 
undergoing differentiation compared to their ‘resting’ state when they are observed as 
metabolically quiescent or relatively inactive. As such, the metabolome, as a reflection of 
the current state of cell metabolism, was used to illustrate the observed divergence of 
phenotypes as differentiation occurs on each substrate F2/S type.  
The project further investigated the potential of endogenous small molecules 
(metabolites) identified using metabolomics, as effective compounds in driving or 
supporting cell differentiation in vitro. From this, the compounds cholesterol sulphate and 
sphinganine were found to induce MSC differentiation along the osteogenic and 
neurogenic routes respectively. A third compound, GP18:0, was observed to have 
influence on promoting both osteo- and chondrogenic development. These results 
highlight the potential role a broad based metabolomics study plays in the identification of 
endogenous metabolites and ascertaining the role(s) they play in cellular differentiation 
and subsequent tissue development. Lastly, the use of F2/S substrates as a potential 
clinical scaffold for the regeneration of cartilage tissue was explored. Long term 
differentiation of pericytes into chondrocytes cultured in 20 kPa F2/S substrates was 
assessed and the cellular phenotype of the resultant chondrocytes compared to the more 
conventionally used induction media method. Pericytes cultured within the biomaterial 
alone showed a balanced expressed of type II collagen and aggrecan with lessened type 
X collagen expression compared to the coupled use of induction media which showed a 
bias towards collagen (both type II and type X) gene expression. This observation 
suggests that in order to mimic native hyaline cartilage tissue in vitro, the use of 
biomaterial mechanics is potentially a better approach in guiding stem cell differentiation 
than the use of chemical cues. 
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1 GENERAL INTRODUCTION 
  
Chapter I – General introduction 
 
 
 
2 
1.1 Regenerative medicine & tissue engineering 
Surgical transplantation and reconstruction of damaged tissues and organs due to 
trauma or disease currently presents a heavy strain on healthcare in terms of both cost 
and patient aftercare (Kamolz et al., 2013). An increase in life expectancies over the last 
thirty years and its extrapolation to continue over the immediate future has led to a 
concomitant rise (and continued anticipation) of the occurrences of tissue trauma such as 
knee and hip replacements for example (Vaupel, 2010). The subsequent increase in 
tissue degeneration places high pressure on expectant development of surgical 
procedures and technologies, which can effectively lead to an understanding and 
treatment of such traumas. 
Current treatment protocols involve the use of autogeneic and allogeneic transplant 
procedures of either similar or different tissue types to act as scaffolds for would healing. 
Examples of these are dermal replacements in burn patients and the use of colon to 
rebuild the oesophagus respectively (Kamolz et al., 2013). Xenogeneic transplant 
procedures are also widely used, typically employing the use of porcine intestinal 
mucosa for arterial and venous grafts as well as the use of urinary bladder matrix for 
reconstruction of urinary tract defects (Badylak, 2004, Benders et al., 2013). 
Alternatively, non-biological components as scaffolding are also used extensively in 
orthopaedics, ophthalmology, cardiovascular and reconstructive surgeries in the form of 
stents and prosthetics. 
While surgical procedures for healing or regenerating lost tissue from disease or trauma 
have brought on significant advances in the field, they are not without their limitations. 
These are inclusive of lack of biocompatibility, infection, added injury sites from 
autogenic implantations and scaffold durability. Strategies in tissue engineering aim to 
find new or improved applications and techniques that overcome the above stated 
limitations with the design and implementation of efficient biological scaffolds that better 
integrate with the human body to assist the healing process. And thus, subsequently, 
alleviate some of the strain compounded by healthcare demands. To do this, a number of 
different disciplines encompassing engineering, chemistry and the life sciences are 
integrated in order to enable an understanding of native tissue cells and their interaction 
with the biomaterial design(s) in order to restore, maintain or enhance tissue integrity and 
function (Fisher and Mauck, 2013). 
 
1.2 Stem cells 
Stem cells are progenitor cells that undergo self-renewal and differentiation into a 
number of specialised cell lineages. These cell lineages are inclusive of cell types that 
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make up and sustain functional tissues and organs such as muscle, tendons or bone. 
Generally, stem cells are categorised either as embryonic or adult. Embryonic stem (ES) 
cells are derived from the inner cell mass of a blastocyst embryo (Figure 1-1). Adult stem 
cells originate from already differentiated postnatal tissue and are functional as a 
regenerative intermediary in cell aging and wound healing (Mimeault and Batra, 2008). 
The ability of a stem cell to differentiate into specialised cell types, however, has 
limitation depending on the cell type and its stage in maturity, inferring a degree of 
‘plasticity’. These restrictions are also used to classify stem cells according to their 
differentiation capabilities (Figure 1-1). A morula; early stage embryo, typically consisting 
of 16 – 32 cells, has the ability to develop into all three human germ layers (ectoderm, 
mesoderm and endoderm) and the trophoblast which later develops into the placenta. As 
such, these cells are termed totipotent. Subsequently, the cells of the morula begin to 
specialise forming the blastocyst; a hollow cellular sphere containing the inner cell mass 
from which the embryo develops. The cells from the inner cell mass that constitute the 
embryo and give rise to ES cells are referred to as pluripotent, that is, these cells are 
able to give rise to most (germ layers) but not all (trophoblast) cells supporting 
development. 
Further down in the hierarchy are adult stem cells, which have a limited scope of 
differentiation capabilities and are termed multipotent. The differentiation capabilities of 
these cells are more or less classed further with regards to their originating tissue. For 
example, neuronal stem cells give rise to neurons, astrocytes & oligodendrocytes; 
mesenchymal stem cells typically develop into cells of the musculoskeletal system and 
intestinal stem cells give rise to goblet and enteroendocrine cells. This nomenclature 
restriction on the multipotent capabilities of adult stem stems however, may not be a true 
reflection on differentiation competence of most adult stem cells as research over the 
past years have noted cross-over behaviour of certain stem cells, an ability to form cell 
types which are not off their native germ layer (transdifferentiation). Examples of these 
include the ability of mesenchymal stem cells to form endothelial (Petersen et al., 1999, 
Wong et al., 2007) and neuronal cell types (Sanchez-Ramos et al., 2000, Woodbury et 
al., 2000), and the development of neural stem cells into early hematopoietic progenitor 
cells (Bjornson et al., 1999).  These observations have led to the argument that a defined 
hierarchy of stem cell plasticity and niche restriction is not necessarily the case but that 
stem cells adopt a state or number of states between being an uncommitted and 
committed cell arguing that stem cell progeny is not a strict lineage but a range of 
capabilities of a cell based on its stage of commitment (Minguell et al., 2001). 
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Figure 1-1 Illustration depicting the differentiation potential of stem cells. The 16-cell 
morula is capable of differentiating into all cells in the body and is generally referred to as 
totipotent. Pluripotent cells are embryonic stem cells, which originate from the inner cell mass 
of the blastocyst and go on to form the cells that make up the 3 germ layers. Adult stem cells 
are multipotent and differentiation capabilities are more restricted than toti- or pluripotent 
cell types. As development progresses the relative plasticity of each cell decreases until a 
specialised cell type is developed. 
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The use of adult stem cells in research is of particular attraction as there are less ethical 
issues surrounding their use, immunomodulatory with the advantage of performing 
autogeneic implants and they are readily available in comparison to ES cells. Of these, 
mesenchymal stem cells (typically derived from bone marrow) are an attractive 
therapeutic tool owing to their relative ease of isolation and expansion in culture as well 
as their potentially wide application range in tissue engineering strategies. 
Nomenclature and identification criteria of mesenchymal stem cells are an element that is 
somewhat plagued with ambiguity. The former due to the evolving nature of research in 
the field and the latter due to an incomplete understanding of what exactly a stem cell 
can be defined by in a physical sense. The observation of colony forming fibroblasts 
which had osteogenic potential identified by Friedenstein et al (Friedenstein et al., 1970, 
Friedenstein et al., 1987) led to the original name of colony forming unit fibroblasts (CFU-
F). This has since evolved into the currently used mesenchymal stem cell (MSC) with a 
few other connotations still in circulation such as marrow stromal cell (MSC), multipotent 
adult progenitor cell (MAPC), marrow stromal fibroblasts (MSF) and mesenchymal 
progenitor cells (MPC). This, however, assumed the primary sources of MSCs were 
typically from bone marrow and as such, recent use of mesenchyme derived stem cells 
tend to refer primarily to their origin source, that is, adipose derived stem cells (ASC) or 
bone marrow derived stem cells (BMSC). This project makes use of bone marrow 
derived stem cell and is here on referred to in the broad term mesenchymal stem cell or 
MSC unless stated otherwise. 
Undefined characteristics, variation in tissue sources and types have been known to 
cause some ambiguity in research results using MSC populations. To standardise 
research findings a minimum requirement for characterising MSCs were put forward by 
the international society for stem cell therapy (Dominici et al., 2006). These were to 
define MSC using three main characteristics; adherence to plastic, an ability to 
differentiate into adipose, cartilage and bone cells (typical mesenchyme lineages) and 
lastly the expression of the surface antigens CD105, CD73 and CD90 as well as the lack 
of the surface markers CD45, CD34, CD14 and CD79α. The list of surface markers are 
by no means restrictive and a number of surface markers in addition to the ones 
mentioned, reviewed by Tare et al, are routinely used to characterise MSC (Tare et al., 
2008).  
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1.2.1 The stem cell niche 
The steady state turnover of stem cells, that is, its ability to undergo self renewal or 
asymmetric division to ensure population survival as opposed to just symmetric division 
into differentiated cell progeny, is thought to be regulated by the interaction of stem cells 
with intrinsic properties of its microenvironment leading to the proposal of a stem cell 
niche by Schofield (Schofield, 1978). In this sense, niche is essentially referred to as the 
components of the cells surrounding matrix in addition to the emitted signals from 
supporting cells as opposed to its spatial location (Figure 1-2). These, in cohort, 
essentially regulate stem cell behaviour determining whether the cells undergo self-
renewal or differentiation. 
This hypothesis was supported by the subsequent identification of a niche for germ line 
stem cells in the apical tip of drosophila ovariole (Xie and Spradling, 2000). Studies in 
mammalian systems resulted in the suggestion of a stem cell niche in the bulge region of 
hair follicles for epithelial cells (Cotsarelis et al., 1990) and the bottom crypt of the 
intestine for intestinal stem cells (Sancho et al., 2004). The stem cell niche for 
mesenchymal stem cells, so far, still remains an unanswered question with regards to 
both matrix structure and spatial location. Options put forward for the MSC niche include 
the endosteal of the bone marrow where extrinsic communication between native cells 
(Calvi et al., 2003, Chow, 2011) and the sinusoidal vessels in the marrow (Katayama et 
al., 2006) contribute to regulating stem cell phenotype (Bianco, 2011, Ehninger and 
Trumpp, 2011). An alternative is a perivascular location as a niche in vivo where were 
resident pericyte cells (considered to be a predecessor of MSCs) not only act a cell 
source for repair but also play functional roles inclusive of regulating blood vessel 
contraction (Caplan, 2008, Crisan et al., 2008, Meirelles et al., 2008).  
A particularly important function of the stem cell niche is also to act as a hub or 
anchorage point where cell adhesion molecules such as integrins or syndecans couple 
adhesion states adapted through matrix properties and developmental signalling to tightly 
regulate stem cell behaviour (Simmons et al., 1997). The regulation of stem cell 
behaviour by its microenvironment is an important factor in tissue engineering as studies 
to maintain stem cell multipotency as well as driving differentiation along defined lineages 
have shown that physical properties such as surface patterning and substrate elasticity 
(Engler et al., 2006, McMurray et al., 2011) in addition to chemical signalling have 
considerable consequence on stem cell behaviour ex vivo, and as a consequence, the 
manner and precision in which biomaterials are designed are therefore of vital 
importance in maintaining or differentiating stem cells (Curran et al., 2010, Gilbert et al., 
2010).  
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Figure 1-2 Depiction of a stem cell niche. The stem cell niche is thought to regulate stem cell 
(S) phenotype through a combination of extrinsic signalling cues (block arrows) between itself, 
niche cells and the extracellular matrix. Changes in signalling events causes stem cells to 
undergo self-renewal, symmetrical or asymmetrical division into progenitor cells (P), which 
subsequently develop into specialised cell types (1 – 3). Image adapted from Watt & Hogan, 
Science 287. 2000. 
 
1.3 The extracellular matrix 
The extracellular matrix (ECM) is the non-cellular component of all tissues and organs 
within a system and is referred to as the cellular microenvironment, albeit within in this 
text the term microenvironment is used in the context in which cells are resident, that is, it 
is inclusive of the substrate used for cell culturing. The ECM is invariably responsible for 
the morphological attributes of different tissue types, playing a major role in imparting 
mechanical strength and scaffolding for cell anchorage and migration (Badylak, 2007, 
Frantz et al., 2010, Gullberg and Ekblom, 1995). 
The design and modelling of the ECM by native cells is a precisely controlled and 
constantly regulated process to continually support tissue homeostasis in response to 
changing external conditions. Impairments in this process can result in a number of 
pathologies such as multiple sclerosis (van Horssen et al., 2007), osteogenesis 
imperfecta (Bateman et al., 2009) and chronic asthma (Bai et al., 2000). 
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1.3.1 Architecture 
The ECM constitutes mainly a loose meshwork of fibrous proteins, proteoglycans and a 
host of regulatory molecules such as cytokines and proteolytic enzymes. While these 
three components are the main facets of the ECM, their design, distribution and 
architecture are tissue specific facilitated by different cell types resulting in the varied 
morphology of resultant tissue types. The makeup is designed to withstand the demands 
of the microenvironment in order to maintain tissue homeostasis, this demand changes 
at various stages in cell and tissue development and as such the ECM becomes a 
dynamic entity undergoing constant remodelling and reorganisation by its denizen. To 
cope with such pressures means that the nature of the ECM is not only tissue specific 
but possess a degree of heterogeneity within tissues themselves to facilitate proper 
functionality (Hunziker et al., 2002, Hwang et al., 1992) 
 
1.3.1.1 Fibrillary proteins 
Of the fibrous proteins found in the ECM, collagen makes up the major constituent. They 
comprise a triple helical structure that has high numbers of the polypeptide repeats Gly-
X-Y, where X and Y are typically proline and hydroxyproline. Collagen currently has 28 
known isoforms (Gordon and Hahn, 2010) resulting mainly from a number of post 
translational modifications (Gordon and Hahn, 2010, Myllyharju and Kivirikko, 2004) and 
although in many tissues types, the collagen populations are heterogeneous, usually one 
form is prevalent, such as type I collagen in bone tissue and type II collagen in cartilage. 
Type II collagen is also definitive of cartilage type being specific to hyaline cartilage 
tissue (Responte et al., 2007). The collagens, as a whole, serve to impart tensile and 
mechanical strength to the tissue as well as directing a number of cell behaviours such 
as cell polarity (Izu et al., 2011, Thery et al., 2006), adhesion and migration (Rozario et 
al., 2009).  
While collagen is capable of forming supramolecular structures through self-assembly, 
organisation and assembly is often undertaken by the cell itself thorough integrin 
interaction and fibronectin cross-linking (Myllyharju and Kivirikko, 2004). This 
reorganisation causes the arrangement of collagen into sheets or bundled cables 
significantly affecting the overall tertiary structure and integrity of the tissue. 
Fibronectin is another fibrillary element of the ECM and contemporarily acts as a bridge 
between collagen and cell surface integrins. Fibronectin is secreted from the cell as a 
loosely folded globular dimer and is unfurled through interaction with the ECM (Engvall et 
al., 1978), the cell (Friedland et al., 2009) or other fibronectin molecules (Frantz et al., 
2010) allowing assembly of fibronectin filaments. Fibronectin repeats contain arginine-
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glycine-aspartate (RGD) binding motifs specific to integrin interaction allowing cell 
adhesion and spreading. Changes in its tensile state, due to constant cellular traction 
indicate that fibronectin has a fair degree of elasticity (Ohashi et al., 1999). This force 
dependent extension of fibronectin is thought to expose cryptic cellular binding sites, 
which can trigger mechanosensory responses (Friedland et al., 2009) mediated through 
the cytoskeleton. 
Elastin is another fibrous ECM protein that is located mainly within tissue types that 
undergo extensive deformation such as the skin, lungs, arteries and elastic cartilage 
(located in the external ear and epiglottis) where they ensure recovery imparting a 
naturally elastic function to the tissue. Elastin is formed from the self-assembly of 
individual tropoelastin molecules through coacervation. This results in the alignment of 
lysine residues on tropoelastin, which subsequently undergo conversion by lysyl oxidase 
(LOX) enzymes to form reactive aldehydes that then form spontaneous desmosine 
cross-links forming a deformable meshwork (Gosline et al., 2002, Mithieux et al., 2013). 
Like fibronectin, elastin also associates with collagen regulating the extent of stretch the 
filament experiences (Wise and Weiss, 2009) as well as interacting directly with cells via 
αvβ3 integrins (Rodgers and Weiss, 2004).  
 
1.3.1.2 Proteoglycans 
Proteoglycans consist of a chain of repeating disaccharide units (glycosaminoglycans, 
GAGs) covalently linked to a protein core. The GAGs are invariably sulphated moieties: 
keratin sulphate, chondrotin sulphate and heparin sulphate, with the exception of 
hyaluronate, which is not sulphated. The high number of sugar groups within GAGs 
promotes interaction with water molecules making proteoglycans hydrophilic molecules. 
The attraction of water fills the spaces between collagen fibrils, adopting a hydrogel 
conformation and allows tissue the ability to resist compressive loads.  
ECM proteoglycans are broadly classed into 1) small leucine rich proteoglycan (SLRPs); 
as well as a structural role, SLRPs are known to be integral in cell signalling events 
influencing inflammatory responses (Nastase et al., 2012). Experiments using mice 
having a double gene knockout of the SLRPs biglycan and decorin had shown extensive 
deformation in bone and dental development (Young et al., 2003) implicating that these 
proteoglycans have an influential role in functional bone development. This observation 
has also been confirmed in a number of similar studies (Bianco et al., 1990, Kimoto et al., 
1994, Xu et al., 1998). 2) Cell surface proteoglycans such as CD44 and syndecans which 
act as co-receptors for a wide variety of ligands increasing binding affinity and the 
strength of adhesion (Carey, 1997, Mythreye and Blobe, 2009) and 3) structural or 
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modular proteoglycans which regulate physical interactions such as cell adhesion, 
migration and proliferation. 
While the above named components occur extensively throughout the ECM, they are by 
no means the only components present in the ECM. Laminins and tenascin are also well 
known ECM components known to play an important role in the structural and functional 
integrity of the ECM. These are reviewed in papers by the following authors: (Daley et al., 
2008, Frantz et al., 2010, Hynes and Naba, 2012).  
 
1.3.2 Dynamics and homeostasis 
The molecular components that make up the tissue specific ECM act not only as 
structural cell support for migration and anchorage but also as signalling cues inducing 
change in cellular behaviour in order to adapt to the environment and through this, tissue 
homeostasis (Frantz et al., 2010) 
Exposure of the ECM to the ‘external’, whether chemical or physical factors such as 
shear, compression or stretch means that the ECM is by no means a static entity and is 
constantly weathered by external forces and remodelled by native cells making it a highly 
changeable and dynamic substrate (Colige et al., 1999, Ruangpanit et al., 2002). In cells, 
ECM production is tempered by proteinase enzyme activity inclusive of matrix 
metalloprotinases (MMPs) and ‘a disintegrin and metalloproteinase with thrombospondin 
motif’ (ADAMTs). MMPs are broad acting degradation proteins which act as 
collagenases (Ruangpanit et al., 2002, Tocchi and Parks, 2013) but also acts on a 
number of cell membrane proteins and receptors (Tocchi and Parks, 2013) recycling and 
remodelling cell surface properties. ADAMTs, on the other hand, tend to act specifically 
where isoforms like ADAMT2 promote the formation of collagen from procollagen and 
ADAMTS4 specifically cleaves the GAG aggrecan found in cartilage tissue (Colige et al., 
1999, Tortorella et al., 1999). 
SLRPs, through their hydrogel properties typically act as a reserve for sequestered 
growth factors and cytokines immobilising them into the matrix and cleavage of these 
proteins by MMPs release them to bind with cell receptors. Matrix proteinase activity is 
tightly regulated and, in general, occurs in response to tissue injury and repair (Chen and 
Parks, 2009, Gill and Parks, 2008), effectively playing an overall regenerative role in 
ECM modulation. Albeit, some MMPs are consistently expressed by cells (Tocchi and 
Parks, 2013), suggesting that they also play a role in general tissue maintenance and 
homeostasis. 
The constant turnover of the ECM through continual probing by the cells has a profound 
effect on the innate composition of the resultant matrix defining its chemical, 
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topographical and elastic nature. As the ECM interacts with the cells cytoskeleton via 
transmembrane integrins (Maniotis et al., 1997) these ECM characteristics have been 
shown to be powerful instructional cues, eliciting cell responses with regards to  
polarisation (Thery et al., 2006), alignment (Wood, 1988), migration (Korpos et al., 2010, 
Wood, 1988), adhesion formation (Schiller, 2013) and differences in stem cell 
differentiation states (McBeath et al., 2004). 
 
1.3.3 Biomaterial design to emulate the ECM 
In order to ascertain the intricacies of cell behaviour and capabilities in tissue 
engineering, an understanding of cell interactions with the ECM is of fundamental 
importance. With the intention of replicating innate cell behaviour ex vivo, a number of 
naturally occurring and synthetic substrates have been developed for use in tissue 
engineering. These aim to cater for a range of demands from being able to support 
adherence and viability to the more intricately tailored designs geared towards 
researching a particular hypothesis. These substrates are generally of an instructional 
nature and include both modifiable and patterned substrates. 
The most obvious and convenient source of a cellular scaffold or biomaterial for culturing 
cells in vitro is the use of the ECM itself. The material is designed and produced by cells 
and by this link, guarantee the primary requisite of biocompatibility. Being designed by 
the cells, it is also amenable to vascularisation and diffusion of small molecules, which 
act as a nutrient source to the seeded cells. The use of naturally derived ECM substrate 
in regenerative medicine has garnered considerable success with most being 
commercially available, some examples of these are listed in reviews by Badylak 
(Badylak, 2007) and Dawson (Dawson et al., 2008). Success rates with the use of 
natural ECM as surgical stents, however, do present with mixed results and this is 
thought to be due to an averaging effect of use of an efficient, but not necessary optimal, 
biomaterial.  
In addition, reconstituted ECM gels are also widely used in cell culture, materials such as 
Matrigel and type I collagen, which can be assembled into a fibrillary meshwork with 
tuneable mechanics that readily supports cell adhesion and proliferation (Kleinman et al., 
1982, Levental et al., 2009, Sawkins et al., 2013). The above examples tend to make use 
of cell culture in three dimensions; surface or two dimensional cell culture, however, has 
allowed the widespread use of a natural/synthetic hybrid by way of ECM adsorbed 
polymer surfaces (Dawson et al., 2008). The use of fibronectin, laminin or vitronectin 
coated surfaces have found widespread use in research applications but are not without 
their idiosyncrasies. While the three mentioned ECM proteins are able to support cell 
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adhesion and activity on synthetic surfaces, protein interaction with the biomaterial 
polymer can develop their own interactions which can lead to changes in protein 
conformational state and adsorption properties leading to differential cellular interactions 
both between biomaterial types and from that observed in vivo (Bale et al., 1989, 
Lewandowska et al., 1992).  
While these biomaterials have great usefulness in comparative cell studies, their 
heterogeneity, chemical complexity and alteration in their organisation presents a 
number of difficulties in providing an instructional tool in the form of a substrate. To 
achieve a particular outcome from the cell, like directed wound healing for example, it is 
important that the biomaterial used is able to bias the cell activity towards achieving this 
aim with minimal interference. 
The differential behaviour of protein types used to coat polymer surfaces lead to the 
characterisation studies where binding kinetics showed that there is an optimal 
concentration at which cells interact with ECM proteins to facilitate cell adhesion and 
spreading (Akiyama and Yamada, 1985, Underwood and Bennett, 1989). Studies by 
Bale et al (Bale et al., 1989) had shown that the ECM protein/polymer composition has 
the tendency to affect the type of proteolytic cleavage that occurs during adsorption. This 
effect may also account for the varied expression of cellular integrins when cells seeded 
onto ECM coated polymers (Rezania and Healy, 1999, Sinha and Tuan, 1996). 
These noted differential behaviourisms led to strategies to improve the specificity with 
which cells interact with their ECM, some of these presented in the form of the 
development and use of biological adhesion motifs on biomaterial surfaces. The 
identification of specific cell-ECM binding motifs such as the RGD peptide motif present 
on fibronectin, VPGVG on elastin, IKVAV from laminin and GFOGER from collagen are 
now commonly used in cell culture studies (Huang et al., 2009, Silva et al., 2004, Zhang 
et al., 2003a). Immobilisation of these adhesive sites on other inert synthetic polymers 
allows for precise patterning of the substrate surface, which has enabled studies to show 
the considerable effect ligand conformation and spatial orientation has on cell behaviour 
such as integrin clustering (Schiller, 2013), cell polarisation (Thery et al., 2006), migration 
(Cavalcanti-Adam et al., 2007, Maheshwari et al., 2000) and differentiation (Kilian et al., 
2010, McBeath et al., 2004). 
 
In addition to density and spatial orientation of surface ligands, the topographical detail of 
the cell substrate is known to act as a recognisable instructional cue to elicit specific cell 
responses. Tissue structures in themselves possess varied topologies from smooth or 
striated muscle to the roughened surface of trabecular bone. It is likely therefore that 
Chapter I – General introduction 
 
 
 
13 
mimicking these patterns in vitro can cause behavioural changes in the cells placed 
within these defined microenvironments to closely match that which occurs in vivo. 
Integrins, the means by which cells sense their environment, are typically in the size 
range of 9 – 12 nm in length (Xiong et al., 2001, Xiong et al., 2002) and as such, 
changes in topographical detail at the nanometre scale can be detected by cells and 
subsequently elicit powerful cell responses. Examples include the use of near ordered 
(controlled disorder) nanopits to prompt osteogenesis (Dalby et al., 2007c) and highly 
ordered nanopits to maintain stem cell phenotype (McMurray et al., 2011), myoblasts 
cultured on grooved  polyacrylamide surfaces were particularly influential in promoting 
their eventual fusion and striation (Choi et al., 2012b) and MSCs cultured on 15 nm 
nanopillared titanium surface were observed to optimally promote osteogenic 
development (McNamara et al., 2011). 
 
While these materials are particularly effective at unravelling the intricacies of the cell-
ECM interface, they do not, however, emulate the structure and orientation properties of 
naturally occurring ECM as a complete entity. Of recent, the use of hydrogels as 
biomaterials for cell culture has garnered increasing popularity. The use of a cross-linker 
molecule interspersed in water to create a gel medium is symptomatic of the ECM 
composition. Cross-linkers include the use of synthetic polymers such as polyacrylamide 
and polyethylene glycol (PEG) but also the use of peptide moieties that self-assemble to 
form nanofibres likened to collagen fibres (Gerecht et al., 2007, Jayawarna et al., 2006, 
Orbach et al., 2009). Relative stiffness of the hydrogel biomaterials can subsequently be 
tuned by restricting the extent of cross-linking using alterations in pH, temperature or 
concentration during fabrication. This allows the researcher to maintain a constant 
chemistry while properties that relate to elasticity can be used to investigate effects on 
cellular behaviour. Studies employing this approach have shown that the rigidity of a 
substrate has consequences on properties such as cell survival (Flanagan et al., 2002, 
Saha et al., 2008), optimal function (Engler et al., 2008, Gilbert et al., 2010, Hoerning et 
al., 2012) and differentiation lineages adopted by stem cells (Engler et al., 2006, 
Huebsch et al., 2010, Trappmann et al., 2012). 
 
1.4 Mechanotransduction 
Mechanotransduction is the process by which cells sense and convert mechanical stimuli 
into biochemical activity, resulting in an adaptive response. Cells are exposed to a 
number of tissue specific physical forces, which range from the shear stress and stretch 
experienced in blood vessels to compressive loads on skin and bone tissue. In addition 
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to these external forces, cells themselves exert their own forces acting as probes on their 
surrounding ECM (Harris et al., 1980). This section focuses on known processes and 
effects of mechanotransduction as instigated through innate cellular activity. 
The phenomenon is initiated at the cell-ECM interface with integrins; transmembrane 
receptors that facilitate cell adhesion and play an important role in cell sensing and 
subsequent regulatory behaviour, making them an important link in translating outside 
information into the cell. This incidence is referred to in some cases as mechanosensing 
(del Rio et al., 2009, Sawada and Sheetz, 2002, Sawada et al., 2006, Galbraith et al., 
2002) 
Transductive effects, in some measure, can be immediate such as the activation of ion 
channels and second messenger activation through mechanical deformation of a number 
of transmembrane receptors (Evans et al., 1976, Martinac and Hamill, 2002). Others, like 
integrin clustering, focal adhesion maturation and cytoskeletal contraction and 
reorganisation occur on a comparatively delayed timescale, which subsequently results 
in ‘larger’ changes in cell adaptation such as gene expression and differentiation (Iyer et 
al., 2012). 
Mechanotranductive effects not only instigate particular change(s) in cell behaviour but 
are also known to contribute to maintaining homeostasis (continuous feedback) on load 
bearing tissues. Examples include the regulation of bone mass where mechanical 
loading triggers the release of signalling molecules by osteocytes which in turn regulates 
osteoblast and osteoclast activity (Klein-Nulend et al., 2013) and in the alignment of 
collagen fibres, proteoglycan content and cell distribution from the superficial to deep 
zone of articular cartilage (Hunziker et al., 1997, Hunziker et al., 2002, Responte et al., 
2007). 
The following sections look into the form and function of constituent parts involved in 
mechanotransduction and aims to elucidate how these then relate together bringing 
about a unified response in cell conduct, such as differentiation or migration. 
 
1.4.1 Integrins: form & function 
Integrins are heterogeneous transmembrane glycoproteins that comprise α and β 
subunits. Together they initiate cell-cell and cell-matrix interactions facilitating functions 
inclusive of anchorage, migration and morphology in adherent cells. 
Each subunit comprises a short ovoid cytoplasmic domain and an elongated extracellular 
domain (tail). The α and β tail units adopt two main conformations; a low affinity state, 
which is characterised by a folding of the external tail and a high affinity state, where on 
binding with a ligand, the tail is then extended and the cytoplasmic domains pull apart to 
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allow binding of focal adhesion proteins (Figure 1-3) (Takagi et al., 2002, Xiao et al., 
2004, Xiong et al., 2001, Xiong et al., 2002). 
Integrins are tethered to localised focal adhesions via the association of the β subunit 
with vinculin and α-actinin (Chen et al., 1985, Damsky et al., 1985) providing an 
extracellular link to the intracellular domain, influencing eventual behavioural outcomes 
such as cell polarisation (Prager-Khoutorsky et al., 2011, Thery et al., 2006), spreading 
(Cavalcanti-Adam et al., 2008, Cavalcanti-Adam et al., 2007), migration and cytoskeletal 
reorganisation (Jiang et al., 2006, Prager-Khoutorsky et al., 2011).  
In mammalian cells, integrins comprise 18 α and 8 β subunits (that are known), which 
can assemble to form 24 different receptors (Hynes, 2002). The variety of these integrin 
subunits and their diverse range of known interactions with extracellular components 
make them major players in terms of cell adhesion dynamics, in particular, the role they 
play in facilitating mechanotransduction where force dependent responses brought on by 
sensing mechanical stress is a characteristic particular to integrin receptors (Wang and 
Ingber, 1994, Wang and Ingber, 1995), making them complicit in mechanotransductive 
events. 
These interactions, in turn, have effects on the overall development of the cell as 
physical matrix characteristics such as substrate elasticity or stiffness are conveyed 
through force induced contacts. For example, myocytes are able to survive on substrates 
ranging from relatively soft to hard but only form striated myotubes when cultured on 
substrates bearing mechanical stiffness resembling its native tissue (Engler et al., 
2004b). This cell-ECM interaction also has bearing on the functionality of cells such as 
myocyte contraction (Engler et al., 2004b), neurite branching (Flanagan et al., 2002, 
Saha et al., 2008) and hepatocyte aggregation and albumin secretion (Semler, 1999). 
At the intracellular domain, individual proteins are recruited to the sight of integrin 
adhesion where they are known collectively as a focal adhesion. It is at this point where 
integrins are bridged with the cytoskeleton, the focal adhesion effectively acting as a 
‘signalling sensor’ regulating the extent of tensile strength experienced at the 
transmembrane end (integrin clustering leading to subsequent adhesion strengthening) 
or within the cytoplasmic domain (cytoskeletal contractility) (Kanchanawong et al., 2010). 
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Figure 1-3 Schematic illustrating the transmembrane structure of integrin molecules. 
The image shows an integrin pair in its inactive or otherwise low affinity state and active (high 
affinity) conformation. Activation causes the cytoplasmic α and β subunits to separate 
facilitating docking of early focal adhesion proteins from which a link between the external 
and internal is made via the cytoskeleton. 
 
1.4.2 Focal adhesions 
Focal adhesions are protein clusters that form a macro molecular signalling hub, 
localising with cellular integrins to convey ECM signals intracellularly. Focal adhesions 
recruit a large number of proteins – currently up to 180+ have been identified (Wolfenson 
et al., 2013) to perform this function. The numbers of proteins that interact within a focal 
adhesion suggest that they interpret and regulate a broad range of functions inclusive of 
migration, cell spreading, proliferation, cell cycle and differentiation. 
The diverse functional output means that focal adhesions maintain a state of fluidity 
where they assemble and disassemble at a high turnover rate with regards to the needs 
of the cell (Choi et al., 2008, Yu et al., 2011, Zaidel-Bar et al., 2003, Wolfenson, 2009b). 
The sizes of focal adhesions depend on a number of factors, such as the cluster of 
integrins formed from interaction with the substrate and their current state in 
development as they approach maturity. Nascent focal complexes are small in size (~ 
1μm long) and relatively short lived as they are subsequently subjected to further growth 
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or disassembly (Choi et al., 2008). They are located mainly in the lamellipodia and their 
formation plays an important role in the leading edge of cell migration while focal 
adhesion disassembly occurs at the tail end of the cell resulting in polarisation. Focal 
adhesions by comparison, are larger structures with a longer life span (Beningo et al., 
2001) and is generally characterised by the presence of the protein zyxin, as it is present 
only in mature focal adhesions (Zaidel-Bar et al., 2003). 
The influence of external forces or forces applied by the cell to the ECM via integrins 
induces the growth and eventual maturation of focal adhesions (Figure 1-4). While the 
exertion of force induces focal adhesion maturation, this process is able to take place 
over a tensional gradient (Oakes et al., 2012) suggesting a degree of flexibility in cell 
anchorage. Relative stability and subsequent strengthening of focal adhesions, however, 
is very much dependent on the tensile strength in actin fibres (Alexandrova et al., 2008) 
showing that even in stable focal adhesions, structures are constantly turned over to 
maintain a balanced tensional force in response to external stimuli. A phenomenon that 
occurs on a time scale spanning seconds (Wolfenson, 2009b, Wolfenson, 2009a). 
The network of focal adhesion proteins that interact with cell integrins are classified 
broadly into two groups: a) Structural proteins – these are proteins that are tethered to 
integrins, the cytoskeleton or allow docking for the recruitment of subsequent focal 
adhesion proteins and b) Regulatory proteins – these comprise proteins that are mainly 
associated with signalling and modulating the activity that occurs within the cell such as 
GTPases, kinases and phosphatases. However, like most biological systems, these 
proteins rarely perform a singular function and a degree of overlap exists between both 
classification groups (Zaidel-Bar, 2009, Zaidel-Bar et al., 2007). 
The interaction of α and β integrin subunits with an extracellular ligand brings about a 
change in conformation to its active state separating the cytoplasmic domains of both 
subunits exposing binding sites to allow the subsequent assembly of the adhesion 
network of proteins currently referred to as the adhesome illustrated in Figure 1-5 (Kim et 
al., 2003, Zaidel-Bar et al., 2007). 
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Figure 1-4 Immunofluorescent image of MSCs on glass coverslip showing focal adhesion 
localisation of vinculin. Focal adhesions (shown in green) are observed as small projections 
throughout the cell at the periphery of actin bundles (shown in red). The inset figure shows a 
close up of the cell edge where smaller focal complexes manifest at the periphery of the cell. 
Mature adhesions throughout the cell are larger and elongated in comparison. The cell nucleus 
is also shown in blue. Image courtesy of J. Roberts. Scale bar – 50 µm 
 
The fluidity of a focal adhesion compounded with the large population of adhesome 
proteins associated makes its exact mode of assembly and recycling something of an 
enigma. Nonetheless, focal adhesions have their tell-tale signs and primary constituents 
such as focal adhesion kinase (FAK), Src and paxillin are ever present in an assembled 
focal adhesion.  
Some, but not all focal adhesion proteins are discussed in the following text, the 
examples are used to illustrate the dynamic nature of a focal adhesion initiated through 
the multiple functions and interactions that can be sustained by a single protein molecule. 
It also, perhaps, gives an insight into the increasing complexity brought on by the 
aforementioned 180 strong adhesome population; most, if not all, of which are capable of 
the same functional and structural diversity (Figure 1-5). 
Recruitment of FAK, Src and paxillin are needed prior to tyrosine phosphorylation of FAK 
at the adhesion site initiating ‘activation’ and thus, recruiting further 
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kinases/phosphatases to the adhesion site (Kirchner et al., 2003). FAK, as well as acting 
as a signalling protein, also functions as a docking site for other proteins such as paxillin, 
Src and p130Cas. The presence of FAK within the adhesome plays an important role in 
the static nature of focal adhesions as its inclusion in a focal adhesion is further 
enhanced by autophosphorylation (Kwong et al., 2003).  
Studies in FAK -/- cells have exhibited enhanced focal adhesions and reduced migration 
ability (Ilic et al., 1995), implicating a role in adhesion maturity. Contradictorily, 
phosphorylation of FAK by Src is known to lead to its exclusion from the adhesome (Katz 
et al., 2003). Reasons put forward for this build up and breakdown by phosphorylation 
events is that it is thought to be regulated by the specific tyrosine residue that is subject 
to phosphorylation events ensuring continuous recycling of FAK in and out of a focal 
adhesion (Wozniak et al., 2004) regulating adhesion strength.  
Src acts as a docking protein for FAK and paxillin as well as having catalytic activity on 
binding with FAK. Loss of Src function showed impaired regulation of focal adhesions 
likely through lessened tyrosine phosphorylation events (Cary et al., 2002), implicating 
Src in adhesion co-ordination.  
Paxillin, while exhibiting similar phosphorylation and docking activity, is implicit in the 
activation of small GTPases like Rac, which are active in actin assembly (Lamorte et al., 
2003). FAK, FAK-Src and paxillin bind directly to the cytoplasmic domain of either 
integrin subunit and, in the case of paxillin, inhibit migratory behaviour when bound to an 
α4 subunit (Arias-Salgado et al., 2003, Cooper et al., 2003, Liu et al., 2002). Their 
function as a docking point for other proteins also facilitates an indirect link between 
integrins and the cytoskeleton among other cytoplasmic domains (Kuo, 2013). 
Other focal adhesion proteins within the adhesome, however, provide a direct link 
between integrins and actin filaments. Inclusive of these are filamin, α-actinin and talin. 
All three proteins are known to bind to β integrin (Calderwood et al., 2001, Greenwood et 
al., 2000, Pfaff et al., 1998) as well as being implicated in force sensing and adhesion 
strengthening through integrin clustering (Giannone et al., 2003, von Wichert et al., 2003, 
Yamazaki et al., 2002). Filamin, through integrin-cytoskeletal interactions has been 
shown to modulate cell migratory behaviour (Calderwood et al., 2001) while talin is also 
implicated in protein docking as its presence within a focal adhesion acts as a recruiting 
site for vinculin (Izard et al., 2004). α-actinin is present in nascent focal adhesions 
suggesting a role in focal adhesion genesis as well as maintaining cross-links between 
actin filaments (Greenwood et al., 2000). 
Force induced focal adhesion assembly or disassembly regulates the type of adhesion 
that is eventually adopted (Geiger and Bershadsky, 2002). That is, the size, strength and 
adhesome of a focal adhesion as a mechanosensor act to maintain the isomeric tensile 
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state a cell adopts in conjunction with the mechanics of its microenvironment. The 
formation of focal adhesions in response to mechanical stimulus, inclusive of ECM 
rigidity, has been chronicled in a number of studies (Balaban et al., 2001, Katz et al., 
2000, Riveline et al., 2001). 
 
 
 
 
Figure 1-5 Actin-integrin interconnections formed within a focal adhesion. The 
illustration shows known physical interacts connecting the cell membrane to the cytoskeleton. 
The population comprises transmembrane proteins (green), adaptor proteins (purple 
rectangles), actin modulators (purple ovals) and actin itself at the apex. A chronicle of 
molecules associated with focal adhesions can be found at www.adhesome.org or referring to 
(Zaidel-Bar et al., 2007). Molecules mentioned within this thesis are highlighted in dashed 
ovals. Image adapted from Zaidel-Bar et al., 2007. 
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1.4.3 The cytoskeleton 
The cytoskeleton is an intricately linked network of fibres that radiate throughout the cell 
body. It plays a number of diverse functions within the cell from determining structural 
integrity and withstanding mechanical stresses to facilitating the organisation of the cell 
acting as a scaffold and trafficking system for transport of small molecules. The 
cytoskeleton also plays an important role in relaying feed back to the cell eliciting a 
plethora of adaptive responses that include migration, differentiation and overall 
metabolism. The cytoskeleton comprises three main features known as microtubules, 
intermediate filaments and microfilaments. 
 
1.4.3.1 Cytoskeletal elements 
Microtubules 
Microtubules are hollow filaments made up of polymerized α and β tubulin dimers. 
Structurally, microtubules radiate outwards from the microtubule organising centre 
(centrosome) adjacent to the nucleus toward the periphery of the cell (Figure 1-6A). The 
tubules facilitate the movement of intracellular vesicles and organelles around the cell 
body as well as acting as a central axis during cell division as the mitotic spindle. 
Microtubule polymerisation and depolymerisation is a dynamic process facilitated by GTP 
hydrolysis of both α and β tubulin. As a cytoskeletal component, microtubules also 
regulate cell shape and play an influential role in facilitating cell migration where they 
play a role focal adhesion disassembly (Kirchner et al., 2003). 
 
Intermediate filaments 
Intermediate filaments, aside from being named for size, differ from the other two 
cytoskeletal components (microtubules and microfilaments) in that they are not globular 
assembled filaments but fibrous peptide chains. They are broadly sorted into five 
categories based on their primary peptide sequences. Type I & II comprise acidic and 
basic keratin and are localized in epithelial and hair cells, type III constitute vimentin, 
desmin and glial fibrillary acidic protein (GFAP), type IV are neurofilaments and type V 
are the nuclear lamins. 
Vimentin is the main cytosolic intermediate filament found in cells of mesenchyme 
lineage (Figure 1-6B). Vimentin maintains the mechanical integrity of the cell forming a 
mesh like structure whose cross-link density can by altered in the presence of divalent 
ions (Koester et al., 2010, Qin et al., 2009a, Qin et al., 2009b). For this function, it also 
exhibits a degree of viscoelasticity and dynamism as it undergoes extensive remodeling 
under stress as well as showing varied expression patterns during differentiation and at 
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different stages in cell development (Ivaska et al., 2007). In addition, vimentin serves as 
a scaffold for other cell organelles and maintain membrane traffic inclusive of 
transporting integrins to the cell membrane (Ivaska et al., 2007). 
Lamins are intermediate filaments that are located at the periphery of the cell nucleus 
where, along with their associated proteins, are referred to as the nuclear lamina or 
nucleoskeleton (Figure 1-6C). Lamins provide structural support to the nucleus and 
regulate its shape and mechanical loading. They are also implicated in chromatin 
organisation, DNA repair and in replication and transcriptional activity (Zuela et al., 
2012). Lamins are intricately linked with cytosolic filaments via the LINC (linking nucleus 
to the cytoskeleton) complex (Crisp et al., 2006, Lombardi et al., 2011) providing a 
connection between the nucleus and the external environment, which has profound 
effects on consequential cell behaviour. 
 
Microfilaments (Actin) 
Cytoskeletal microfilaments are made up from polymerised globular actin monomers (G-
actin) to form filamentous actin (F-actin) (Figure 1-6D). Polymerisation of F-actin occurs 
in both directions but at different rates giving rise to fast (+) and slow (-) growing ends 
orientated toward the cell membrane and into the cytoplasm respectively (Begg et al., 
1978, Stossel, 1984) (Figure 1-7B).  
Actin in its globular and filamentous form co-exists in equilibrium. At a critical 
concentration of G-actin, the + end of actin grows constantly while the – end undergoes a 
degree of decay, an effect known as treadmilling (Bonder et al., 1983). Treadmilling is 
ATPase driven brought on from ATP hydrolysis of the conversion of G-actin to F-actin 
(Bonder et al., 1983, Oda et al., 2009). 
The regulation of actin polymerization and depolymerisation is carried out by a number of 
proteins inclusive of villin, cofilin, profilin & gelsolin, which function to keep actin filaments 
of a certain length. Others such as fimbrin & filamin facilitate cross linking of f-actin and 
subsequent formation of filament bundles, while vinculin, talin and α-actinin integrate f-
actin with the cell membrane. The cross linking properties of these proteins are also 
implicated in the formation of stress fibres which are usually a bundle of 10 to 30 actin 
filaments. These assemble to form ventral stress fibres located at the base of the cell and 
attached to focal adhesions at both ends (Figure 1-4), dorsal stress fibres that emanate 
from the cell periphery (anchored to focal adhesions) toward the cell centre and 
transverse arcs located mainly in the lamella. α-actinin cross-linked stress fibres are 
subsequently displaced by myosins, which are intertwined within the filaments. 
Movement or contraction of f-actin is consequently brought about by its association with 
myosins, in particular myosin II.  
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Figure 1-6 Images illustrating cytoskeletal forms. Fluorescence images of β-tubulin for 
localisation of microtubule network radiating from the centrosome (A), of intermediate 
filaments vimentin (B) and lamin B (C) localised within the cell nucleus and actin 
microfilaments (D). Image A was courtesy of J. Roberts, images B & C – P. Tsimbouri and image 
D – Alakpa unpublished data. 
 
Myosin II 
Myosins are motor proteins that play a major role in general cell motility. They occur 
widely in eukaryotic organisms, organized into 24 classes based on their head domain 
sequence and organisation (Syamaladevi, 2012). Myosin II is found mainly in muscle and 
the cell cytoplasm (non-muscle myosin II) where they interact with f-actin fibres 
promoting cytoskeletal contraction and influencing a number of cell functions such as cell 
shape, division, polarization, adhesion and migration (Syamaladevi, 2012, Vicente-
Manzanares, 2009). 
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Non-muscle myosin II (NMM-II) comprises two heavy chains that form a α-helical coiled 
tail, a regulatory light chain that regulates its activity and an essential light chain, which 
forms a complex with the globular actin binding head (Figure 1-7A). Actin contraction by 
myosin II is dependent on ATP hydrolysis where the energy produced by the release of 
an inorganic phosphate drive a conformational change in the actin bound globular 
myosin head resulting in cytoskeletal contraction (Vicente-Manzanares, 2009). 
The regulatory light chain of NMM-II can be phosphorylated by a number of kinases 
triggering activation or inactivation of NMM-II. These are also inclusive of focal adhesion 
GTPases RhoA and Rac, which promote and inhibit NMM-II activation respectively 
(Geiger et al., 2009, Vicente-Manzanares, 2009, Vicente-Manzanares et al., 2009). As 
focal adhesions mature, Rac signalling is modulated and RhoA activation increases 
mediating actin filament formation and increasing NMM-II activity (Beningo et al., 2001, 
Galbraith et al., 2002, Vicente-Manzanares et al., 2009) resulting in enhanced 
actomyosin bundles. The contractile forces generated in these bundles, in turn, exert 
forces on the distal focal adhesions affecting further maturation and adhesion dynamics.  
 
 
 
Figure 1-7 Structural orchestration of non-muscle myosin type II (NMM-II). A) Structural 
domains of NMM-II showing the α-helical coiled rod which ends in a dimerised globular head 
containing an actin binding site adjacent to an ATP motor domain. B) The organisation of 
NMM-II with filamentous actin; an interaction that drives acto-mysin contraction. The α-
helical rods are arranged to form the myosin thick filament allowing the globular head domain 
to bind with actin and facilitate the formation of stress fibres. On binding to actin, ATP 
hydrolysis causes a change in the head domain of NMM-II resulting in filament movement 
(contraction). 
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1.4.4 Cytoskeletal reorganisation in response to external stimuli 
The association of F-actin with the cell membrane through focal adhesion proteins such 
as vinculin and talin means that actin organization throughout the cell is sensitive to 
changes or the activity of membrane bound receptors inclusive of integrins. The 
continuous treadmilling of actin filaments is a constant dynamic process and as such 
affected by the properties of the external microenvironment mediated through these 
receptors, which subsequently brings about changes in cell activity, morphology and 
behaviour (McBeath et al., 2004, Papakonstanti et al., 2000) (Figure 1-8). 
 
 
 
Figure 1-8 Cytoskeletal organisation in response to external stimulus. Fluorescence 
images of the actin cytoskeleton of MSCs undergoing early stage adipogenic differentiation (A) 
and early stage osteogenic differentiation (B). Cells undergoing adipogenesis are rounded and 
actin fibres largely localised at the periphery of the cell body. Cells undergoing osteogenesis in 
comparison are more spread and form thicker stress fibres that span the length of the cell 
(Alakpa, unpublished data). 
 
Exploration of the immediate extracellular space is facilitated by a number of projections - 
the lamellipodia, a broad sheet like extension that is characterized by a rapid turnover of 
focal complexes and actin flow which play a major role in the leading progression of cell 
migration (Alexandrova et al., 2008). And filopodia, which are finger like projections that 
extend beyond the lamellipodium due to the presence of rapid actin polymerisation 
(Pollard and Borisy, 2003). 
Actin filaments associate with a number of proteins that regulate its polymerization, 
depolymerisation and branching processes. Of these Cdc42 actively regulates 
polymerisation in filopodia and Rac in lamellipodia, both of which inherently inhibits 
NMM-II activity while RhoA promotes it, driving acto-myosin contractility and giving rise to 
stress fibres (Burridge and Wennerberg, 2004, Sander et al., 1999). Regulation of these 
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G-proteins is mainly via the activation of a host protein kinases or phosphatases 
regulating phosphorylation states of the cytoskeletal associated proteins. The balance 
created between these three proteins; Rho, Rac and Cdc42 are the main factors that 
drive cell polarisation and migration (Sander et al., 1999), and in cell types such as 
neurons regulate the outgrowth of dendrites (Kuhn et al., 1998, Swetman et al., 2002). 
Mechanosensing however, is based on generating intracellular tensile forces to 
counteract that experienced extracellularly. As such, transductive effects are significantly 
influenced by the contractile properties exerted by the cytoskeleton. 
The importance of the Rho family GTPases in stress fibre formation was initially shown 
by the inability of Vero cells to form microfilaments when treated with clostridium 
botulinum C3, a toxin known to inhibit Rho protein activity (Chardin et al., 1989), as well 
as the observation of increased stress fibre formation when cells are overexposed to 
recombinant RhoA (Paterson et al., 1990). Although all three Rho isoforms (A, B and C) 
are implicated in stress fibre formation (Giry et al., 1995), most research performed 
involves RhoA, which is implicated as the foremost regulator of stress fibre assembly. 
Stress fibre formation and its subsequent contractile activity involves the activity of the 
RhoA downstream effector Rho-associated kinase (ROCK), which directly 
phosphorylates myosin light chain kinase (MLCK) (Amano et al., 1996, Somlyo and 
Somlyo, 2003). MLCK in turn phosphorylates myosin II light chain causing an increase in 
myosin ATPase activity resulting in actin contraction (Katoh et al., 2001). While it is 
known that MLCK can also induce stress fibre contraction in the absence of ROCK 
through its activation by calcium/calmodulin activity, inhibition of ROCK activity leads to 
the disassembly of focal adhesions, actin stress fibres and overall loss of cellular tension, 
indicating that Rho/ROCK mediated activity is important for continuous cell contraction 
that is required for mechanotransduction (Katoh et al., 2001). In addition, ROCK, as well 
as being able to instigate actin contraction via MLCK, also plays a role in regulating this 
function as it is known to indirectly inhibit myosin phosphatase activity resulting in 
sustained contractility (Koyama et al., 2000, MacDonald et al., 2001, Murata-Hori et al., 
1999).  
The cytoskeletal organisation and contractile strength generated dependent on the 
mechanical properties, as previously mentioned, affects overall adapted cell morphology. 
Morphological changes brought on by differences in cellular tension have been shown to 
act as a regulator of cell differentiation lineages. For example, studies done using mice 
which were p190B Rho GTPase activating protein negative (RhoGAP -/-); a suppressor 
of RhoA activity had shown impaired adipogenesis (formation of low tensile state cells) 
and enhanced myogenesis (Sordella et al., 2003). Similarly, inhibition of NMM-II in MSCs 
blocking actin contractility was shown to affected adopted differentiation lineages (Engler 
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et al., 2006). Cytoskeletal contractility therefore plays an important role in cells ‘sensing’ 
their matrix properties, having significant consequences with regards to directing stem 
cell differentiation in vitro (Engler et al., 2006, McBeath et al., 2004, Wozniak et al., 2003, 
Bhadriraju et al., 2007, Kilian et al., 2010). 
 
1.4.5 Nuclear deformation due to mechanical stress 
Observed differences in the rate of cell division in fibroblast cells when mechanical stress 
was applied suggested that mechanical stresses or loading is able to affect the nuclear 
activity of cells (Curtis and Seehar, 1978). Reorganisation of the cytoskeleton, nucleus 
and its nucleoli in the direction of an applied tensional force, through manipulation of 
microbeads attached to the cell surface, confirmed an innate link between the cell 
surface actuators and the cell nucleus (Maniotis et al., 1997). As nucleoli occupy specific 
spatial locations, reorganisation brought about by mechanical forces is thought to affect 
gene regulation, associating biophysical cues as causality for gene expression. While it is 
known that the nucleus of a cell is generally stiffer than the cytoplasmic space suggesting 
greater propensity for resistance to mechanical stress, small displacements on the cell 
surface are still significantly ‘felt’ at the nucleus causing a degree of distortion, a 
phenomenon that is dependent on the pre-stressed levels of the cytoskeleton (Hu et al., 
2005). This, in addition to the time dependent changes in actin reorganisation, chromatin 
assembly and nuclear translocation of cytoskeletal associated cofactors (Iyer et al., 
2012), suggest that the feedback mechanism is highly sensitive and does not simply rely 
on general microenvironmental pressures but active input by the cell itself. 
Indeed, changes in cell and nuclear morphology due to adaptation of biophysical cues 
have subsequently been shown to have an effect on cellular transcription turnover and in 
turn protein translation altering cell behaviour (Dalby et al., 2003, Prajapati et al., 2000, 
Dalby et al., 2007a, Dalby et al., 2007b, Gupta et al., 2012). 
Such sensitive propagation of mechanical stimulus to the nucleus is thought to occur via 
the LINC proteins nesprin and SUN as well as their associated adaptor proteins, which 
traverse the perinuclear space of the nuclear envelope providing a bridge between the 
cytoskeleton and nuclear lamins (Crisp et al., 2006, Lombardi et al., 2011, Padmakumar 
et al., 2005). As such, changes in cytoskeletal tension, contractility and reorganisation as 
instigated from integrins at the cell-ECM interface can alter states in gene expression 
and effect changes in cell behaviour. 
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1.5 Cell phenotype as a consequence of metabolism 
1.5.1 Metabolites as a reflection of organism physiology 
According to the National institute of Health, metabolism is defined as a physical or 
chemical process that converts or uses energy. A metabolite is therefore any substance 
that is produced as a result of metabolism. These compounds encompass a diverse 
range of physical, chemical and structural properties carrying out numerous functions 
within the body. For this reason, it is not surprising that metabolism and metabolites are 
generally at the forefront in most research and diagnostic applications, as anomalies in 
known metabolic patterns are often a very telling sign in gauging an individuals’ health 
status. A classic example of this is glucose concentrations for monitoring and diagnosis 
of diabetes mellitus, urine pH tests for kidney function and alkaline phosphatase for liver 
function. With the latter two examples, the biomarkers focused on to assess organ 
function are generally proteins but it is also their metabolic activity that contributes to the 
malaise. 
The body’s ability to metabolise any given compound is also of considerable importance 
in the field of drug design, screening and toxicology. Often, the potency of a particular 
drug is dependent on the rate and manner in which the body acts on a particular drug 
(pharmacokinetics). Administered drugs need to have the ability for the body to neutralise 
and excrete the substance to prevent accumulation and toxification. This is an inherent 
process that is not only restricted to administered drugs but a broad acting process that 
maintains stasis and keeps the system going or allowing it to adapt to change. 
Metabolic behaviour, however, is not an isolated process and from the examples 
mentioned above it is very much an interactive process with the external environment. As 
such the so-called stasis a system achieves is very much influenced by the state of its 
immediate surroundings and how they affect it. While in some cases the effect is 
transient or malady as those seen with drug screening and diabetes, in others it can 
bring about change in physiology, adapting to exist within a changed environment. This 
leads to divergence in metabolic character between individuals where certain stresses 
can be handled without any due effects in one person but another can result in severe 
repercussions. An example of this can be seen in human polymorphism of the 
cytochrome P450 enzyme 2D6 (CYP2D6) that metabolises codeine into morphine. 
On a cellular level, however, metabolites and metabolism create a similar effect in terms 
of maintaining cell stasis or altering cell states for adaptability. These changes, however, 
occur on a much quicker time scale and activity is influenced by subtler environmental 
changes such as topographical detail and substrate rigidity in addition to chemical 
composition. These environmental properties existing at the nano- and microscale are 
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known to have diverse effects metabolic processes resulting in cell migration, growth, 
adhesion, proliferation and differentiation 
In an analytical context and within this thesis, metabolites as measured using a 
metabolomics study is defined as the range of detectable small mass molecules (70 – 
1400 Da) within a study sample. 
 
1.5.2 Metabolomics 
In terms of an analytical approach, metabolomics has been referred to as a non-biased 
identification and quantification of all metabolites present within a biological system 
(Fiehn, 2002). Due in part, to the infancy of metabolomics, an exact execution of this is 
limited by the available analytical techniques against the range of metabolites that are 
produced by a cellular organism which vary widely in their physicochemical, functional 
and structural properties. Metabolomics in the aforementioned sense has been argued 
as too vast and varied a task to be actualised in reality and so proposals are put forward 
to define it as the study of the metabolome under a given set of physiological conditions 
(Hollywood et al., 2006, Villas-Boas et al., 2005). As such, given the amount of debate on 
defining metabolomics, these criteria often coincide with studies referred to as 
metabonomics, albeit individual authors make their distinctions. Titling a study as either 
metabolomics or metabonomics is seemingly influenced to a degree by personal opinion 
rather than the application of stringent qualifying criterion. 
The metabolite composites of a system are generally the substrate or product of active 
protein components, mostly through enzymatic activity. They are therefore considered to 
be downstream of the full protein compliment of a cell. As such, they are placed 
downstream in the ‘omics hierarchy (Figure 1-9). They also occupy this space due to the 
effect the metabolome represents in comparison to the genome or proteome for 
example. The metabolome represents the actions performed by a cell and is therefore a 
definitive snapshot of what process or processes have occurred. In this manner, it is less 
speculative than studying the other ‘omics sectors. 
Study of the metabolome, however, has the added complexity in the sense that, the 
metabolome is not only a result of gene expression and protein activity but also acts as a 
regulatory system, which in turn influences gene expression and protein activity. As such, 
because metabolites are not simply an end point or product, the metabolome has the 
potential to give information on processes that have occurred in the cell due to its 
interaction with external stimuli, and on the flipside, it also gives an insight to its influence 
on activities that may also alter or continually drive/inhibit a particular cell behavioural 
process. This unique position as an entry/exit point means that the metabolome is closely 
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reflective of the physiology or phenotype of the cell or organism at that particular point in 
time. 
 
 
 
Figure 1-9 Simplified schematic illustrating the cellular functional lineage. Each stage 
produces a full complement of classified molecules (suffixed –ome as indicated on diagram) to 
which their study is dedicated (suffixed –omics). This starts at the genome for genes through 
their expression (transcriptome), translation (proteome) to inherent activity (metabolome). 
This process is in no way singular however, as each stage provides regulatory feedback to the 
other. 
 
In this sense, the metabolome and the proteome bear the analytical advantage in that 
their makeup is particularly sensitive to the context in which the cells are placed. That is, 
their makeup is far more sensitive to changes in their microenvironment. This close 
proximity to altering events at the interface means that activity that occurs at this scale is 
highly dynamic. Compared to the genome and its transcription, where processes are 
relatively inflexible, proteins are subject to a number of post translation modifications 
altering structure and function. Activity by most proteins requires initiation of an ‘on 
switch’ (usually by phosphorylation), an action which is not gene regulated but for the 
most part is brought on by the affectations of cellular metabolites. The resultant 
sequestering, depletion or synthesis of metabolites also depend on a number of outwith 
factors such as enzyme specificity, kinetics and the effect they ultimately have on the 
cells regulatory mechanisms (Higuera et al., 2012, Khan and Sheetz, 1997, Wolfenson et 
al., 2011). 
Metabolome: the full 
complement of metabolites.
What has occurred
Proteome: the full 
complement of proteins.
What may occur
Transcriptome: the full 
complement of RNA 
molecules transcribed by a 
cell
Genome: cellular blueprint
CELL NUCLEUS
CYTOPLASMIC SPACE
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A lot of activity at this level is also non-dependent on gene transcription taking its cue 
from the cells own intricate signalling system to regulate intracellular activity. This allows 
for reaction time turnover to occur at rates of milliseconds in response to stimuli rather 
than over longer time scales (Oakes et al., 2012, Wolfenson et al., 2011). Non-gene 
dependent cell activity that rely on such feedback processes which can then eventually 
lead to gene expression are inclusive of focal adhesion turnover and cytoskeletal 
contractility which have been discussed earlier in this chapter. 
Metabolomics requires the integration of a number disciplines (inclusive of biological, 
chemistry, computational and mathematical) to realise its definition. Even if you are of a 
pedantic disposition, and do not necessarily agree with the commonly used definition as 
the analysis of the full complement of metabolites within a system, it is clear, however, 
that this very analogy drives the continued evolution of the methods geared specifically at 
studying the metabolome. The broad net cast for metabolite information means that 
metabolomics itself demands methods and techniques with the capability of reflecting 
what is caught in the net, so to speak. For this reason, amongst others, nuclear magnetic 
resonance (NMR) and mass spectrometry (MS) have become the more popular means 
of metabolite detection. While NMR is able to perform broad range detections, its 
lessened sensitivity makes MS the more attractive option. The flexibility of MS not only 
allows molecular detection by direct infusion (DI-MS) but it can also be coupled with a 
number of separation techniques for quantification such as capillary electrophoresis (CE-
MS), gas chromatography (GC-MS), liquid chromatography (LC-MS) and supercritical 
fluid chromatography (SFC-MS). 
Because this type of study inevitably provides a large amount of data for any one 
experiment, or indeed sample, computational analysis then becomes the workhorse of 
metabolomics in order to transform raw data into an understandable and user friendly 
format that allows meaningful assessments to be made. 
 
1.5.3 A place in regenerative medicine 
From wound healing to organogenesis, an understanding of cell interactions with its ECM 
and their elicited responses to specific cues is an important factor in tissue engineering. 
A first step towards these goals however, requires an understanding of cell interactions 
on a much smaller scale. 
While it has been shown that cytoskeletal and morphological reorganisation leads to 
signalling events that inhibit or initiate a number of cell functions inclusive of 
differentiation (Bhadriraju et al., 2007, Engler et al., 2004a, Ingber, 1991, Kilian et al., 
2010, McBeath et al., 2004), most of the small molecule biochemistry that facilitates 
Chapter I – General introduction 
 
 
 
32 
mechanotransductive effects are lesser known. A single event may be able to access 
behavioural changes within a cell but a single event altering a single signalling route is 
rarely the case with regards to holistic cell events. 
One such means of gaining an insight into the entire orchestration is to make use of a 
metabolomics based approach to investigate the whole over the individual. In other 
words, to gain an understanding of how molecular interactions carried out within the cell 
occurs in response to their microenvironment resulting in a singular specific behaviour 
such as migration, growth, proliferation and differentiation. 
Of recent, a number of studies, such as the investigation of the influence of unsaturated 
molecules on embryonic stem cell pluripotency (Yanes et al., 2010), topographical 
maintenance of MSC phenotype (McMurray et al., 2011) and identification of biochemical 
signalling pathways that affect differentiation (Tsimbouri et al., 2012) have all made use 
of metabolomics to support their findings. These examples highlight the increasing role(s) 
the metabolome and metabolomics plays in furthering cell and tissue engineering. 
Lastly, it is also worthy of mention that while metabolomics can provide a broad insight 
into cell activity, it is still confined to the restraints of its definition. In order to understand 
cell behaviour wholly, the integration of genomics, transcriptomics, proteomics and 
metabolomics is a necessity.  
 
1.6 Project aims/objectives 
The cell-material interface is known to have considerable effect on stem cell function and 
differentiation properties. These interactions are inclusive of the material chemical 
properties through surface functionalisation using functional groups such as alcohols, 
peptide motifs or the use of whole proteins to coat or pattern surfaces (Bhadriraju and 
Hansen, 2002, Kilian et al., 2010, McBeath et al., 2004), nanotopographical detailing 
through lithography or embossing processes (Bettinger et al., 2009, Biggs et al., 2009, 
Chen et al., 1998) and variation in the elasticity or stiffness of the material which can be 
tuned through manipulation of ligand cross-linking (Engler et al., 2006, Saha et al., 2008). 
The design of materials for targeted differentiation of stem cells aim to fulfil a number of 
requirements inclusive of its ease of manufacture and implementation, ability to support 
cell adhesion and expansion as well as acting as an instructional tool to direct 
differentiation, ideally producing a homogenous cell population.  
This project assesses the use of hydrogel biomaterials made using self-assembling N-
terminal capped (Fmoc) peptides (diphenylalanine and serine, F2/S) as an instructional 
tool for driving stem cell differentiation through fine tuning of the relative elasticity of the 
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hydrogels to mimic that of naturally occurring tissue types as previously shown (Engler et 
al., 2006), (Chapter 2). 
The comprehensive investigation of cell activity such as gene and proteomic expression 
have allowed the discovery of a number of gene and protein level expressions that are of 
particular relevance to stem cell biology. These include genomic sequences correlating 
to histone methylation as a regulatory mechanism in embryonic stem cell pluripotency 
which are distinct from their differentiated progeny (Azuara et al., 2006). Graumann et al 
also showed that these changes in chromatin states correlated with changes in protein 
expression profiles in ES cells (Graumann et al., 2008). Although these represent 
important findings in researching stem cell pluripotency, it is known that due to post 
translational modifications and altered activity states, gene expression and protein 
expression do not provide a complete insight into how a cell adapts and controls it 
altered phenotype (Gygi et al., 1999).  
Metabolites, on the other hand, offer an insight into the protein activity of cells bypassing 
the ambiguity brought on through altered protein states and reflect function over mere 
expression. The metabolites represent a snapshot of the cell in its currently active state 
and therefore its current phenotypical state. Studies have shown measured altered 
metabolic states that characterise the pluripotent state of stem cells (McMurray et al., 
2011, Tsimbouri et al., 2012, Yanes et al., 2010). The use of mechanically tuned F2/S 
biomaterials has the ability to alter the conformation adopted by a number of biochemical 
molecules under differential stress states, in turn altering their kinetics (Ingber, 2006, 
Khan and Sheetz, 1997). This alteration in kinetics and activity states are likely to have 
an effect on the overall metabolic states of the cell(s) driving change such as 
differentiation in stem cells. This being the case, investigating the global metabolome of 
stem cells under such stresses can give an insight into altered cell activity, which lead to 
adoption of different phenotypes on differentiation. A facet, which is explored in this 
project (Chapter 3). 
The use of a global unbiased metabolomics study to investigate stem cell behaviour 
inevitably gives information on a host of naturally occurring molecules that exist within 
the cell which may be implicated in signalling events leading up to differentiation. This is 
considered possible as the cells are coaxed into differentiation using the biomaterial 
elasticity as the sole instructional tool leaving the system free from chemical interference 
(use of tailor made differentiation media). From the information garnered, metabolites 
that are likely to play an influential role in driving differentiation were singled out and 
investigated in further detail under the hypothesis that currently experienced problems 
such as population heterogeneity observed with synthetic chemicals used in in vitro 
differentiation protocols (Bujalska et al., 2008, Ding and Schultz, 2004, Klemm et al., 
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2001, Zuk et al., 2001) can be reduced by researching the effect of lesser known 
metabolites or small molecules on differentiation (Chapter 4). 
The project concludes by encompassing the study scope (stem cell biology, metabolism 
and material interactions) and focusing on potential applications in regenerative medicine 
as well as looking into the efficacy of substrate tuned biomaterials to be used as an 
instructional differentiating tool toward a singular cell line. Chapter 5 investigates the 
ability of F2/S hydrogel biomaterials to act as means of optimising chondrogenic 
development of pericyte cells in vitro in the longer term for use in cartilage tissue 
engineering either for use as a cell source or as a potential transplant material.  
 
Summary of project objectives 
 Ascertain the suitability of F2/S hydrogels as a substrate for cell culture 
and the ability of the substrate to guide MSC differentiation along a 
number distinct cell lineages based on their mechanical properties  
 To investigate whether the use of an unbiased metabolomics study is 
able to distinguish between different behavioural patterns as MSCs 
undergo differentiation on the F2/S substrates 
 To make use of a metabolomics based approach to investigate the 
effect or role of lesser known or researched metabolites may have in 
inducing or guiding lineage commitment on differentiation. 
 To combine biomaterial design and metabolomics as an exploratory 
tool for the potential use of F2/S as a clinical scaffold for use in cartilage 
regeneration and repair. 
 
  
 
 
 
2 MSC DIFFERENTIATION USING PEPTIDE HYDROGEL 
SUBSTRATES WITH TUNED MECHANICAL PROPERTIES 
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2.1 Introduction 
2.1.1 Substrate mechanics & stem cell differentiation 
While the mechanics of a substrate is known to affect the physical qualities of specialised 
cell types, in stem and progenitor cells, these physical states have a large influence on 
lineage commitment whilst driving differentiation. Naturally, these observed effects have 
garnered much interest in the way that biomaterials are designed and developed for use 
in regenerative medicine (Engler et al., 2006, Gilbert et al., 2010). 
For example, the relative deformability or elasticity (measured as the Young’s modulus in 
the unit Pascal) of tissue types within the human body show considerable variation from 
the soft adipose and brain tissue with a Young’s modulus of around 1 kPa (Elkin et al., 
2007) at one extreme to the less flexible likeness of calcified bone at the opposite 
extreme measuring in the range of 6 – 10 GPa (Discher et al., 2005, Reilly and Burstein, 
1974). These qualities bear considerable importance to tissue functionality and 
specialised cells housed within these niches are adapted to exist as such. Stem cells, 
having the propensity to form a number of any of these specialised cell types that exist 
within these very different niches need to be able to interpret the mechanical properties 
of the extracellular matrix in order to undergo development into a fully functional 
specialised cell type.  
As part of the cohort to reduce the occurrence of randomised events or spontaneous 
differentiation in vivo that can be observed with the formation of teratomas for example, it 
is considered that physical characteristics of the ECM inclusive of its elastic properties 
have substantial influence on inherent tissue assembly and functionality (Evans et al., 
2009, Krieg et al., 2008, Rozario et al., 2009). In order to maintain such organisation, 
cellular sensing of changes in ECM stiffness is mediated through a constant cycle of 
mechanosensing and responses mediated through focal adhesions that generate 
intracellular cytoskeletal tensional states (Choquet et al., 1997, Yamada and Geiger, 
1997). 
Increased intracellular tension resulting from cells cultured on substrates able to 
withstand high cytoskeletal contractility have been shown to influence changes in broad 
signalling events culminating in the up regulation of transcription factors such as RUNX-2 
and bone morphogenic proteins leading to the osteogenic development of MSCs cultured 
on these substrates (Engler et al., 2006). 
On the other hand, MSCs cultured on deformable substrates mean that less tension is 
generated within the cell, modulating contractility and in turn influencing certain physical 
characteristics such as cell morphology and spreading. These changes are also related 
to the expression of transcription factors such as peroxisome proliferator-activated 
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receptor gamma (PPAR) and neuronal cell adhesion molecule 1 (NCAM1) associated 
with the development of cell types associated with the softer adipose and neuronal tissue 
types respectively (Engler et al., 2006, Kilian et al., 2010, McBeath et al., 2004, 
McMurray et al., 2011, Tsimbouri et al., 2012). 
As well as influencing the production of particular transcription factors that promote the 
formation of certain cell types, the optimised functional state of the cell(s) are also 
affected by their native tissue physical characteristics. For example, studies have shown 
that neural cells survive better with cultured in vitro on soft substrates as opposed to 
more rigid surfaces (Flanagan et al., 2002, Saha et al., 2008) and optimal differentiation 
of MSCs into naïve osteoblasts occurs when cells are cultured on substrates that 
measure a Young’s modulus of approximate 40 kPa, an elasticity measurement that is 
similar to non-mineralised bone tissue (Engler et al., 2006, Place et al., 2009, Rowlands 
A., 2008, Trappmann et al., 2012, Wang et al., 2012). 
In addition, studies involving differentiation along the myocardial route not only echo the 
trends of the previously mentioned examples (Engler et al., 2008, Engler et al., 2006), 
but also noted that increased functionality is also due to an innate mechanical coupling of 
the cells mechano-sensory adhesions to that of its surrounding microenvironment 
(Hoerning et al., 2012).  
In light of these, the importance of designing biological mimics for cell culture needs to 
take into consideration the manner in which cells ‘feel’ and response to certain cues, 
making the mechanical integrity of the substrate a highly important factor with regards to 
guiding specific behavioural responses in vitro. 
 
2.1.2 The substrate  
Preceding sections in this thesis have highlighted the importance substrate mechanics, 
specifically elasticity, have on eliciting particular behavioural responses in stem cells. The 
influence of which is such that mechanical substrate properties can promote phenotypical 
changes rather than resort to use of soluble factors and chemical formulations (Curtis 
and Wilkinson, 1997, Engler et al., 2006). 
Hydrogels, in a general context, are cross-linked polymer networks of which water is the 
main dispersion media. They represent an excellent biomaterial choice as they offer 
flexibility - being able to incorporate a host of different chemistries and topographical 
design. Also, their high hydration and viscoelastic property renders their make up very 
close to that of native tissue. The given ability to mimic the latter property means that cell 
behaviour on these biomaterials is a close approximation of their in vivo likeness 
(Discher et al., 2009). 
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The use of supramolecular hydrogels have of recent allowed the formation of 
biomaterials with flexible elasticity, nanoscale features and simple chemical 
functionalisation (Benoit et al., 2008, Jayawarna et al., 2009), which are of particular 
importance to cell interpretation. The added quality of these biomaterials to self-
assemble is also of the advantage in the sense that contamination issues from external 
handling during fabrication is eliminated. 
This project makes use of short chain self-assembling peptides to comprise a hydrogel 
biomaterial. The primary function of the material is to direct lineage commitment on 
differentiation by cell interpretation of the biomaterial mechanical properties as the sole 
instruction. Prof R. Ulijns group at Applied Chemistry at the University of Strathclyde 
have developed the hydrogel biomaterials used for this thesis. 
 
Short chain peptides capped at the N-terminus with a 9-fluorenylmethoxycarbonyl moiety 
(Fmoc) have been shown previously to have the tendency to form hydrogels through 
formation of filamentous micelles (Vegners et al., 1995) that also have the ability to 
undergo liquid-solid phase transitions by tailoring pH and temperature (Tang et al., 2009, 
Zhang et al., 2003b). Specifically, Fmoc capped diphenylalanine (Fmoc-F2) is known to 
form cytocompatible hydrogels at physiological pH, which are formed by π-π stacking 
between aromatic groups (Jayawarna et al., 2006, Smith et al., 2008, Tang et al., 2009, 
Zhou et al., 2009). This interaction also enables the use of small peptide molecules to 
impart functionality to the hydrogel (Jayawarna et al., 2009). 
The substrate used within this project comprises the short chain peptides Fmoc-F2 in 
equimolar concentrations with Fmoc-Serine (Fmoc-S). This results in a nanofibrous 
hydrogel with surfactant properties (F2/S). As separate entities, Fmoc-F2 forms 
nanofibres in solution while Fmoc-S form aggregated spheres. In conjunction with one 
another, the fibres remain present in solution while the aggregates are lost as Fmoc-S 
acts as a surface coating, imparting functionality to the resultant structure (Figure 2-1). 
The physical characteristics of hydrogels can be controlled in a number of ways, through 
careful manipulation of factors such as temperature, pH and concentration. The changes 
of which facilitate the extent of fibre formation as well as influencing the cross linking 
capabilities of the polymer resulting in elasticity variability. 
The Youngs’ modulus or rigidity of the F2/S hydrogels have been tailored successfully 
through either sole manipulation of the peptide solution pH or in conjunction with careful 
management of F2/S concentrations within the solution which give rise to the hydrogels 
finished characteristics (Figure 2-2). 
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Figure 2-1 Components of self-assembled peptide hydrogel, F2/S. (A) Chemical structures 
of Fmoc-diphenylalanine (F2) and Fmoc-serine (S); the peptide moieties are highlighted as that 
within the dashed enclosure. (B) Illustration of the proposed interaction between Fmoc-F2 and 
Fmoc-S when together in solution. (C) AFM images of Fmoc-F2, Fmoc-S and 1:1 F2/S. Images B 
& C were kindly provided by R. Ulijn. 
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Figure 2-2 Characterisation of F2/S hydrogels. Oscillatory rheology analysis of F2/S 
hydrogel stiffness fabricated by tailored concentration (A) and pre-gelation pH manipulation 
of a 20 mM F2/S solution (B). Approximate modulus of 10mM and pH 7.2 is 2 kPa, 20mM and 
pH 7.9 is 7 kPa and 40mM and pH 8.4 is 36 kPa respectively. TEM and SEM images of pre-
gelation solutions are shown in (C) & (D) respectively. Images were kindly provided by V. 
Jayawarna and R. Ulijn. 
 
2.1.3 Objectives 
This study aims to answer a number of questions that deal with biomaterial properties on 
the behavioural patterns of mesenchymal stem cells. In the first instance, it shows that 
the F2/S substrate supports cell attachment and growth and as such is a suitable material 
for cell culture. Secondly, to show that mesenchymal stem cells cultured on F2/S 
hydrogel biomaterials at differing elasticity instruct these cells to undergo differentiation 
into specialised cell types. Thirdly, to ascertain what differentiation lineages are adopted 
by the stem cells on each of the substrates and whether these lineages are particular to 
those of innate tissue types as observed in previous studies.  
C
pH 7.2
pH 7.9
pH 8.4
D
A B
10 mM 20 mM 40 mM
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2.2 Materials & methods 
2.2.1 Materials 
Materials/reagents Supplier(s) 
Human bone marrow mesenchymal stem cells Promocell GmBH, Germany. 
Fmoc-diphenylalanine Bachem, UK 
Fmoc-serine Bachem, UK 
Sodium hydroxide Fisher chemicals, UK 
Water Invitrogen, UK 
Dulbeccos modified eagle medium (DMEM) Sigma Aldrich, UK 
Foetal bovine serum (FBS) Sigma Aldrich, UK 
Penicillin streptomycin Sigma Aldrich, UK 
Trypsin Sigma Aldrich, UK 
Calcein acetoxymethyl ester  Invitrogen, UK 
Propidium iodide Vector laboratories, USA 
Phosphate buffered saline (PBS)
*
 In-house 
Fixative
*
  In-house 
Permeability buffer
*
 In-house 
1% BSA in PBS
*
 In-house 
Vectashield-DAPI Vector laboratories, USA 
Rhodamine-phalloidin Invitrogen, USA 
Primary antibodies 
Abcam, UK & Santa Cruz 
biotechnologies, USA 
Biotinylated secondary antibodies Vector laboratories, USA 
Streptavidin-FITC Vector laboratories, USA 
0.5% Tween 20 in PBS
*
 In-house 
Trizol Life technologies, UK 
Chloroform Sigma Aldrich, UK 
Glycoblue Ambion, UK 
Isopropanol Sigma Aldrich, UK 
Ethanol VWR Chemicals, France 
RNase free water Qiagen, UK 
Quantitech reverse transcription kit Qiagen, UK 
Quantifast SYBR green PCR kit Qiagen, UK 
 
                                               
* Preparation procedures for reagents & buffers made in house are detailed in the appendix 
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2.2.2 Cell culture 
Human mesenchymal stem cells obtained from purified bone marrow were cultured and 
maintained at 37˚C and 5% CO2 atmosphere in DMEM culture media supplemented with 
100 µM sodium pyruvate, 0.8 mM L-glutamine, 10% foetal bovine serum (FBS) and 1% 
of penicillin streptomycin (10 mg/ml solution) of the total volume. This supplemented 
DMEM culture mix was used for all cell culture procedures unless defined otherwise. 
Cells were sub-cultured when approximately 80 – 90% confluent by incubating with 
trypsin for approximately 5 minutes to detach the adherent cells from the culture flask. 
The action of trypsin was then halted by the addition of an equal volume of culture media 
and the resulting cell suspension transferred into 20 ml flasks and centrifuged for 5 
minutes at 1400 g to sediment the cells. The trypsin/media supernatant was then 
decanted to waste and the cells resuspended in an appropriate volume of fresh media 
(cell numbers used in subsequent experiments were maintained between 1 and 2 x 105 
cells unless otherwise stated). Cells were then either seeded into another culture well 
flask and allowed to grow confluent as the subsequent passage or used for pending 
experiments. Cells used for all ensuing experiments were between passage 1 and 3 and 
media changes were performed twice weekly. 
 
2.2.3 Substrate fabrication 
Prior to use, all compounds were sterilised under ultraviolet light for 40 minutes. 0.0214 g 
of peptide powders Fmoc-diphenylalanine and 0.0138 g of Fmoc-serine (Bachem Ltd, 
UK) were weighed and dissolved in 4 ml distilled water and 0.5 M sodium hydroxide 
(Sigma-Aldrich, UK) by alternate sonication and vortexing to make a 20 mM Fmoc-
diphenylalanine/serine (F2/S) peptide solution. The end physical characteristic (rigidity) of 
the resulting hydrogel was varied by altering the pH of each peptide solution with sodium 
hydroxide. The rigidity, expressed as the Young’s modulus of the hydrogel and pH of 
each peptide solution as determined from previous optimisation experiments, is shown in 
Table 2-4.  
The dissolved peptide solutions were then incubated at 4˚C for a minimum of 1 hr before 
being warmed to 37˚C in a water bath or incubator. Hydrogels were made by dispensing 
0.3 ml of each peptide solution into a 12-well culture plate insert and 1.4 ml of DMEM 
culture medium dispensed into the well itself so that the media comes in contact with the 
membrane at the base of the insert. The culture plates were then incubated at 37˚C for at 
least 1.5 hrs to allow hydrogel formation. Following incubation, the culture medium in 
each well was decanted to waste and replaced with fresh medium. 0.2 ml of culture 
medium was then added onto the formed hydrogels in the well inserts. The culture plate 
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was then returned to incubate at 37˚C overnight to allow the gels to equilibrate to 
physiological pH for cell culturing. 
 
2.2.3.1 Cell culture using F2/S hydrogels 
Human bone marrow mesenchymal stem cells expanded in cell culture flasks were 
detached from the flasks by incubating with trypsin for 3 – 5 minutes and then quenching 
by the addition of culture media after time had elapsed. The tripsinised cell-media mix 
was centrifuged for 4 minutes at 1500 g to pellet the cells from the culture medium and 
the supernatant decanted to waste. The pellet was re-suspended in an appropriate 
amount of cell culture media to give a cell number of approximately 2 x 105 cells per ml.  
The medium in the well insert holding the hydrogels was carefully aspirated to waste and 
0.1 ml of the cell suspension was added onto the hydrogel. 1.4 ml of DMEM was added 
to the culture well plate and the samples incubated for 2 hours to allow cell adherence. 
Following this, the media on each hydrogel was carefully removed and replaced with 0.3 
ml of fresh media. The media within the wells were also replaced during this time. Cells 
were then maintained at 37˚C and 5% CO2 atmosphere changing the media twice weekly 
until required for assay. 
 
2.2.4 Cell viability 
Cell viability was assessed using the fluorescent dyes calcein acetoxymethyl ester 
(calcein AM) and propidium iodide (Invitrogen, UK). 
Calcein acetoxymethyl ester is a non-fluorescent compound that is cell permeable. On 
transportation into cells, the acetoxymethyl group is cleaved by cellular esterases 
causing the resulting molecule (calcein) to give off a strong green fluorescence signal 
(ext/em 495/515) indicating an active cell population. Propidium iodide is a membrane 
impermeable dye that binds to nucleic acids to give a red fluorescence. Cells emitting red 
fluorescence therefore have compromised cell membranes and are thus considered 
dead. 
Culture medium was carefully aspirated from each culture well and from the well inserts 
holding the hydrogels then decanted to waste. Hydrogel discs were then removed from 
the insert and placed into clean well plates. 0.4 ml of a solution containing 2 μM calcein 
AM and 2 μM propidium iodide in phosphate buffered saline (PBS) was added to each 
well and then allowed to incubate at 37˚C in the dark for approximately 25 minutes. 
Fluorescence microscopy images of live and dead cells were taken on days 1, 3 and 7 of 
culturing to ascertain viable cell populations on the hydrogels. 
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2.2.5 Immunocytochemistry 
Cell samples or material substrates were rinsed once in PBS and fixed at 37˚C for 15 
minutes. They were then permeabilised and blocked using 1% BSA in PBS. Following 
this, cells were then incubated at 37˚C for an hour with rhodamine conjugated phalloidin 
and the required primary antibody (Table 2-1). After 1 hr, cells were washed three times 
for 5 minutes with 0.5% tween in PBS (cells cultured within substrates were washed for 
15 minutes to ensure removal of excess antibody from the hydrogels) and incubated for 
an hour at 37˚C with the corresponding secondary antibody. Cells were again washed 
thrice with 0.5% tween in PBS as required, incubated at 4˚C for 30 minutes with 
streptavidin conjugated FITC and washed again as before after the incubation time 
elapsed. 
Samples were then mounted onto a drop of vectashield-DAPI (a glycerol based mounting 
medium for preserving fluorescence containing DAPI for nucleic acid staining) on a 
microscope slide. For biomaterial substrates, vectashield-DAPI was diluted in PBS and 
added to the well plates. All samples were stored at 4˚C wrapped in foil to protect from 
photobleaching until ready for viewing under a microscope. 
 
Table 2-1 Biomarkers used for detection of cellular differentiation 
Differentiation 
lineage 
Biomarker Primary antibody 
Secondary 
antibody 
Fluorophore  
Neurogenesis Nestin 
Mouse 
monoclonal IgG 
Biotinylated anti 
mouse 
Stretavidin 
conjugated FITC 
Adipogenesis PPAR-γ 
Goat polyclonal 
IgG 
Biotinylated anti 
goat 
Myogenesis MyoD 
Mouse 
monoclonal IgG 
Biotinylated anti 
mouse Osteogenesis RUNX-2 
Chondrogenesis SOX-9 
Cytoskeleton F-actin   
Phalloidin 
conjugated 
rhodamine 
Nucleus    DAPI 
 
2.2.6 Microscopy & Imaging 
Epifluorescence and phase contrast images were taken using an inverted Axiovert 200 
microscope (Carl Zeiss, Jena, Germany) equipped with a charge coupled devive (CCD) 
camera (QImaging, Canada).  
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Greyscale fluorescence images obtained using ImagePro software were converted to 
RGB format and coloured overlays made using Adobe Photoshop Creative Suite (Adobe 
Inc. Ireland), version 8.0 to reflect the fluorescence colour emission of the fluorophores 
used in experiments (Table 2-2). 
To represent scale, 1000 μm rule images were taken using the appropriate objective 
lens. Number of pixels was then converted into the equivalent distance in µm as 
measured on the ruler. Conversion of pixel to distance was done using ImageJ software 
(National Institute of Health, USA) and used as scale reference in all microscopy images. 
Final images were then compiled for representation using Microsoft power point. 
 
Table 2-2 Excitation and emission wavelengths of fluorophores used for microscopy 
   
FITC λext: 494     λem: 525 Green 
TRITC λext: 557     λem: 576 Red 
DAPI λext: 358     λem: 461 Blue 
 
 
2.2.7 RNA extraction & reverse transcription 
Hydrogels were removed from the culture well plate and placed into 500 μl of trizol 
reagent. The samples were allowed to stand at room temperature for approximately 10 
minutes to allow the hydrogel biomaterials to fully dissolve within the reagent. 
0.1 ml of chloroform was added to each tube, shaken vigorously and allowed to incubate 
at room temperature for 2 minutes. Samples were then centrifuged at 12000 g for 5 
minutes at 4°C to separate each sample mixture into a lower phenol-chloroform and an 
upper aqueous phase. 
The aqueous phase was carefully aspirated from each sample and placed into a clean 
eppendorf tube to carry out RNA isolation. The phenol-chloroform phase was stored at 
4°C for protein extraction. 
To the aqueous phase 5 μl of a 3mg/ml glycoblue solution was added to each sample 
followed by 250 μl of isopropanol. Glycoblue is a blue dye conjugated to glycogen. 
Glycogen is precipitated with RNA in alcohol and its addition serves as a means of 
visualising RNA by way of producing a blue pellet during the extraction procedure. 
Samples were mixed by inverting each tube lightly and then incubated at room 
temperature for approximately 10 minutes. After incubation, samples were centrifuged at 
12000g for 10 minutes at 4°C. The supernatant was aspirated to waste and the pellet 
washed in 500 μl of 75% ethanol solution. Samples were then centrifuged at 7500g for 5 
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minutes at 4°C to draw down the pellet. The supernatant was aspirated to waste and the 
pellet allowed to air dry. The pellet was then resuspended in 20 μl of RNase free water 
and incubated for 10 minutes on a heat block set to 55°C. to dissolve the RNA. Samples 
were stored at – 80°C until ready for use. 
Reverse transcription was carried out using the QuantiTect reverse transcription kit 
(Qiagen) as per the manufacturers’ instructions. Resultant cDNA samples were then 
stored at -20°C or used immediately for qRT-PCR experiments. 
 
2.2.8 QRT-PCR analysis 
Human specific primers designed to detect a number of differentiation biomarkers (Table 
2-3) was done using the universal probe library assay design centre available from 
Roche Applied Sciences (RocheAppliedSciences). PCR was carried out using a 7500 
Real time PCR system & corresponding software (Applied Biosystems, UK). Samples 
had a total reaction volume of 20 µl containing 2 µl of cDNA, each reverse and forward 
primer at a final concentration of 100 µM and analysed using SYBR green chemistry. 
Samples were held at 50°C for 2 minutes then 95°C for 10 minutes then amplified using 
95°C for 15 seconds and 60°C for 1 minute for 40 cycles. The specificity of the PCR 
amplification was checked with a heat dissociation curve (measured between 60 – 95°C) 
performed subsequent to the final PCR cycle. Gene expression levels were standardised 
using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal control. 
Quantification analysis was performed using the comparative ΔΔCt method (Schefe et 
al., 2006) and gene expression calculated as fold change relative to the defined control 
sample. Details of the PCR primers used within this chapter are given in Table 2-3 
 
Table 2-3 PCR primers designed for human genes 
Gene   
PPAR-γ 
Forward 5’-TGT GAA GCC CAT TGA AGA CA-3’ 
Reverse 5’-CTG CAG TAG CTG CAC GTG TT-3’ 
GLUT-4 
Forward 5’-ATG TTG CGG AGG CTA TGGG-3’ 
Reverse 5’-AAA GAG AGG GTG TCC GGT GG-3’ 
RUNX-2 
Forward 5’-GGT CAG ATG CAG GCG GCC-3’ 
Reverse 5’-TAC GTG TGG TAG CGC GTC-3’  
OPN 
Forward 5’-AGC TGG ATG ACC AGA GTG CT- 3’ 
Reverse 5’-TGA AAT TCA TGG CTG TGG AA -3’ 
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SOX-9 
Forward 5’-AGA CAG CCC CCT ATC GAC TT-3’ 
Reverse 5’-CGG CAG GTA CTG GTC AAA CT-3’ 
Collagen type II 
(COL2A1) 
Forward 5’-GTG AAC CTG GTG TCT CTG GTC-3’ 
Reverse 5’-TTT CCA GGT TTT CCA GCT TC-3’  
Nestin 
Forward 5’-GTG GGA AGA TAC GGT GGA GA-3’ 
Reverse 5’-ACC TGT TGT GAT TGC CCT TC-3’ 
β3-tubulin 
Forward 5’-CAG ATG TTC GAT GCC AAG AA -3’ 
Reverse 5’-GGG ATC CAC TCC ACG AAG TA-3’ 
GAPDH 
Forward 5’-ACC CAG AAG ACT GTG GAT GG-3’ 
Reverse 5’-TTC TAG ACG GCA GGT CAG GT-3’ 
  
2.2.9 Statistical Analysis 
Suitable statistical tests were applied where warranted. Unpaired student t-tests were 
carried out using Microsoft excel for comparisons between two test groups. Analysis of 
variance (ANOVA) and Bonferroni post hoc tests were performed using GraphPad prism 
software to compare more than two study groups. One-way ANOVA was used when 
tests present with a single variant and two-way ANOVA for sample sets with more than 
one variable. Statistical significance is noted where the calculated probability that the null 
hypothesis is true (p-value) is less than 5% confident (0.05) using four biological 
replicates unless otherwise stated. 
Mean values for replicate experiments, standard deviations (StDev) and standard error 
from the mean (SEM) were calculated using Microsoft excel. 
 
2.3 Results & discussion 
2.3.1 Hydrogel fabrication 
The elastic properties of equimolar concentrations of Fmoc-F2 and Fmoc-S (F2/S) were 
tailored by pH manipulation of the peptide solution prior to formation of the hydrogels. 
Changes in the pH at time of gelation (range 7 – 8) gives rise to network cross-linking 
and fibre thickening resulting in differential hydrogel elasticity. Pre-gelation solutions 
where prepared at pH values of 7.2, 7.9 and 8.1. The cross linking and gel formation 
process was then stabilised at physiological pH by immersion in culture media. 
Immersion in culture also facilitates cross-linking of the peptide fibres due to the 
presence of divalent ion sourced from the culture media. An account of the step taken to 
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fabricate the F2/S hydrogels is illustrated in Figure. Elastic properties of the substrate 
determined previously by Jayawarna et al using rheology are given in Table 2-4. 
 
 
 
 
Figure 2-3 Schematic illustrating the process by which F2/S hydrogel biomaterials are 
prepared prior to cell culture. The rigidity or elastic moduli of the resultant hydrogel discs 
were determined by careful pH control of the peptide solutions prior to full gel formation. 
Fmoc-F2 and Fmoc-S powders are first dissolved into solution and the pH of the peptide mixture 
tailored with NaOH (A). On standing, the solution then forms a highly viscous solution (B). This 
is then transferred to culture well inserts and allowed to gel fully at 37°C (C). The fully formed 
F2/S hydrogels are then immersed in culture media and allowed to equilibrate to physiological 
pH prior to seeding (D).  Representative images of the fully formed F2/S hydrogel used for cell 
culture are shown in E – G. Approximate modulus for each F2/S hydrogel was 2, 6 and 38 kPa 
respectively. 
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Table 2-4 Hydrogel properties 
 Soft Hydrogel Stiff Hydrogel Hard Hydrogel 
0.5 M NaOH 130 μl 145 μl 155 μl 
Peptide solution pH 7.2 7.9 8.1 
Young’s Modulus of 
resulting hydrogel 
1.7 ± 0.45 kPa 6.36 ± 1.02 kPa 38.3 ± 0.86 kPa 
 
2.3.2 Cell adhesion, viability & morphology 
Phase contrast images of MSCs cultured on the hydrogel biomaterials differed 
morphologically from those cultured on the more conventionally used tissue culture 
plastic. Cells cultured on the hydrogels were observed as smaller in size and rounded 
compared to wider spread and flatter cells on culture well plastic  (Figure 2-4). This is 
thought to be due to the nature of the biomaterial itself. When compared with tissue 
culture plastic, the substrates of all three hydrogels are orders of magnitude softer. Cells 
cultured on relatively soft substrates are known to inherently produce less focal 
adhesions than those on relatively harder surfaces (Bershadsky et al., 2003).  
 
 
 
Figure 2-4 Phase contrast images showing the morphology of human mesenchymal 
stem cells seeded onto culture well polystyrene (A) and onto a 2 kPa F2/S hydrogel 
surface (B). The images illustrate the two distinctive morphologies that MSCs adopt when 
seeded on to each substrate. Cells seeded on well plates are flatter and widely spread compared 
to those on the hydrogels which are less spread and rounded in shape. Scale bar - 100μm. 
 
A B
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As the viability of the cells cultured on the F2/S hydrogels cannot be determined by 
simply viewing under a light microscope, they were assessed for viability by monitoring 
fluorescence activity of calcein and propidium iodide. Using this method it was 
ascertained that cells cultured on each hydrogel were found to have a healthy population 
of live cells at each observed time point and as such, were deemed suitable for use 
within this duration (Figure 2-5).  
 
 
 
Figure 2-5 Fluorescence images showing viable cell populations of MSCs cultured on 
F2/S hydrogel substrates. Cells were cultured on 2, 6 and 38 kPa F2/S hydrogels and assessed 
using live (green)/dead (red) viability staining. Fluorescence staining was carried out after 
cells had been in culture for 1, 3, and 7 days. MSCs showed good viability on all three F2/S 
substrates indicating that they are suitable for cell culture. Scale bar - 100μm. 
 
Further investigation into the morphological characteristics of MSCs cultured on the F2/S 
hydrogels were performed by assessing the substrate effects on cell spreading and 
cytoskeletal arrangement using fluorescence staining of f-actin (Figure 2-6). 
Measurements taken from distal tips of cells showed that cells on the 2 kPa hydrogel 
were generally longer than the remaining two hydrogels. There was no statistically 
significant difference in cell lengths between the 6 kPa and 38 kPa hydrogels. 
Examination of f-actin showed that cells cultured on the 2 kPa F2/S surface form 
Day 1
6 kPa F2/S hydrogel 38 kPa F2/S hydrogel
Day 1
Day 3Day 3
2 kPa F2/S hydrogel
Day 3
Day 7 Day 7Day 7
Day 1
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cytoplasmic extensions similar to dendrites. Although it is not claimed that the cells form 
dendrites, dendrite out growth is characteristically driven by actin polymerisation via the 
Rho GTPases RhoA, Rac1 and Cdc42 (Hall, 1998, Swetman et al., 2002). It is however 
likely that the activation of Rac1 and Cdc42 (known to promote filopodia outgrowth) over 
RhoA produces the same type of effect observed with cells cultured on the 2 kPa 
hydrogel and to a lesser extent on the 6 kPa, a phenomenon that is also noted to be 
dependent on substrate property (Engler et al., 2006, Kuhn et al., 1998, Swetman et al., 
2002). It is a feature that may, however, be related to constrictions the cells experience 
due to differences in the physical cross-links formed in each hydrogel type. 
While this type of cytoskeletal arrangement is not typically observed of MSCs in vitro, this 
type of conformation; filopodial outgrowth that extends over several micrometers through 
the extracellular matrix, is one that has been noted in MSCs monitored in chick embryo 
limb buds in vivo (Boehm et al., 2010, Kelley and Fallon, 1978, Sanders, 2013). 
Experiments performed by Sanders et al reported MSCs in vivo that possess actin based 
cytoskeletal protrusions that play an active role in cellular communication, facilitating the 
transport of sonic hedgehog protein into the extracellular space along long distances. 
Rho contractility of the cytoskeleton for cells on the F2/S substrates does not produce 
stress fibres like those typically seen on substrates such as glass cover slips but active 
rigidity sensing by the cell mean that they maintain their rounded morphology as they 
lose tension to the substrate (Schiller, 2013). 
 
2.3.3 Cellular differentiation on substrate surfaces 
The elasticity of the hydrogel biomaterials were tuned to mimic certain tissue types; 
adipose at 2 kPa, muscle at 6 kPa and osteoid (demineralised bone tissue) at 38 kPa 
(Engler et al., 2006) with the hypothesis that MSCs will interpret these properties and 
differentiate accordingly. As such, cells were stained for formation of cell types of typical 
mesenchyme lineage.  In addition, cells were also checked for neuronal development as 
development along this lineage by MSCs has been observed on rigidity-tuned hydrogels 
(Kopen et al., 1999, Mareschi et al., 2006, Woodbury et al., 2002). 
Immunofluorescent-labelled biomarkers showed that differential behaviour of cells on the 
F2/S hydrogels were not as clear-cut as suggested by the aforementioned hypothesis. 
Cells showed a heterogeneous mix of lineages on the substrates staining positively for 
more than one cell lineage.  
Cells cultured on the soft (2 kPa) F2/S hydrogel surface stained positively for the early 
neurological biomarker nestin, adipogenic marker PPAR-γ and the chondrogenic marker 
SOX-9. There was no observed production of the osteogenic biomarker RUNX-2 (Figure 
2-7). 
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Figure 2-6 Analysis of morphological properties of MSCs cultured on 2 kPa, 6 kPa and 38 
kPa F2/S substrates. Cells were analysed for degree of cell spreading (cell lengths measured 
from distal tips) on each substrate (A) and cytoskeletal properties (F-actin, shown in red and 
cell nucleus shown in blue) were also investigated (B-D). Cells cultured on 2 kPa F2/S hydrogels 
(B) showed the presence of filopodia like out growths emanating from the cell body. Shorter 
processes were observed on the 6 kPa substrate (C) while cells on the 38 kPa substrate were 
lacking in the outgrowths showing a diffused actin composition (D). Error bars in (A) denote 
standard error; *** indicates statistical significance where p < 0.001 as calculated using one 
way ANOVA; n > 40; Scale bar – 50 μm. 
 
Cells cultured on the stiff (6 kPa) F2/S hydrogel surface stained positively for nestin, 
PPAR-γ, SOX-9 and RUNX-2 with the highest population observed for PPAR-γ and 
SOX-9 (Figure 2-8). Cells cultured on the rigid (38 kPa) F2/S hydrogel surface stained 
positively for nestin, PPAR-γ, SOX-9 and RUNX-2 with the highest population observed 
for SOX-9 and RUNX-2 (Figure 2-9). 
Cells stained for myoblast formation (MyoD), as was expected for the stiff (6 kPa) 
hydrogel, did not give any positive results. As such it was concluded that the hydrogels 
did not support cell differentiation along the myogenic lineage.  
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Figure 2-7 Immunofluorescence microscopy images to ascertain phenotypical 
development of MSCs cultured on 2 kPa F2/S hydrogel surfaces. Cells were cultured on 2 
kPa F2/S surfaces and maintained for 1 week. Fluorescence staining was carried out for 
detection of the differentiation biomarkers (shown in green) nestin, for neurogenesis (A), 
PPAR-γ for adipogenesis (B), MyoD for myogenesis (C), SOX-9 for chondrogenesis (D) and 
RUNX-2 for osteogenesis (E). Cells had stained positively for neurogenic, adipogenic and 
chondrogenic development but were negative for myogenesis and osteogenesis. Cell nuclei are 
shown in blue (DAPI). Scale bar – 50 μm. 
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Figure 2-8 Immunofluorescence microscopy images to ascertain phenotypical 
development of MSCs cultured on 6 kPa F2/S hydrogel surfaces. Cells were cultured on 6 
kPa F2/S surfaces and maintained for 1 week. Fluorescence staining was carried out for 
detection of the differentiation biomarkers (shown in green) nestin, for neurogenesis (A), 
PPAR-γ for adipogenesis (B), MyoD for myogenesis (C), SOX-9 for chondrogenesis (D) and 
RUNX-2 for osteogenesis (E). Cells had stained positively for all tested lineages with the 
exception of myogenesis. Cell nuclei are shown in blue (DAPI). Scale bar – 50 μm. 
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Figure 2-9 Immunofluorescence microscopy images to ascertain phenotypical 
development of MSCs cultured on 38 kPa F2/S hydrogel surfaces. Cells were cultured on 38 
kPa F2/S surfaces and maintained for 1 week. Fluorescence staining was carried out for 
detection of the differentiation biomarkers (shown in green) nestin, for neurogenesis (A), 
PPAR-γ for adipogenesis (B), MyoD for myogenesis (C), SOX-9 for chondrogenesis (D) and 
RUNX-2 for osteogenesis (E). Cells had stained positively for all tested lineages with the 
exception of myogenesis. Cell nuclei are shown in blue (DAPI). Scale bar – 50 μm. 
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As the cells cultured on each of the F2/S substrates had stained positively for a number 
of cell lineages using immunocytochemistry techniques, the degree to which the 
observed population heterogeneity had occurred was then ascertained by quantifying 
biomarker gene expression on each of the substrate types using qRT-PCR. 
Cells were analysed for expression of early and subsequently expressed biomarkers 
particular to neuronal, adipogenic, chondrogenic and osteogenic development after 1 
week in culture. 
While also reflecting the heterogeneity observed using immunofluorescence, quantitative 
results obtained by qRT-PCR was able to give a more defined picture of the adopted 
differentiation lineages of cell populations cultured on the hydrogels. From this, primary 
differentiation lineages on each F2/S were determined. 
Cells on the 2 kPa substrate showed high expression of nestin compared to the other two 
hydrogels suggesting initial differentiation along the neuronal route. Elevated levels of 
β3-tubulin were also observed for cells cultured on this substrate albeit not statistically 
significant (Figure 2-10). A statistically significant increase in GLUT-4 expression was 
also noted on this hydrogel illustrating adipogenic development. Levels however, were 
far less compared to that observed for nestin and β3-tubulin (approximately 900 and 8 
times respectively). On the 6 kPa substrate, type II collagen was observed to have the 
highest expression of all tested genes (Figure 2-11). In addition, SOX-9 levels were also 
observed to be highest on the 6 kPa hydrogels compared to the 2 kPa and 38 kPa 
substrates – expression levels of SOX-9 were approximately 17 times greater on 6 kPa 
than on 38 kPa F2/S and 194 times higher than measured on 2 kPa F2/S.  
Cells cultured on the 38 kPa substrate showed highest expression of osteopontin (Figure 
2-12). The earlier expressed RUNX-2 was also observed as showing higher expression 
on the 38 kPa hydrogel compared to the remaining two substrates – expression levels of 
RUNX-2 were approximately 5 times greater on 38 kPa than on 6 kPa F2/S and 14 times 
higher than measured on 2 kPa F2/S. 
Although there is some underlying overlap, these results suggest that the stiff (6 kPa) 
and rigid (38 kPa) substrates are best adept at influencing chondrogenic and osteogenic 
development respectively. 
Relative to the control, expression of adipogenic markers PPAR-γ and GLUT-4 were 
found to be elevated on all three substrates but did not show any preference to any one 
substrate in particular.  
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Figure 2-10 Gene expression analysis of MSCs undergoing phenotypical development on 
2 kPa F2/S hydrogel surfaces. Cells were cultured for 1 week on 2 kPa F2/S hydrogels and 
samples subsequently analysed for expression of early and latterly expressed differentiation 
specific biomarkers. Cells were analysed for production of nestin & β3-tubulin for neurogenesis, 
PPAR-γ & GLUT-4 for adipogenesis, SOX-9 & COL2A1 for chondrogenesis and RUNX-2 & OPN 
for osteogenesis. Gene expression was measured as fold change compared to cells maintained 
on plain surfaces as a negative control (held nominally at 1). Error bars denote standard error 
from the mean; n = 4 replicates; * notes statistical significance compared to the control where 
p < 0.05 and *** where p < 0.001 as calculated using one way ANOVA followed by Bonferroni 
post hoc tests. 
 
 
 
Figure 2-11 Gene expression analysis of MSCs undergoing phenotypical development on 
6 kPa F2/S hydrogel surfaces. Cells were cultured for 1 week on 6 kPa F2/S hydrogels and 
samples subsequently analysed for expression of early and latterly expressed differentiation 
specific biomarkers. Cells were analysed for production of nestin & β3-tubulin for neurogenesis, 
PPAR-γ & GLUT-4 for adipogenesis, SOX-9 & COL2A1 for chondrogenesis and RUNX-2 & OPN 
for osteogenesis. Gene expression was measured as fold change compared to cells maintained 
on plain surfaces as a negative control (held nominally at 1). Error bars denote standard error 
from the mean; n = 4 replicates; *** notes statistical significance compared to the control 
where p < 0.001 as calculated using one way ANOVA followed by Bonferroni post hoc tests. 
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Figure 2-12 Gene expression analysis of MSCs undergoing phenotypical development on 
38 kPa F2/S hydrogel surfaces. Cells were cultured for 1 week on 38 kPa F2/S hydrogels and 
samples subsequently analysed for expression of early and latterly expressed differentiation 
specific biomarkers. Cells were analysed for production of nestin & β3-tubulin for neurogenesis, 
PPAR-γ & GLUT-4 for adipogenesis, SOX-9 & COL2A1 for chondrogenesis and RUNX-2 & OPN 
for osteogenesis. Gene expression was measured as fold change compared to cells maintained 
on plain surfaces as a negative control (held nominally at 1). Error bars denote standard error 
from the mean; n = 4 replicates; ** notes statistical significance compared to the control where 
p < 0.01 as calculated using one way ANOVA followed by Bonferroni post hoc tests. 
 
 
2.4 Summary 
Mesenchymal stem cells were found to be viable on all three F2/S hydrogel types (2, 6 
and 38 kPa) over the time period tested (1 week). It was also noted that cells did not 
adopt the spread morphology as when maintained on culture well plastic but adopted a 
rounded morphology. This difference is thought to be due mainly to the structural 
properties and the tensile strength offered by the substrate itself as the cells perform a 
‘balancing act’ to achieve a state of equilibrium with their microenvironment. 
When tested for expression of specific differentiation markers, MSCs were found to be 
positive for a number of lineages using immunocytochemistry inferring that although the 
cells do undergo differentiation, the cells tend to adopt a heterogeneous population 
suggesting that interpretation of mechanical properties of the substrate is of a 
transcendent nature. That is, a degree of overlap exists in cell interpretation on 
differentiation as opposed to the substrate having a restrictive or defined effect on what 
differentiation lineage is permissible. 
However, in order to determine what primary differentiation lineages were adopted by 
MSCs on each hydrogel type, a quantitative approach was used measuring relative gene 
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expression of each biomarker from cells cultured on each hydrogel. From this, it was 
ascertained that the 2 kPa hydrogels promoted neurological development, the 6 kPa 
hydrogel chondrogenesis and osteogenesis on the 38 kPa hydrogel. The variations in 
cell processes or activity that occurs as MSCs begin to develop into the determined 
phenotypes will be further explored in the following chapter. 
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3.1 Introduction 
The breadth of metabolomics has enabled the development of a number of structured 
approaches in its continuous efforts at unravelling the metabolome. These options 
require a preformed idea of what it is the researcher is pursuing and available options are 
then tailored toward achieving the aim as best possible. Selective methods for studying 
the metabolome are considered at every stage; from experimental design through to 
analysis of the results. This introduction makes mention of some but not necessarily all 
available analytical routes with particular focus on those that are used within this thesis. 
 
3.1.1 Metabolite analysis 
3.1.1.1 The targeted and untargeted approach 
Targeted analysis encompasses the measurement or quantitation of a single or small 
number of known metabolites affected within a certain pathway and is more or less the 
method of choice for carrying out metabolite/metabolic analysis of specific pathways or 
classes of biomolecules. Metabolites investigated are of a known interest and analysis is 
focused around the behaviour of the molecule(s) in question. Compounds within certain 
metabolic pathways usually bear related chemistries and methodologies are 
concentrated around optimisation for these classes of molecules. 
While consideration is given to sample extract and clean up methods, it depends mostly 
on chromatographic separation of metabolite moieties and the specificity of detection. 
Targeted analysis is generally employed where specificity and accuracy in quantitation 
are of particular importance such as drug screening, design, toxicology or enzyme 
kinetics. 
Untargeted analysis, on the other hand, is closer to metabolomics in the defined sense 
and utilises the entirety of small mass molecules that can be detected or measured within 
the restriction of the chosen methodology. As this method bears less constraints on 
metabolite detection compared with using a targeted approach, its means for 
investigation include a broad, if not the entire range of extraction, separation and 
detection methods that best suit the study. 
 
3.1.1.2 Fingerprinting & footprinting  
Both fingerprinting and footprinting can be done using targeted or untargeted 
measurements coupled with high throughput methodologies. Analysis is performed by 
way of semi-quantitation of detectable metabolites within the system which may or not be 
wholly identified (Dunn et al., 2005). Fingerprinting is referred to general analysis of 
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sample extracts, focussing on the intracellular complement of metabolites - also referred 
to as the endometabolome (Nielsen and Oliver, 2005, Oldiges et al., 2007). Footprinting, 
on the other hand, refers to the analysis of metabolites expelled or exhausted by the cells 
into the culture system, termed the exometabolome (Allen et al., 2003, Nielsen and 
Oliver, 2005). This method in some respects is particularly advantageous as it is non-
invasive, negates the need for rapid quenching techniques to preserve the cell 
metabolome accurately, as is required for fingerprinting and measurement variations 
brought about through sample handling is lessened.  
This chapter makes use of an untargeted fingerprint approach. It aims to measure the 
metabolome, incorporating as wide a range of chemistries possible to acquire as much 
information as the method allows for investigating cell behaviour. Fingerprinting was 
favoured over footprinting as it is thought better suited to stem cell culture. It is thought 
that footprinting will not provide any discernible information due to the fact that early 
stage differentiation is generally characterised by internal changes in cell activity (Salti et 
al., 2013). Also, changes occur on a less rapid timescale compared to yeast cultures for 
example (Hojer-Pedersen et al., 2008, Raamsdonk et al., 2001), measuring accurate 
changes in media composition are therefore inevitably hampered by cell maintenance 
over time through constant media changes for the duration of the experiment. 
 
3.1.2 Analytical methodology  
To collect reliable metabolome datasets, uniformity of culture and sampling conditions, 
as well as the cellular metabolic state are crucial. For this reason, method 
standardisation becomes important (Oldiges et al., 2007). There is no set standard 
protocol for sample preparation, as samples subject to metabolomic analyses tend to 
vary widely from microbes to plants and human samples (Hojer-Pedersen et al., 2008, 
Raamsdonk et al., 2001, Maharjan and Ferenci, 2003, Tsimbouri et al., 2012). It is also 
dependent on the fraction of the sample to be investigated. For example, samples to be 
processed come in a variety of forms; from urine and whole blood to tissue samples. 
Each of these is handled differently in order to extract metabolites in as efficient a 
manner possible. As such, the first port of call is deciding on what type of extraction 
procedure is suited to the experimental demands. 
 
3.1.2.1 Metabolite extraction 
For global untargeted metabolite analysis, extraction methods ideally should be non-
specific, able to recover the largest population of metabolites possible and have little or 
non-detrimental effects on the metabolite by elimination or modification. The rapid 
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turnover of some cell processes, like glycolysis for example,  requires that cell-quenching 
methods are particularly effective and the use of appropriate controls compensate for any 
differences experienced from the native state.  
Traditionally, quenching and extraction is performed using methanol (although ethanol is 
also widely used) in a variety of ways, ranging from 100% - 50% content either as a cold 
or hot solution (Dietmair et al., 2010, Maharjan and Ferenci, 2003, Paglia et al., 2012). 
Methanol also is of added advantage for metabolic fingerprinting, as it is known to cause 
protein denaturation, damaging the cell membrane and allowing the expulsion of 
intracellular metabolites. A number of studies looking into the extraction efficiencies of a 
number of solvents have shown that extraction solvents tend to be more favourable for a 
certain class of compounds over another dependent of their make up (Dietmair et al., 
2010, Maharjan and Ferenci, 2003). For example, the extraction efficiency and total 
abundance of polar metabolites are best in solution like methanol or perchloric acid but is 
lowered when extracted in the less polar 1:1 v/v solution of methanol:chloroform 
(Maharjan and Ferenci, 2003). On the whole, tempering one extraction solvent with 
another can affect the extraction efficiencies, as solubility of some metabolites are duly 
affected but it broadens the range of metabolite species contained within the sample as it 
no longer caters for the extraction of a single class of compounds (Dietmair et al., 2010, 
Maharjan and Ferenci, 2003, Tokuoka et al., 2010). 
The wide range of chemistries of metabolites makes this a difficult task to incorporate 
every species in its entirety, and inevitably, some metabolites are compromised (through 
low or null extraction efficiencies) for the sake of the majority. 
  
3.1.2.2 Metabolite separation 
On acquisition of a pool of metabolite species, the next step in isolating individual 
metabolites is their separation from one another. Separation is generally performed 
based on the physicochemical properties of each compound, enabling exclusion based 
on characteristics such as size and polarity amongst others.  
A number of separation methods are widely used in metabolomics, these are inclusive of 
capillary electrophoresis, gas chromatography and liquid chromatography. 
Separation by liquid chromatographic methods conventionally employ the use of a two 
phase system; a stationary and mobile phase. Metabolite separation is dependent on 
optimisation of the interplay between the stationary phase (usually C8 or C18 columns) 
as the retentive agent interacting with the metabolite and the mobile phase (which 
consists of aqueous and organic solvent phases) as the eluting agent prior to introduction 
to the detection system. 
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For studying the metabolome, the use of Hydrophilic Interaction Liquid Chromatography 
(HILIC) has become widely popular, its main attraction being that it is particularly 
effective at the separation and elution of small polar molecules (Paglia et al., 2012). As 
cells constitute a high degree of water, it can be put forward that a high population of its 
metabolome are very likely polar molecules, a system that can make distinctions within 
the majority therefore such as HILIC makes it a highly desirable tool for metabolomics.   
HILIC combines a number of characteristics employed by the three mainstream 
chromatographic methods; reverse phase for mobile phase eluent, allows organic 
solvents for molecules to stay in solution (> 50% organic), this less viscous composition 
also allows for better separation of strongly polar compounds compared to other 
available LC methods (Gritti et al., 2010); ion exchange, allowing the analysis of charged 
species and the adsorption stationery phase properties of normal phase LC. 
 
 
Figure 3-1 Total ion chromatogram (TIC) showing separation of extracted stem cell 
metabolites. The chromatogram shows the separation of the entire metabolite population 
obtained from cell sample extraction using HILIC. Metabolites elute from the column in order 
of increasing polarity, allowing increased retention of polar molecules while non-polar 
metabolites are eluted earlier (Alakpa, unpublished data). 
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3.1.2.3 Detection 
There are a number of options that can be used for detection of separated metabolite 
species within a sample, these are generally spectrometric methods inclusive of 
ultraviolet (UV), fluorescence, Raman, nuclear magnetic resonance (NMR) and by mass 
analysis; typically mass spectroscopy (MS). Both NMR and MS allows detection based 
on a broad scope of properties inclusive physical, chemical and structural characteristics 
using separation & mass analysis in MS or chemical shifts due to magnetic resonance in 
NMR. Due to the reduced sensitivity of NMR spectroscopy however, it is often used in 
conjunction with MS, or MS can be utilised as the sole detection resource. 
Mass spectrometry in itself, allows the analysis of the principal composition of a sample 
by measuring the presence and abundance of ionised molecules in the form of a single 
spectrum of the charged (ionised) species relative to its molecular weight (mass to 
charge ratio, m/z). As such, broad analysis of the constituents of a system is best 
described by this method. Information garnered by mass spectrometry can sometimes 
involve the use of multiple mass analysis stages in time or space (MS/MS or MSn), 
typically referred to as tandem mass spectrometry. Structural information of a singular 
ion of interest detected on first mass analysis (MS) can be obtained by fragmentation of 
that specific mass, producing daughter ions, which are subsequently re-analysed 
(MS/MS). Fragmentation patterns of a parent ion offer high specificity in distinguishing it 
from others of similar mass, as fragmentation patterns are often specific to its parent ion 
aiding molecule identification. 
Mass spectrometry itself incorporates a broad range of mass analysers – quadrupole, ion 
trap, Fourier transform (FT) and time of flight (TOF) based on the physics that is used to 
build each mass analyser.  
The orbitrap mass spectrometer is based on the phenomenon of orbital trapping of ions 
around a central dielectric (Kingdon, 1923, Makarov et al., 2006) and integrates a 
number of features from the previously mentioned mass analysers (Figure 3-2). The 
orbitrap mass analyser allows for measurements with high mass accuracy and 
resolution, enabling distinction between a number of molecules that have similar 
descriptive masses, typically to less than 1 part per million (ppm) with use of locked mass 
internal calibration. 
Mass spectrometry, typically coupled to liquid chromatography separation and in tandem 
is referred to as liquid chromatography-mass spectrometry (LC-MS). Typical data 
acquisition file obtained from an LC-MS sample injection is shown in Figure 3-3. 
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Figure 3-2 Illustration of a cross section through an orbitrap mass analyser (A) and 
schematic of a linear transfer quadrupole (LTQ) orbitrap mass spectrometer. (A) Ions 
sequestered in the storage quadrupole are injected perpendicular to the long axis. Tailored 
voltage parameters between the central and outer electrodes create a radial electric field and 
centrifugal force, which holds the ions in a near circular trajectory about the central electrode. 
Image adapted from Scigelova & Krusel, Thermo Fisher scientific. (B) Ions are produced at the 
electrospray ion source where the samples are introduced into the MS (i). Ions then pass 
through the LTQ (ii) into the storage quadrupole (iii) where they are sequestered facilitating a 
link between a continuous electrospray ion source and a pulsed orbitrap mass analyser (iv). 
The central electrode also acts as a receiver digitised current detection of oscillating ions, 
which is ultimately represented as a time acquired mass spectra. Image B adapted from 
Makarov et al, 2006. 
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Figure 3-3 Diagram illustrating a mass spectrum obtained from a TIC. The spectrum 
shows the array of metabolite masses detected by MS between m/z 70 – 600 (A) at the 
chromatogram peak retention time of 13 minutes (B). Putative identification of the amino acid 
glutamine (m/z – 145.0617) is also highlighted on the spectrum (A). Alakpa, unpublished data. 
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3.1.3 Bioinformatics 
The process of extraction, separation and detection, especially with regards to a global 
metabolomics study, typically generates a large volume of numerical output. How then to 
handle all this data and morph it into something which describes the system as a whole 
inevitably becomes an important focus. To do this, pattern analysis models are 
generated to analyse linear or non-linear correlation patterns, and in this manner different 
biological systems are elucidated using a data driven process (Hogeweg, 2011).  
It is not surprising then that of all the steps in the metabolomics work flow, data analysis 
and interpretation is the most time consuming. Garnering information relies heavily on 
good visualisation of numerical output for comparisons and conclusions to be made. 
Prior knowledge of various biochemical processes also allows the integration with 
transcriptome and proteome data to create network pathways, putting interconnected 
biological activity into context. 
This chapter incorporates the use of several bioinformatics platforms to analyse, 
visualise and interpret the data generated (Creek et al., 2011, Creek et al., 2012, Leader 
et al., 2011, Scheltema et al., 2011, Xia et al., 2009), inclusive of metabolite mass 
identification by cross referencing a number of available databases, uni- and multivariate 
statistics, correlation analysis and pathway networking. 
A comprehensive list for software on pathway and interactome resources can be found at 
www.pathguide.org. 
 
3.1.4 Objective 
Being able to influence the differentiation behaviour of mesenchymal stem cells through 
substrate mechanics is a non-invasive means of effecting cellular changes. That is, cells 
are not pushed into differentiation by interfering directly with signalling pathways but are 
directed through the action of micro-environmental interpretation by the cells themselves. 
By effecting phenotypical changes without chemical means, naturally occurring cellular 
activity reflects innate behaviour as the cells undergo initial differentiation. By employing 
the earlier described metabolomics workflow adapted to fit the experimental objective 
(Figure 3-4), obtaining a snapshot of the metabolome should give insight into cell activity 
as it undergoes initial differentiation, reflecting changes that occur in its metabolite pool 
to alter phenotype. 
This chapter aims to ascertain whether the use of an unbiased global metabolomics 
approach can detect metabolic changes that occur as MSCs adopt a newly acquired 
phenotype on differentiation.  
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Figure 3-4 Schematic summarising the metabolomics workflow. The figure illustrates the 
working protocol undertaken for this chapter. Cells cultured on biomaterial substrates (A) had 
their intracellular metabolite content extracted and pooled (B) then separated and detected 
using LC-MS (C) and the obtained data subject to identification analysis and interpretation (D). 
The metabolite information garnered gives an insight into the physiological state of the cell(s) 
at the time of extraction 
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3.2 Materials & methods 
3.2.1 Materials 
Materials/reagents Supplier(s) 
Mesenchymal stem cells Promocell GmBH, Germany. 
Fmoc-diphenylalanine Bachem, UK 
Fmoc-serine Bachem, UK 
0.5 M sodium hydroxide Fisher chemicals 
Distilled water Invitrogen, UK 
Dulbeccos modified eagle medium (DMEM) Sigma Aldrich, UK 
Foetal bovine serum (FBS) Sigma Aldrich, UK 
Penicillin streptomycin Sigma Aldrich, UK 
Trypsin Sigma Aldrich, UK 
Isopropanol Sigma Aldrich, UK 
Ethanol VWR Chemicals, France 
Guanidine hydrochloride Sigma Aldrich, UK 
Sodium dodecyl sulphate (SDS) Sigma Aldrich, UK 
Bio-rad protein assay kit Bio-Rad, UK 
Tecan GENios microplate reader Tecan Group, Switzerland 
Chloroform Sigma Aldrich, UK 
Methanol Sigma Aldrich, UK 
Phosphate buffered saline (PBS) 
*
 In-house 
ZIC-HILIC pre column, sulfobetaine functional group, 20 x 
2mm 
Merck Sequant, Sweden 
ZIC-HILIC chromatography column, sulfobetaine functional 
group, 150 x 4.6mm 
Merck Sequant, Sweden 
Acetonitrile Sigma Aldrich, UK 
Formic acid Sigma Aldrich, UK 
Ultimate 3000 RSLC LC system Thermo Finnigan, UK 
Orbitrap Exactive mass spectrometer Thermo Finnigan, UK 
Xcalibur, version 2.1 (acquisition software) Thermo Finnigan, UK 
                                               
* Preparation procedures for reagents and buffers made in house are detailed in the appendix 
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3.2.2 Hydrogel fabrication & cell culture 
Hydrogel substrates (2, 6 & 38 kPa) were fabricated and used for culturing MSCs as 
described earlier in sections 2.2.3. Cells were cultured for up to 1 week before harvesting 
for use in metabolomics experiments. 
 
3.2.3 Protein extraction and measurements 
Protein extracts were obtained from the same samples used to generate RNA extracts in 
the previous chapter using the phenol-chloroform extract. 
750 μl of isopropanol was added to each phenol-chloroform extract and the mixture 
incubated at room temperature for 10 minutes. Samples were next centrifuged at 12000 
g for 10 minutes at 4°C and the supernatant aspirated to waste. Pellets were then 
incubated for 20 minutes and washed three times with 1 ml of a 0.3 M guanidine 
hydrochloride solution made up in 95% ethanol. Samples were then centrifuged at 7500 
g for 5 minutes at 4°C to draw down the pellet. The supernatant was aspirated to waste 
and the pellet washed thrice using 0.5 ml of a 0.3 M guanidine hydrochloride solution in 
95% ethanol, incubated for 20 minutes at room temperature and then centrifuged at 4˚C, 
7500 g for 5 minutes. The pellets were washed in 1ml of 100% ethanol by vortexing 
briefly and re-sedimented by centrifuging at 4˚C, 7500 g for 5 minutes. The ethanol was 
aspirated to waste and the pellets allowed to air dry for 10 minutes, the pellets were re-
suspended in a 0.01% sodium dodecyl sulphate (SDS) solution by pipetting the solution 
up and down a number of times. The tubes were then incubated on a heating block at 
55˚C for 10 minutes to dissolve proteins and centrifuged at 13000 g for 10 minutes to 
sediment any insoluble material. The supernatant was transferred into clean eppendorf 
tubes and used for subsequent protein assays. 
Relative amounts of protein were determined using the Bio-Rad microassay procedure 
according to the manufacturers’ protocol. 
 
3.2.4 Metabolomics 
3.2.4.1 Metabolite extraction assay 
Metabolite extraction from samples were done using a solvent comprising 
chloroform:methanol:water (1:3:1, v/v). The methanol serves to disrupt cellular integrity 
and denature proteins. As a solvent for metabolites, the composition acts to incorporate a 
broad range of compounds from non-polar metabolites such a lipids on the one extreme 
(dissolved in chloroform) to more polar components on the other extreme contained 
within the methanol. 
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Hydrogel substrates were washed once with warm PBS solution and placed in clean 
culture well plates and 0.5ml of ice-cold extraction solvent (chloroform: methanol: water, 
1:3:1 v/v) added. The culture well plates were then wrapped in parafilm and kept on ice 
(to minimise evaporation) and agitated gently on a shaker for one hour in a cold room 
(4C). Samples were subsequently centrifuged at 13,000 g for 5 minutes to sediment cell 
debris and the supernatant transferred into vials to be analysed by LC-MS. Otherwise 
samples were aspirated into clean eppendorf tubes and stored at -80˚C until ready for 
LC-MS analysis.  
A set of ‘zeroes’ (biomaterial with no cells seeded) was also taken through the 
methodology detailed above to act as a zero sample for mass spectrometric analysis. 
 
3.2.4.2 LC-MS 
5 µl of each sample used within a batch were pooled into a single aliquot to be used as a 
quality control (pooled QC). These were injected several times over the duration it took to 
run a single batch of samples to monitor metabolite quality and stability. Batches were 
also run with three standard samples; these contain a number of known metabolites used 
for identification and LC retention time predictions. 10 µl of each sample was injected 
onto the LC-MS system for analysis. 
 
High performance liquid chromatography 
Chromatographic separation of metabolites was done routinely using a zwitterionic 
hydrophilic interaction liquid chromatography (ZIC-HILIC) 150 x 4.6mm, 100Å column as 
the stationary phase, acetonitrile containing 0.08% formic acid as the organic mobile 
phase and water containing 0.1% formic acid as the aqueous mobile phase. The mobile 
phase was run as a gradient over 46 minutes, the details of which are given in Table 3-1. 
A ZIC-HILIC 20 x 2.0 100A was also used as a guard column to protect the main column 
from impurities that may be strongly retentive or cause blockages on the main column. 
Chromatography columns were maintained at 25C. 
 
Mass Spectrometry 
Mass spectrometry was performed using an Orbitrap Exactive accurate mass orbitrap 
mass spectrometer. Scans were performed at 50,000 resolution at 100 m/z in alternating 
positive and negative ion modes within the mass range 70 – 1400 m/z for the duration of 
the LC gradient.  
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Prior to acquisition, mass calibration was performed in both positive and negative modes 
using a calibration mix that contains a number of compounds with masses spanning the 
acquisition range. 
 
Table 3-1 Gradient elution conditions used for chromatographic separation 
Time (min) Aqueous (%) Organic (%) Flow rate Curve 
0 20 80 0.3ml/min 1 
30 20 80 0.3ml/min 6 
32 80 20 0.3ml/min 6 
40 95 5 0.3ml/min 6 
42 95 5 0.3ml/min 6 
46 20 80 0.3ml/min 6 
 
3.2.4.3 Data processing 
Raw data file conversion, chromatographic peak selection and metabolite identification 
were done using IDEOM/MzMatch Excel interface (Creek et al., 2012, Scheltema et al., 
2011) and measured chromatographic peak intensities (area under the curve) by LC-MS 
were normalised against calculated protein content. Identification was done using a set of 
known standards to define mass and chromatographic retention times, as mentioned 
previously. Putative metabolites were also identified on this basis using predicted 
retention times as described by Creek et al (Creek et al., 2011). 
 
3.2.5 Statistical analyses 
Statistical analysis was carried out as detailed in 2.2.9. Multivariate, correlation and 
hierarchical cluster analyses were performed using Metaboanalyst 2.0 (Edmonton, 
Canada) (Xia et al., 2009, Xia and Wishart, 2010). 
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3.3 Results & discussion 
3.3.1 Protein expression profiles 
The phenol phase from cell samples used to acquire RNA samples for PCR experiments 
in the previous chapter were also used to determine the total amount of protein present 
in each sample set. These were calculated as fold change from the control sample (cells 
cultured on plain substrate) after 24 hours in culture as a baseline (Figure 3-5). 
 
 
 
Figure 3-5 Protein content analysis for MSCs cultured on F2/S hydrogel substrates. 
Protein concentrations were observed to be generally higher for cells cultured on the F2/S 
hydrogels with a steady increase occurring from day 2 to 7. Fold change in protein content was 
normalised against negative control, set nominally at 1. Negative control set is annotated as 
‘Plain’; these are MSCs that are maintained normally on planar culture well plastic. Inset is a 
representative graph of BSA standards used to measure protein abundance in each sample. 
Error bars denote standard deviations; n = 6 replicates. 
 
General protein abundance was noted to be higher for cells cultured on the F2/S 
substrates compared to the plain.  A dip in protein quantities was observed at 48 hours (2 
days) after which the protein abundance increased steadily over 1 week for all substrates 
with the exception of 2 kPa F2/S. Levels for cells on the plain substrate more or less 
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remain uniform for the entire experimental duration. Whether or not this observed effect 
(dip in concentrations at 48 hrs) is real cannot be said with any real certainty due in part 
to the large variation in biological replicates. One plausible explanation however, would 
be the effect of the substrates initiating a flurry of activity as the cells adhere and settle in 
their microenvironment. The same effect, albeit much subtler, is also noted for cells 
cultured on the plain substrate. The highest change was measured at 1 week (Day 7) for 
cells cultured on the 6 and 38 kPa F2/S hydrogel substrates. 
The acquired protein profiles were then used to normalise identified metabolite peak 
intensities subsequently detected by LC-MS. 
 
3.3.2 Total metabolite activity: illustrating the metabolome as a whole 
The total metabolite abundance measured by LC-MS was approximated for each sample 
by averaging the measured peak intensities of all detected masses. This is intended to 
give an idea into the overall activity the cells adapt in comparison to the plain substrate 
which does not harbour actively differentiating cell populations (Figure 3-6). LC-MS noise 
filtering and removal of irreproducible peaks were also done in IDEOM prior to averaging 
peak intensities.  
No significant change is noted for cells cultured on the plain substrates at 24 and 168 hrs 
(1 week). The measurements reflect metabolic quiescence of MSCs inferring stability of 
the cells metabolic processes. 
Cells cultured on the F2/S substrates however, showed a different effect. Total metabolite 
amounts were significantly lower for all three F2/S hydrogels at 24 hrs compared to the 
plain, an effect that may be due to the cells undergoing drastic changes as they interpret 
their microenvironment. Features such as cell attachment, spreading morphology and 
phenotype all undergo an extent of change on the F2/S hydrogels (Figure 2-4) and these 
naturally make a high demand of the cells. 
By one week however, metabolite amounts increase for the cells on the F2/S substrates 
returning to levels that are comparable to the ‘basal’ activity seen with the plain 
substrate. 
To better envisage the metabolome as a whole, metabolite dispersions were visualised 
using volcano plots. The volcano plots maps out the fold change calculated for each 
metabolite relative to that observed at 24 hours on the plain substrate against its 
corresponding p-value (calculated using unpaired students t-test) enabling visualisation 
of changes in metabolite populations that are of statistical significance. 
After one week (168 hrs) in culture, cells on the plain substrate reflect the measurements 
observed in Figure 3-6, showing very little dispersion from those measured after 24 hrs 
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(Figure 3-7D). Cells cultured on the F2/S hydrogels however showed very broad 
dispersion from the control sample as the subsequent depletion and increase in 
metabolite amounts is also reflected (Figure 3-7A - C). Worthy of note, is the overall 
patterning adopted by the metabolite dispersion on each of the graphs. Each substrate 
adopts its own unique imprint; a by product that is thought to manifest from the degree of 
difference in cell activity on each of the hydrogel substrates giving rise to different cell 
lineages as they undergo differentiation. The volcano plots (Figure 3-7) also illustrate that 
which cannot be represented by the bar graph. That is, although at 168 hrs, total 
metabolite abundance reaches comparable levels between all four substrates as a 
whole, the metabolic ‘arrangements’ contributing towards this overall stasis is very 
different between substrate types. 
 
 
Figure 3-6 Averaged peak intensities of identified metabolite masses detected using LC-
MS. The graph depicts a general overview of the metabolome of MSCs cultured on plain, 2 kPa, 
6 kPa and 38 kPa F2/S hydrogels after 24 hrs and 168 hrs (1 week) in culture. Average peak 
intensities remain unchanged for MSCs maintained on the plain substrate (control), while MSCs 
on the F2/S substrates show significant deviation from both the plain substrate and each other 
indicating differences in overall cell behaviour between substrates. Error bars denote standard 
deviations from the mean; n = 3. Statistical significance is noted as *** where p < 0.001, as 
calculated using two way ANOVA ascertaining whether the observed effect is due to time in 
culture, substrate type or the interaction between both variables (inset). Bonferroni post hoc 
tests were also performed and significance noted as * where p < 0.05, ** where p < 0.01 and *** 
where p < 0.001 on the graph compared to the plain substrate. § where p < 0.05 and §§ where p 
< 0.01 compared to 2 kPa F2/S substrate 
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Figure 3-7 Volcano plots illustrating the metabolome of MSCs cultured on F2/S hydrogel 
substrates. Cells were seeded onto F2/S hydrogels with elastic moduli of approximately 2 kPa 
(A), 6 kPa (B) and 38 kPa (C) and their metabolome ascertained after 24 and 168 hrs in 
culture. Each hydrogel gave a widely dispersed pattern compared to MSCs maintained on plain 
culture well plastic as a control (D). By 168hrs, the dispersion patterns manifest in each 
volcano plot is unique to each F2/S hydrogel as the cells adopt varying differentiation lineages 
reflected in their cellular activities.  
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3.3.3 Metabolic pathways: assessing differential behaviour as a 
consequence of substrate properties. 
 
Having determined the overall metabolic activity on each hydrogel substrate, a more 
intricate scrutiny of cell activity was undertaken. To do this, cell activity was examined for 
differential behaviour between substrates by performing a series of multivariate statistical 
tests (Xia et al., 2009) on smaller subsets of the acquired data. In the first instance, 
putative metabolites identified using Ideom were classified into broadly recognised 
metabolic pathways; carbohydrate, amino acid, vitamin and lipid metabolism and 
analysed as such. From this, it was noted that these groups could be classed based on 
their observed overall activity. These were anabolic metabolism, where activity showed a 
general increase on the hydrogel substrates and catabolic metabolism where the 
opposite effects were observed. 
Anabolic metabolism was noted for metabolites classed under vitamin & cofactor 
metabolism and amino acid metabolism while lipid and carbohydrate metabolism was 
observed to be catabolic (Figure 3-8). This observation compliments each other nicely as 
catabolism of carbohydrates and lipids generally produce energy for anabolic reactions 
(Dressel et al., 2003, Tozzi et al., 2006). The observed increase (anabolism) of amino 
acids inherently leads to the formation of functional and structural proteins that are 
pivotal to altering cell phenotype as the increase in cofactor metabolism indicate the 
need to drive a number of cellular reactions greater than when the cell is in a ‘restive’ 
state (plain substrate) (Figure 3-8). 
 
 
3.3.3.1 Total metabolic activity 
Of the two catabolic pathways, carbohydrate metabolism showed the most constant 
degree of depletion over time, the differences from the plain substrate being of greater 
significance at 168 hrs compared to lipid metabolism (Figure 3-8). 
The observed pattern/outlier with this particular pathway could be attributed to the fact 
that these metabolites are primarily driven to meet the energy demands of the entire cell 
and it’s continuous catabolism provides for the changes in phenotypes as the cells 
undergo differentiation.  
Although energy requirements of the cell can be met by other means (lipid & amino acid 
metabolism), carbohydrate metabolism mainly involves the breakdown of complex 
sugars to simpler molecules (glucose), which is the basic substrate for glycolysis (Lunt 
and Vander Heiden, 2011). As such, the metabolism of carbohydrates to form glucose is 
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a more readily available and less complex process when compared to lipid metabolism 
for example. It follows that the observed lessened activity at day 7 is in line with meeting 
the cells energy demands as carbohydrate metabolism is a preferred route over lipid 
metabolism. 
Overall lipid metabolism was observed to be particularly active at 24 hours and less so 
by 168 hrs. In a similar manner to carbohydrate metabolism cells cultured on the F2/S 
hydrogels at 168 hrs were still significantly active compared to the plain substrate. 
Overall activity between F2/S substrate types also become apparent at this point as 
differences between the 2 kPa and 38 kPa are also noted. 
Putative metabolites classified as participating in amino acid metabolism were observed 
as having no overall change after 24 hrs for MSCs cultured on all four substrates. At 168 
hrs, however, amino acid metabolism showed significant increase in activity on all three 
hydrogel substrates compared to the plain surface, where metabolite abundance 
remained unchanged from that observed at 24 hrs (Figure 3-8). Divergent behaviour 
between F2/S hydrogels is also noted here as activity on the 2 kPa F2/S hydrogel was 
generally higher than the 6 and 38 kPa substrates. 
These results suggest an inclination toward the synthesis of structural and functional 
proteins that are geared towards supporting differentiation on each of the hydrogels. The 
theory is further supported by the fact that most stem cells undergoing differentiation are 
known to show up regulation in gene expression early on in culture and have a more 
established presence by 1 week (168 hrs) when they become sensitive to most detection 
methods. 
Total activity of putative metabolites identified as those involved in vitamin and cofactor 
metabolism were observed as, albeit not significantly, having increased activity at 24 hrs 
on the F2/S hydrogel substrates (average metabolite abundance on the 2 kPa substrate 
was 2x the plain substrate while 6 kPa measured a 1.7x increase). The exception to this 
being the cells cultivated on the 38 kPa hydrogel substrate (on average 3.7x fold 
change), which was statistically significant. Cells cultured on the 2 kPa surface showed 
highest activity after 168 hrs in culture while those on the 6 kPa and 38 kPa hydrogel 
peaked at 24 hours. Overall behaviour shows a distinction on the soft hydrogel substrate 
whilst the general trend between the 6 kPa and 38 kPa hydrogels are similar. 
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Figure 3-8 Average metabolite abundance illustrating metabolic pathway activity in 
cells cultured on plain, 2 kPa, 6 kPa and 38 kPa F2/S hydrogel substrates. Total 
metabolite abundance was averaged from peak areas of all putatively identified metabolites 
classified into carbohydrate (A), amino acid (B), lipid (C) and vitamin & cofactor (D) 
metabolism after 24 and 168 hrs in culture. Distinct catabolic (A & C) and anabolic (B & D) 
behaviour was noted for cells cultured on the F2/S substrates while those on the plain substrate 
remain unchanged. Error bars denote standard deviations from the mean; n = 3. Statistical 
significance is noted as * where p < 0.05, ** where p < 0.01 and *** where p < 0.001, as 
calculated using two way ANOVA, ascertaining whether the observed effect is due to time in 
culture, substrate type or the interaction between both variables (inset). Bonferroni post hoc 
tests were also performed and significance noted as * where p < 0.05, ** where p < 0.01 and *** 
where p < 0.001 on the graph compared to the plain substrate. § where p < 0.05 and §§§ where 
p < 0.001 compared to 2 kPa F2/S substrate. where p < 0.05 compared to the 6 kPa F2/S 
substrate. 
 
Principal component analysis (PCA) 
Principal component analyses were performed on data sets obtained from each time 
point (24 hr and 168 hr). The factor scores of each principal component was used to 
generate scatter plots to best describe the variance within the data sets. The separation 
of clusters in the scatter plots therefore represents the existence of distinct differences 
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between each sample set (Fiehn, 2001, Robinson et al., 2005, Roessner and Bowne, 
2009), in this case, by way of its metabolic arrangement or differences.  
Illustrated in Figure 3-9 and Figure 3-10 are the scatter plots generated from combining 
the first two principal components, that is, the components that best describe sample 
variances. Details of variance description accounted for by PCA are shown in Table 3-2. 
The high percentage of combined variables accounted for (greater than 73%), is 
suggestive of the presence of strong relationships between the data sets (Robinson et 
al., 2005). This is explored in more detail using hierarchical cluster analysis in the 
following section. 
 
Table 3-2 Amount of variance explained using principal component analysis. The table 
describes the percentage variance described in each dataset using metaboanalyst 2.0 for 
individual and combined principal components. 
 24 hours 168 hours 
 PC1 PC2 Combined PC1 PC2 Combined 
Carbohydrate 
metabolism 
73.2% 9.5% 82.7% 71.8% 14.9% 86.8% 
Amino acid 
metabolism 
48.3% 24.8% 73.1% 69.3% 17.4% 86.7% 
Vitamin & 
cofactor 
metabolism 
72.7% 14.2% 86.9% 67.6% 19.5% 87.1% 
Lipid 
metabolism 
60.9% 21.5% 82.5% 51.2% 31.6% 82.7% 
 
Metabolite behaviour of cells cultured on the plain substrate remained distinct from those 
on the F2/S hydrogel for all pathways and at both time points, indicating that cell activity 
on this substrate is markedly different from that on the F2/S substrates. 
At 24 hours, cells cultured on all three F2/S surfaces showed an appreciable degree of 
overlap implying that there is very little dissimilarity between cell activities for all three 
substrates at this point in time. By 1 week in culture (168 hrs) cells on the 2 kPa 
hydrogels developed behaviour that is largely distinct in all four assessed pathways from 
the 6 and 38 kPa F2/S surfaces. The 6 and 38 kPa substrates however, exhibited a very 
close relationship with considerable overlap occurring in amino acid and lipid metabolism 
(Figure 3-9 & Figure 3-10 C & D).  
Interestingly, the pathway with the most distinct activity across all four substrate types 
was seen with vitamin and cofactor metabolism at 168 hrs (Figure 3-10B). Metabolites 
classed within this group are responsible for facilitating a large number of redox reactions 
as building blocks for coenzymes (Depeint et al., 2006a, Depeint et al., 2006b) and as 
such, are likely to have an insurmountable impact on specific cellular function and 
behaviour. 
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Figure 3-9 Principal component analysis (PCA) of metabolites detected in MSCs cultured 
on plain, 2 kPa, 6 kPa and 38 kPa F2/S hydrogel substrates. Data sets were obtained from 
putative metabolites identified from cells that were analysed after 24 hrs and 168 hrs in 
culture classed within carbohydrate metabolism (A & B respectively) and amino acid 
metabolism (C & D respectively). Plot points represent individual samples from each substrate 
set (n =3) for plain (red), 2 kPa (green), 6 kPa (blue) and 38 kPa (cyan) F2/S hydrogels. Cell 
metabolism on the F2/S substrates for both pathways remains distinct from the plain substrate 
at both time points. The observed overlap of the F2/S hydrogels at 24 hrs is diminished as cells 
on the 2 kPa F2/S adopts distinctive behaviour from the 6 and 38 kPa F2/S substrates, which 
remain similar. Coloured ellipses illustrate spatial borders of each sample set calculated to 
95% confidence. 
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Figure 3-10 Principal component analysis (PCA) of metabolites detected in MSCs 
cultured on plain, 2 kPa, 6 kPa and 38 kPa F2/S hydrogel substrates. Data sets were 
obtained from putative metabolites identified from cells that were analysed after 24 hrs and 
168 hrs in culture classed within vitamin & cofactor metabolism (A & B respectively) and lipid 
metabolism (C & D respectively). Plot points represent individual samples from each substrate 
set (n =3) for plain (red), 2 kPa (green), 6 kPa (blue) and 38 kPa (cyan) F2/S hydrogels. Cell 
metabolism on the F2/S substrates for both pathways remains distinct from the plain substrate 
at both time points. The observed overlap of the F2/S hydrogels at 24 hrs is diminished as cells 
on all four substrates adopt distinctive behaviour from one another for vitamin metabolism at 
168 hrs (B). Lipid metabolism at 168hrs remains similar for the 6 and 38 kPa substrates with a 
small distinction observed for the cells on the 2 kPa F2/S (D). Coloured ellipses illustrate spatial 
borders of each sample set calculated to 95% confidence. 
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3.3.3.2 Hierarchical cluster analysis 
 
Cluster analysis groups metabolites together by measuring sample similarity using 
correlation analysis. Numerical data are then represented in colour scales (heat map) 
allowing sample dissimilarities to be easily observed. 
It is noteworthy that although heat maps are good at spotlighting highly contrasting 
behaviour, some measurements, especially where data populations are very high, make 
changes that occur on a subtle scale difficult to single out in cluster analysis. 
 
For the most part, the cluster analysis echo the observations derived by principal 
component analysis. That is, the noted general likeness in cellular activity between F2/S 
substrates at 24 hours and the more obvious distinction of cell activity on the 2 kPa 
hydrogel at 168 hrs. Profiles for the 6 and 38 kPa hydrogels were also perceived as very 
similar to each other in all instances (Figure 3-11, Figure 3-13, Figure 3-17 & Figure 
3-16). The principal component analysis also indicated however, that there is some 
amount of distinction between the 6 and 38 kPa F2/S hydrogel sets, the likes of which 
may be considered in some instances too subtle to be represented on a colour gradient 
heat map. 
Irrespective, what the cluster analyses enable is the isolation of areas of divergence 
within each metabolic pathway allowing the data to be whittled down to more specific 
modes of action within the subset. To assess this, regions of interest were restricted to 
three main facets; metabolites that showed the most change (up and down regulated) 
between the plain and F2/S substrates, together representing regions where the most 
active change occurs and regions where contrasting change is particular to a certain F2/S 
hydrogel type. 
Performed searches for these distinct points, pertain only to the 168 hr data set as they 
show the most polarised change in cell behaviour. 
 
Carbohydrates 
Although for the most part, there was active catabolism for MSCs cultured on all three 
F2/S hydrogels compared to the plain substrate. At 168 hrs, there were occurrences that 
are contrary to the observed general trend where higher activity on the F2/S hydrogels 
was noted (Figure 3-11).  
Masses of the compounds isolated as described previously were analysed using Pathos; 
a web based facility which allows for detected MS masses to be allocated and mapped 
using the Kyoto Encyclopaedia for Genes and Genomes (KEGG) to the metabolic 
pathways in which they may occur (Kanehisa and Goto, 2000, Leader et al., 2011). 
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Metabolites tend not to participate wholly within a single pathway, playing a number of 
diverse functions and as such a single metabolite cannot be attributed to a sole purpose. 
By combining the entire population, an idea of which specific pathway(s) may be of 
importance in cell differentiation is highlighted by the number of hits gained from the total 
population. For pathway mapping, the population consists of those metabolite masses 
that showed a considerable amount of change, defined earlier as regions of interest and 
by the annotations used on the cluster heat maps. 
 
The pathways that gave the most number of hits for metabolites considered the most 
active compared to the plain substrate were pentose & glucuronate interconversion, 
ascorbate & aldarate metabolism, pentose phosphate metabolism and amino & 
nucleotide sugar metabolism respectively. Contrasting behaviour particular to a F2/S 
substrate was observed for the 2 kPa hydrogel only, and pathway mapping prioritised the 
same as those named previously. 
Of these, the pentose phosphate pathway was of considerable note as it is the primary 
source of NADPH for use in a number of biosynthetic reactions. It is also the source of 
the five carbon sugar ribose-5-phosphate and its derivatives for DNA and RNA synthesis. 
The pentose phosphate pathway also recycles C3 to C7 sugars for reincorporation into 
glycolysis (Figure 3-12) as well as entry points in pentose and glucuronate 
interconversion. 
Glucuronate is a component of proteoglycan and as such occurs in high concentrations 
in the extracellular matrix. It is also a known precursor of ascorbate (Bublitz et al., 1958, 
Grollman and Lehniger, 1957), which is required for the degradation of procollagen into 
collagen by hydroxylation of proline residues into hydroxyproline (Eleftheriades et al., 
1995, Rosenblat et al., 1999, Sullivan et al., 1994).  
These observations; glucuronate and ascorbate metabolism being 2 of the pathways 
having the most contrasting change between the plain and F2/S substrates coupled with 
the fact that ascorbate is widely used to promote cell differentiation in vitro (Lin et al., 
2005, Mirmalek-Sani, 2006, Pittenger et al., 1999, Sekiya et al., 2002), suggest that 
these processes may, in part at least, drive the synthesis of extracellular matrix 
components. 
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Figure 3-11 Hierarchical cluster analysis performed for cells cultured on plain, 2 kPa, 6 
kPa and 38 kPa F2/S hydrogel substrates. Data sets were obtained from putative 
metabolites that were classed within carbohydrate metabolism and analysed at 24 and 168 
hours from each substrate set. The image shows the heat maps generated from individual 
samples (n=3) cultured on each substrate type. At 168 hrs (considered to be the time point 
where the most divergent activity lies), regions are annotated that show the most contrasting 
change where metabolites were most up regulated on the F2/S hydrogels (a) and most up 
regulated on the plain substrate (b). Together, these both highlight regions of most activity 
brought on by substrate change. Region (c) is defined by areas that are particular to a certain 
F2/S hydrogel type as indicated on the image. 
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Figure 3-12 KEGG metabolite map illustrating the pentose phosphate pathway. Detected 
metabolite masses are highlighted in yellow. Masses that showed considerable change from the 
plain substrate when seeded on F2/S hydrogels are circled in blue. Masses that showed 
particular change on the 2 kPa hydrogel are circled in purple. Most of the circled masses lead 
into pentose & glucuronate interconversions or DNA/RNA synthesis. This pathway also 
primarily provides NADPH to drive biosynthetic reactions. The points in the pathway where 
NADPH is produced are denoted with a red asterix. The shaded box singles out non-oxidative 
inteconversions of sugars. 
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Amino acids 
Due to the large population of putative metabolites detected within this pathway, only the 
100 most significantly changed features were included in this analysis. Features were 
selected using one way ANOVA analysis in Metaboanalyst and discriminatory behaviour 
assessed from these before investigation in Pathos. 
Within this population, pathways that gave the most number of hits were for metabolites 
involved in arginine & proline metabolism, aminoacyl tRNA biosynthesis and 
phenylalanine metabolism. Like the previous, contrasting behaviour particular to a F2/S 
substrate was observed for the 2 kPa hydrogel only, and pathway mapping prioritised as 
the same.  
Arginine & proline metabolism plays an essential role in the production of nitric oxide, 
which acts as a powerful signalling molecule in a number of regulatory pathways (Pegg, 
2009). It is also responsible for the biosynthesis of polyamines through the 
interconversion of ornithine by ornithine decarboxylase (ODC). Polyamines are 
ubiquitous cationic molecules that play an essential role in the regulation of a number of 
cell functions inclusive of gene expression (Childs et al., 2003, Pegg, 2009). The net 
positively charged polyamines are known to bind to acidic site of molecules 
characteristically found in cells such as DNA, RNA, proteins and the phospholipid 
membrane. As such, they have a vast effect on the regulation of gene expression and a 
number of other cellular functions such as cell proliferation, stem cell self-renewal (Zhao 
et al., 2012) and differentiation (Childs et al., 2003, Igarashi and Kashiwagi, 2010, Ishii et 
al., 2012, Tjabringa et al., 2008). 
Intriguingly, within this pathway, metabolites that show considerable changes between 
the plain and F2/S substrates have a high number of detected masses clustered around 
proline interconversions (Figure 3-14). Proline through interconversion between it cis and 
trans conformations, plays an important role in defining the secondary and tertiary 
structure of proteins (Wedemeyer et al., 2002).  
Considerable activity observed for aminoacyl tRNA synthesis, suggests increased 
proteinogenic activity of cells cultured on the F2/S hydrogels compared to the plain 
substrate. An observation that is also supported by the overall behaviour in amino acid 
metabolism observed in Figure 3-8. 
 
Analysis of individual amino acids showed a varied composition, with the cells cultured 
on the 2 kPa F2/S substrate having the highest abundance levels of all the substrates. 
This was followed by the 38 kPa F2/S, then the 6 kPa F2/S and lastly the plain substrate 
(Figure 3-15). Interestingly, levels of the amino acid leucine were observed to be highest 
on the 38 kPa F2/S hydrogel where the most amount of osteogenic development was 
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observed (Figure 2-12). Increased levels of leucine associated with osteogenic 
development of MSCs have also been noted in studies assessing the osseointegrative 
properties of cell substrate topographies in orthopaedic medicine (McNamara et al., 
2011). Metabolomic analysis of MSCs differentiating into osteoblasts on nanopatterned 
titanium pillars of various heights by McNamara et al had shown that the optimal 
osteoinductive pillar height of 15 nm also resulted in the highest abundance of the amino 
acid leucine during cellular differentiation (McNamara et al., 2011). 
 
 
 
Figure 3-13 Hierarchical cluster analysis performed for cells cultured on plain, 2 kPa, 6 
kPa and 38 kPa F2/S hydrogel substrates. Data sets were obtained from putative 
metabolites that were classed within amino acid metabolism and analysed at 24 and 168 hours 
from each substrate set. The image shows the heat maps generated from individual samples 
(n=3) cultured on each substrate type. At 168 hrs (considered to be the time point where the 
most divergent activity lies), regions are annotated that show the most contrasting change 
where metabolites were most up regulated on the F2/S hydrogels (a) and most up regulated on 
the plain substrate (b). Together, these both highlight regions of most activity brought on by 
substrate change. Region (c) is defined by areas that are particular to a certain F2/S hydrogel 
type as indicated on the image. 
 
24 hr
168 hr
Plain
2 kPa 
F2/S
6 kPa 
F2/S
38 kPa 
F2/S
Plain
2 kPa 
F2/S
6 kPa 
F2/S
38 kPa 
F2/S
4
3
2
1
0
-1
-2
-3
-4
a b bc
(2 kPa)
c
(2 kPa)
Chapter III – Metabolomics as a tool for illustrating differences in cell phenotype 
 
 
 
90 
 
 
Figure 3-14 KEGG metabolite map illustrating arginine & proline metabolism. Detected 
metabolite masses are highlighted in yellow. Masses that showed considerable change from the 
plain substrate when seeded on F2/S hydrogels are circled in blue. Masses that showed 
particular change on the 2 kPa hydrogel are circled in purple. Most metabolites that showing 
considerable change from the plain substrate are clustered around proline metabolism (shaded 
box).  
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Figure 3-15 Average peak intensities of amino acid as detected using LC-MS, for cells 
cultured on plain, 2 kPa F2/S, 6 kPa F2/S and 38 kPa F2/S substrates. In general, amino 
acid abundances were higher for cells cultured of the F2/S substrates when compared to the 
plain substrate. Cells cultured on the 2 kPa F2/S hydrogels show the highest abundance for 
most of the amino acids with the exception of leucine, phenylalanine and valine. Measurements 
were averaged from 3 replicate injections. 
 
Lipids 
The cluster profiles for lipids have the most contrast of all four pathways between the 
plain substrate and the F2/S substrates. They also represent the bulk of the metabolites 
identified. Most of the lipids are present in appreciable quantities on the plain substrate of 
which little or none are detected on the F2/S substrates (Figure 3-16). Mapping in Pathos 
had revealed that the pathways with the highest number of hits for the population were 
for arachidonate metabolism. Arachidonate is a cell membrane lipid and plays a role in 
second messenger cell signalling processes (Janmey and Lindberg, 2004, Merrill and 
Schroeder, 1993). The lack of detection of most of these masses on the F2/S hydrogels 
could suggest a redesign or redistribution in the cell membrane composition on substrate 
change (Kellam et al., 2003). 
The approach used with amino acids for sample comparison (100 most changed 
metabolites by ANOVA) could not be applied here, so a different tack was taken. 
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Metabolites with little or no information on the F2/S substrate were removed from the 
compound list and only those present in at least 3 of the 4 substrates as ‘functional’ 
metabolites were analysed further. This process reduced the metabolite population from 
260 to 71 and the cluster analysis of the truncated list is shown in Figure 3-16.  
An underrepresentation of most lipids, and a general lack of understanding about their 
principal function(s), does not allow straightforward mapping in most integrated software 
tools and only a small number of these were represented in Pathos (less than 16%, with 
the most number of hits per pathway being 3). Use of the human metabolome database 
(HMDB) (Wishart et al., 2009) identifiers were mapped using Metaboanalyst but were 
only slightly better compared to Pathos. Given this result, a reasonable assessment of 
the role of identified metabolites in known biochemical pathways could not be made. 
The results from attempted lipid mapping are summarised in Table 3-3. 
 
Table 3-3 Summary of detected LC-MS masses putatively identified as lipids. Masses were 
mapped using metaboanalyst and the top four pathways listed 
 Pathway Hits p-value 
Mapped  
(43 masses) 
1. Sphingolipid metabolism 6/25 3.12e-6 
2. Glycerophospholipid metabolism 4/39 0.0046 
3. Propanoate metabolism 3/35 0.023 
4. Butanoate metabolism 3/40 0.033 
Unmapped (382 masses) 
 
 
Propanoate and Butanoate metabolism are not endogenous cell processes and are 
thought to occur through extracellular acquisition of these short chain fatty acids, mostly 
likely from the culture media. Research into sphingolipid metabolism is mainly centred on 
its two key active molecules; sphingosine-1-phosphate and ceramide-1-phosphate. Both 
compounds are known to act as cell membrane components imparting stasis and fluidity 
to the membrane as well as acting as intracellular signalling molecules (Pyne and Pyne, 
2000, Spiegel and Milstien, 2002). 
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Figure 3-16 Hierarchical cluster analysis performed for cells cultured on plain, 2 kPa, 6 
kPa and 38 kPa F2/S hydrogel substrates. Data sets were obtained from putative 
metabolites that were classed within lipid metabolism and analysed at 24 and 168 hours from 
each substrate set. The image shows the heat maps generated from individual samples (n=3) 
cultured on each substrate type. The top two traces show the profiles for the complete 
population of detected lipids at each time point. The bottom trace shows a truncated version of 
168hr having restricted the population to only those detected in the majority of substrates. At 
168 hrs (considered to be the time point where the most divergent activity lies), regions are 
annotated that show the most contrasting change where metabolites were most up regulated 
on the F2/S hydrogels (a) and most up regulated on the plain substrate (b). Together, these 
both highlight regions of most activity brought on by substrate change. Region (c) is defined by 
areas that are particular to a certain F2/S hydrogel type as indicated on the image. These are 
also annotated on the condensed heat map. 
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Sphingosine-1-phosphate, however, is also known to act as a mediator of extracellular 
signals (Spiegel and Milstien, 2002) and is of particular influence in the adaption of cell 
morphology (Harma et al., 2012). 
Glycerophopholipids are the major constituent of the cell membrane. The name 
encompasses a vast host of molecules comprising a glycerol moiety with variations 
occurring at their head groups, producing phosphatidylinositols, phosphatidylcholines or 
phosphatidylglycerols to name a few. All of which incorporate an added degree of 
complexity through variations in fatty acid chain length and degree of saturation. 
Although most known functions of glycerophospholipids are as structural components 
promoting cell integrity, a number of studies have shown that these compounds in their 
own right carry out signalling and regulatory functions (Kilpinen et al., 2013, Li et al., 
2007, Sims et al., 2013). 
 
Vitamins & cofactors 
The small numbers of metabolites detected within this group make it hard to postulate 
with any degree of certainty where the bulk of cell activity specifically lies. Analysis of 
detected masses in Pathos broadly distributes these into a number of pathways not 
necessarily known to overlap. That is the number of hits per pathway were no higher 
than 3 lending little confidence about making assessments attributed to a specific 
process. 
Nevertheless, differential behaviour between substrate for specific compounds can be 
observed (Figure 3-17). In a general sense, the bulk of the total population can be placed 
within B-vitamin metabolism (80%). The difficulty to pin point areas of particular interest 
may also be due to the fact that these metabolites deal with functional molecules that 
have a high degree of recyclability; B3 vitamins are precursor to nicotinamide adenine 
dinucleotide (NAD/NADH) and adenosine triphosphate (ATP), B2 vitamins are precursors 
to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). The nature of 
these molecules and the roles they play in facilitating reactions mean that they are in 
constant and rapid flux; therefore their activities may not be wholly captured by the 
currently employed methodologies.  
One such pathway of interest is nicotinate and nicotinamide metabolism which plays a 
major role in the synthesis of NAD and NADH as well as ensuring the cell maintains 
these in optimal proportions (Stein and Imai, 2012). The ratios of NAD/NADH maintained 
by the cells are differential, and observed to be specific to particular cell types (Alano, 
2007).  
As such, it could be postulated that demands of such a specific nature, can be taken into 
account when considering differences in phenotype adopted by MSCs cultured on each 
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of the substrate surfaces. This also likely goes some way to influencing the effect seen in 
Error! Reference source not found.F where substrate properties produce the 
differential effects observed by principal component analysis. 
Although they do not form mature cell types within the 24 hr time frame it is likely that 
early adopted behaviour to meet energy demands reflect the intentions of the cells as 
they develop on the substrates. 
 
 
 
Figure 3-17 Hierarchical cluster analysis performed for cells cultured on plain, 2 kPa, 6 
kPa and 38 kPa F2/S hydrogel substrates. Data sets were obtained from putative 
metabolites that were classed within vitamin & cofactor metabolism and analysed at 24 and 
168 hours from each substrate set. The image shows the heat maps generated from individual 
samples (n=3) cultured on each substrate type. At 168 hrs (considered to be the time point 
where the most divergent activity lies), regions are annotated that show the most contrasting 
change where metabolites were most up regulated on the F2/S hydrogels (a) and most up 
regulated on the plain substrate (b). Together, these both highlight regions of most activity 
brought on by substrate change. Region (c) is defined by areas that are particular to a certain 
F2/S hydrogel type as indicated on the image. 
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3.4 Summary 
Each sample set was analysed for the total protein content measured using UV (Bradford 
assay). Peak intensity values measured using LC-MS were then normalised against 
respective protein content. 
Total metabolite abundance was assessed after 24 hrs and 168 hrs (1 week) in culture.  
The plain (control) substrates did not show any discernible change over the two 
measured time points. MSCs cultured on the hydrogel surfaces showed a significant 
decrease in concentrations at 24 hrs and these levels were observed as ‘recovered’ 
(comparable to control) after one week. It is thought that when cells are introduced into a 
microenvironment they undergo a period of adaptation and eventually reach a point of 
stability where the net change in cell activity is comparatively negligible as observed by 
day 7. This equilibrated state, however, manifests differently for each of the substrates 
when the metabolome is analysed as a whole (illustrated using volcano plots) showing 
unique dispersion patterns for cells cultured on each substrate.  
From this, smaller subsets (classified into metabolic pathways – amino acid, lipid, 
carbohydrate, vitamin & cofactor metabolism) were used to highlight differences that 
occur on a subtler scale. Cell activity was observed as generally anabolic for amino acid 
and vitamin metabolism and catabolic for carbohydrate and lipid metabolism.  
PCA analysis of each pathway had shown that cell activity of MSCs cultured on the plain 
substrates were distinct from those on the F2/S hydrogel substrates. MSCs on the F2/S 
hydrogel showed no discernible distinction from one another at 24 hrs but began to differ 
after 1 week (168 hrs) in culture. Of the three F2/S substrates, cells cultured on the 2 kPa 
F2/S showed the most distinctive metabolic behaviour with cells cultured on the 6 and 38 
kPa F2/S surface having a degree of overlap. Vitamin & cofactor metabolism however, 
showed unique metabolic patterns for all four substrates independent of one another. 
Assessment by cluster analysis more or less echoed the sentiments of PCA with cells on 
the 2 kPa F2/S showing distinctive metabolic profile from the 6 and the 38 kPa F2/S which 
were otherwise very similar to each other. 
Assessment by cluster analysis however, enabled pathway mapping of metabolite 
masses showing the most contrasting differences between the plain and F2/S substrate 
and for masses showing differing activity between the F2/S substrates themselves. Of 
these, the pentose phosphate pathway was highlighted for NADPH generation for 
biosynthetic processes as well as arginine & proline metabolism for the observed effect 
on proline interconversion. 
Whilst total amino acid metabolism is observed as steady over 24 hrs in culture (Figure 
3-8), the results suggest that the proteinogenic process to affect change is somewhat 
delayed (later than 24 hrs) as the cells explore their external surrounding and adjust to it 
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accordingly. The overall biosynthetic process observed at 7 days (168 hrs) requires 
energy input and catabolism of the required carbohydrate and lipid molecules. 
Interestingly, in line with this, the precursors needed to drive this process show the most 
effect after 24 hrs (vitamins & cofactors, carbohydrate metabolism) leading up to 
phenotypical differences that begin to manifest around 168 hrs in culture. 
Mapping metabolite masses for vitamin and cofactor metabolites were of a sporadic 
nature returning only a few hits per pathway reducing confidence. As such making any 
plausible assessments proved very difficult. As a collective, it was noted that most of the 
masses could be attributed to B vitamin metabolism which is responsible for the building 
blocks of cofactors such as NAD, FAD & ATP, compounds that are responsible for 
driving many a reaction. 
Lipid metabolite masses had presented with the same problem as those for vitamin and 
cofactor metabolism albeit, for a different reason. Whereas with vitamin and cofactor 
metabolism most masses were few or not identified, most of the lipid masses could be 
identified but not mapped due to a lack of general information on the role these 
compounds play within the cell. This finding is somewhat frustrating given that lipid 
metabolism was the only pathway that had detected regions on the clusters where 
change in behaviour particular to a substrate was not restricted for the most part to the 2 
kPa F2/S, but regions of change were also noted for the 6 and 38 kPa substrates also 
(Figure 3-16).  
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4.1 Introduction 
The use of small molecules to direct stem cell fate on differentiation is a practice that has 
been in place for many years. They have shown particular usefulness as a means of 
modulating cell behaviour and function through targeting certain cell signaling 
mechanisms. Phenotypical screening, sometimes involving the use of high throughput 
processes, has led to the use of singular or combinatorial chemistries for influencing cell 
behaviour. Of these, purmorphamine, dexamethasone and ascorbic acid have been 
shown to influence osteogenic and chondrogenic development of cells (Lin et al., 2005, 
Mirmalek-Sani, 2006, Pittenger et al., 1999, Sekiya et al., 2002, Wu et al., 2004) and are 
used conventionally as such in vitro. Isobutylmethylxanthine (IBMX), indomethacin and 
rosiglitazone through induced PPAR-γ activation are known to drive adipogenesis of 
stem cells (Benvenuti et al., 2007, Janderova et al., 2003, Klemm et al., 2001, Mirmalek-
Sani, 2006, Zuk et al., 2001). While all trans retinoic acid and β-mercaptoethanol are 
broadly used in culture systems for neuronal differentiation (Yim et al., 2007, Woodbury 
et al., 2000). 
These compounds tend to have broad acting, non-specific modes of action, modulating a 
number of pathways that have generic effects on cellular behaviour such as Smad, 
extracellular signal regulated kinase (ERK) or protein kinase C (PKC). For example, 5-
aza-cytidine, a DNA methylating compound, has no direct induction on any specific 
differentiation pathway but acts by switching the cell into a state whereby it is susceptible 
to spontaneous differentiation (Ding and Schultz, 2004). As a result, 5-aza-cytidine is 
implicated in myogenic (Lassar et al., 1986, Taylor and Jones, 1979), adipogenic (Taylor 
and Jones, 1979) and chondrogenic (Taylor and Jones, 1979) development of stem cells. 
This characteristic, on one hand, allows the ability to able to induce cells along a primary 
lineage with careful consideration. And on the other, they are also prone to generate 
heterogeneous cell populations due to the effects of cross reactivity.  
However, the promise of the role of small molecules in pharmacology is considerable 
given the focus on the generation of research libraries for stem cell therapies. They also 
provide some distinct advantages over other currently used techniques; such as gene 
manipulation, lessening the risk associated with viral integrated transcription factors in 
induced pluripotency of stem cells (Ding and Schultz, 2004). As such, it would be of great 
advantage to be able to isolate small molecules that have the propensity to reduce 
population heterogeneity when seeking to either maintain stem cells in an 
undifferentiated state or looking to drive them toward a particular cell fate by acting 
through more discrete cell mechanisms.  
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Metabolite (biological small molecule) profiling of stem cell behaviour during 
differentiation using a broad metabolomics approach gives information on the plethora of 
naturally occurring small molecules that exist within the cell as illustrated in the previous 
chapter. These populations are likely inclusive of small molecules that are vital in 
influencing signalling transduction pathways such as PKC or mitogen activated protein 
kinase (MAPK) for example, affecting functions such as DNA transcription, cell 
differentiation and apoptosis. 
The exploration of small compounds generated as a result of innate cell activity may give 
an insight into metabolites that facilitate stem cell differentiation through more discrete 
pathways leading to the development of more uniform cell populations in vitro, as well as 
finding application in cellular re-programming methods. 
 
4.1.1 Objective 
As illustrated in the previous chapter, an unbiased study of the cells metabolome by LC-
MS is able to reflect changes in cellular phenotype as they undergo differentiation. 
Further scrutiny of the LC-MS data has the potential to give more detail into the activity of 
the cells beyond illustrating general trends. It was postulated that careful analysis of the 
obtained data could give information on lesser researched intrinsic molecules that may 
play a role in influencing stem cell lineage commitment during differentiation.   
 
4.2 Materials & methods 
4.2.1 Materials 
Materials/Reagents Supplier(s) 
Mesenchymal stem cells Promocell GmBH, Germany. 
Fmoc-diphenylalanine Bachem, UK 
Fmoc-serine Bachem, UK 
Sodium hydroxide Fisher chemicals, UK 
Distilled water Invitrogen, UK 
Dulbeccos modified eagle medium (DMEM) Sigma Aldrich, UK 
Foetal bovine serum (FBS) Sigma Aldrich, UK 
Penicillin streptomycin Sigma Aldrich, UK 
Trypsin Sigma Aldrich, UK 
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Cholesterol sulphate (sodium salt) Sigma Aldrich, UK 
1-octadecanoyl-sn-glycero-3-phosphate (GP18:0) Avanti polar lipids Inc., USA 
Sphinganine Sigma Aldrich, UK 
Dimethyl sulfoxide (DMSO) Sigma Aldrich, UK 
Human insulin Sigma Aldrich, UK 
Dexamethasone Sigma Aldrich, UK 
Ascorbate-2-phosphate Sigma Aldrich, UK 
Transforming growth factor β1 (TGF-β1) Sigma Aldrich, UK 
Sodium pyruvate Sigma Aldrich, UK 
Phosphate buffered saline (PBS)
*
 In-house 
Fixative
*
  In-house 
Permeability buffer
*
 In-house 
1% BSA in PBS
*
 In-house 
Vectashield-DAPI Vector laboratories, USA 
Rhodamine-phalloidin Invitrogen, USA 
Primary antibodies 
Abcam, UK & Santa Cruz 
biotechnologies, USA 
Biotinylated secondary antibodies Vector laboratories, USA 
Streptavidin-FITC Vector laboratories, USA 
0.5% Tween 20 in PBS
*
 In-house 
Alizarin red S Sigma Aldrich, UK 
RNeasy micro kit Qiagen, UK 
Trizol Life technologies, UK 
Chloroform Sigma Aldrich, UK 
Glycoblue Ambion, UK 
Isopropanol Sigma Aldrich, UK 
Ethanol VWR Chemicals, France 
RNase free water Qiagen, UK 
Quantitech reverse transcription kit Qiagen, UK 
Quantifast SYBR green PCR kit Qiagen, UK 
                                               
*
 Preparation procedures for reagents & buffers made in-house are detailed in the appendix. 
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4.2.2 Test compounds 
5mg of cholesterol sulphate and 1-octadecanoyl-sn-glycero-3-phosphate (GP18:0) was 
dissolved in 0.25 ml of DMSO to give a stock solution of 20 mg/ml. 10mg of sphinganine 
was dissolved in 0.5 ml of DMSO by sonication at 40°C to give a stock solution of the 
same concentration.  
All stock solutions were subsequently stored at -20°C. 
 
4.2.3 Cell culture 
29.4 μl, 18 μl and 26.4 μl of each compound (Cholesterol sulphate, Mw 488.7; 
sphinganine, Mw 301.51 and GP18:0, Mw 460 respectively) were added to 12 ml of 
DMEM culture media to give a uniform starting concentration of 100 μM of each 
compound. Care was taken to ensure that the final DMSO concentration in this solution 
was less than 0.3% to make certain that cell culture conditions are affected only by the 
test metabolites. 
Starting solutions were then serially diluted 10x to give 10 μM, 1 μM, 100 nM, 10 nM and 
1 nM solutions. All 6 solutions were then stored at -20°C until ready for use in cell culture. 
Cells were cultured in well plates with each compound at each concentration initially for a 
period of two weeks to assess for toxic effects and subsequently for three weeks with all 
three test compounds for their ability to influence MSC differentiation lineages.  
 
4.2.3.1 Micromass cell culture 
To aid chondrogenic development of MSCs, cells were maintained in culture using a 
micromass protocol. Micromass cell culture is an adapted version of the pellet culture 
system generally used for chondrogenic development of bone marrow stromal cells. The 
micromass culture system maintains the three dimensional support needed to maintain 
phenotypic integrity of chondrocyte cells, in particular, it also allows in vitro monitoring of 
chondrogenic development to occur at a smaller scale compared to the pellet culture 
method (Johnstone et al., 1998, Muraglia et al., 2003). Cells are cultured within a 
confined space and at high density to encourage formation of the spherical phenotype 
adopted by chondroblast cells as is already attained in pellet culture. This method of cell 
culture was used to assess the ability of GP18:0 to influence the chondrogenic 
development of MSCs in vitro. 
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Cell suspension droplets (50 μl) were incubated at 37°C for at least 1½ hours on culture 
well plates to allow the cells to adhere. Care was taken to ensure that this small volume 
did not evaporate over the time taken to allow adhesion to occur. 
After cells had adhered to the culture well 500 μl of chondrogenic induction media or the 
required concentration of GP18:0 was gently added to the well and the cells maintained 
in culture for 10 days. 
4.2.3.2 F2/S hydrogel cell culture 
Soft hydrogel substrates (2 kPa) were fabricated and used for culturing MSCs as 
described earlier in 2.2.3. MSCs cultured on the F2/S were used to assess the effect of 
the test compound sphinganine on neuronal differentiation of the MSCs over a two week 
period. F2/S culture with sphinganine was carried out as results can conflict when 
inducing a low tension phenotype on hard and soft biomaterials. 
4.2.3.3 Standard differentiation controls 
Directed differentiation of MSCs was accomplished by supplementing standard DMEM 
culture media with tailored cocktailing of inducing agents. These were used as positive 
controls against the relevant test items. 
Chondrogenic differentiation was induced as described elsewhere (Lin et al., 2005, 
Sekiya et al., 2002) using DMEM containing 10% FBS, insulin (6.25 μg/ml), 
dexamethasone (100 nM), ascorbate-2-phosphate (50 nM), transforming growth factor 
(TGF-β1, 10 ng/ml) and sodium pyruvate (110 μg/ml). 
Osteogenic differentiation was induced using DMEM containing 10% FBS, 
dexamethasone (100 nM) and ascorbate-2-phosphate (350 μM). 
Cells were then maintained at 37°C in differentiation media and the media changed twice 
weekly for the duration of the experiment. 
 
4.2.4 Cytotoxicity 
Cells were rinsed once in PBS and fixed at 37˚C for 15 minutes. They were then 
permeabilised and blocked using 1% BSA in PBS. A drop of vectashield-DAPI was 
placed over the cells and samples stored at 4˚C wrapped with tin foil to protect from light 
until ready for viewing under a microscope. 
Cells visualised by fluorescence staining of their nuclei were counted by observation 
using a cell counter. An average count was taken from five repeat samples and used to 
ascertain what concentration ranges were suitable for further experiments. 
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4.2.5 Immunocytochemistry 
Immunocytochemistry and microscopic analysis was carried out as detailed in 2.2.5 and 
2.2.6. Details of the primary, secondary and tertiary antibodies used for this chapter are 
given in Table 4-1. 
 
Table 4-1 Biomarkers used for detection of cellular differentiation 
Differentiation 
lineage 
Biomarker Primary antibody 
Secondary 
antibody 
Fluorophore  
Osteogenesis 
OPN 
Mouse 
monoclonal IgG 
Biotinylated anti 
mouse 
Stretavidin 
conjugated FITC 
OCN 
Chondrogenesis 
SOX-9 
COL2A1 
Aggrecan 
Cytoskeleton F-actin   
Phalloidin 
conjugated 
rhodamine 
Nucleus    DAPI 
 
4.2.6 Alizarin red staining of osteogenic cultures 
2 grams of alizarin red was weighed and dissolved in 100 ml of distilled water to create a 
20mg/ml or 8.3 mM solution. The pH was then adjusted to 4.2 with sodium hydroxide and 
the solution passed through a 0.2 µm filter. 
Culture media was aspirated to waste and the cells washed once with 500 µl of PBS. 
After washing, 500 µl of 10% formalin (fixative) was added to each well and allowed to 
incubate at room temperature for 20 minutes after which the cells were then washed 
twice for 5 minutes on a shaker with water. 
Following this, 500µl of alizarin red s solution was added to each culture well and 
incubated at room temperature for 30 minutes. Cells were then washed four times with 
1ml sterile water or repeatedly until the liquid was clear. Samples were stored in PBS 
solution at 4˚C until ready for viewing under a microscope. 
 
4.2.7 RNA extraction and reverse transcription 
RNA extractions of cells cultured in plastic well plates were done using the RNeasy 
microkit (Qiagen) as per manufacturers protocol and extractions from cells cultured on 
the 2 kPa hydrogel substrates were done as described in 2.2.7. 
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Reverse transcription of all samples was carried out using the QuantiTect reverse 
transcription kit (Qiagen) as per the manufacturer’s instructions. 
Resultant cDNA samples were then stored at -20°C or used immediately for qRT-PCR 
experiments. 
 
4.2.8 QRT-PCR 
Samples intended for qRT-PCR analyses were handled as described in 2.2.8. Details of 
the PCR primers used within this chapter are given in Table 4-2. 
 
Table 4-2 PCR primers designed for human genes 
Gene   
GLUT-4 
Forward 5’-ATG TTG CGG AGG CTA TGGG-3’ 
Reverse 5’-AAA GAG AGG GTG TCC GGT GG-3’ 
OPN 
Forward 5’-AGC TGG ATG ACC AGA GTG CT- 3’ 
Reverse 5’-TGA AAT TCA TGG CTG TGG AA -3’ 
Collagen type II 
(COL2A1) 
Forward 5’-GTG AAC CTG GTG TCT CTG GTC-3’ 
Reverse 5’-TTT CCA GGT TTT CCA GCT TC-3’  
Nestin 
Forward 5’-GTG GGA AGA TAC GGT GGA GA-3’ 
Reverse 5’-ACC TGT TGT GAT TGC CCT TC-3’ 
β3-tubulin 
Forward 5’-CAG ATG TTC GAT GCC AAG AA -3’ 
Reverse 5’-GGG ATC CAC TCC ACG AAG TA-3’ 
GFAP 
Forward 5’-GCT TCC TGG AAC AGC AAA AC-3’ 
Reverse 5’-AGG TCC TGT GCC AGA TTG TC-3’ 
GAPDH 
Forward 5’-ACC CAG AAG ACT GTG GAT GG-3’ 
Reverse 5’-TTC TAG ACG GCA GGT CAG GT-3’ 
 
4.2.9 Statistical Analysis 
Suitable statistical tests were applied where warranted. Unpaired student t-tests were 
carried out using Microsoft excel for comparisons between two test groups. Analysis of 
variance (ANOVA) and Bonferroni post hoc tests were performed using GraphPad prism 
software to compare more than two study groups. One-way ANOVA was used when 
tests present with a single variant and two-way ANOVA for sample sets with more than 
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one variable. Statistical significance is noted where the calculated probability that the null 
hypothesis is true (p-value) is less than 5% confident (0.05) using four biological 
replicates unless otherwise stated. 
Mean values for replicate experiments, standard deviations (StDev) and standard error 
from the mean (SEM) were calculated using Microsoft excel. 
 
4.3 Results & Discussion 
4.3.1 Isolating compounds of interest from the metabolome 
In the previous chapter, numerical data obtained by mass spectrometric analyses were 
translated into heat maps to easily visualise regions or metabolites that show differential 
behaviour when cells were cultured on each substrate (plain, 2 kPa F2/S, 6 kPa F2/S and 
38 kPa F2/S). The heat maps and volcano plots were investigated in conjunction with one 
another in order to choose metabolites that may be of further interest, that is, metabolites 
that showed unique behaviour to a particular substrate. Although the heat maps give an 
insight into the abundance of metabolites the volcano plots serve as an added 
confidence, singling out molecules that are also of statistical significance (Figure 4-1). To 
reduce the search size, selected metabolites were taken from those identified as being 
involved with lipid metabolism.  
While it is acknowledged that metabolomics carried out for assessment of the lipid 
population using HILIC is far from ideal, indeed a lipidomics approach optimising 
methods toward lipid detection is advisable were it the only facet of interest. The 
presently used HILIC technique however, is not necessarily a method that is considered 
entirely devoid of information on cellular lipids. In this vein, metabolite masses putatively 
identified as being involved in lipid metabolism were chosen for further investigation for a 
number of reasons. Samples within the lipid metabolism pathway showed the most 
amount of change on differentiation compared to the other investigated pathways. It also 
gave the most visible differential change between the F2/S substrates when compared to 
the other pathways for which the most contrasting change was noted only for the 2 kPa 
F2/S hydrogel. Lastly, within cell biology generally, functional changes are widely 
researched with regards to the genomic and proteomic changes. Relative to these, 
limited information is available about the role of lipids as regulators of cell behaviour and 
function as is highlighted in the previous chapter. 
It therefore stands to reason that this facet of cell biology be explored further as the 
metabolomics study allows the means for doing so.  
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Due to the limitations associated with performing a global metabolomics study as 
discussed in the previous chapter, a number of precautions were taken when selecting 
metabolites for further study which also contributed to downsizing the search field: 
 
a) The confidence value: the measure of confidence makes use of an arbitrary value 
between 1 and 10 (10 indicating the highest confidence) based on the retention time 
drift of the measured mass from the calculated/predicted retention when performing 
metabolite identification in Ideom. Selection was restricted to metabolites with a 
confidence factor of 6 and above. 
 
b) The number of putative metabolites identified for a chosen mass from database 
cross-referencing is kept as low as possible. This reduces the risk of choosing false 
positives from metabolites with similar masses that could not be distinguished 
through chromatographic separation. It is acknowledged however, that this condition 
applies to the confines of the analytical tools used in this thesis. That is, metabolite 
identification of noted isomers is restricted to the scope of the databases that Ideom 
uses for identification. 
 
c) Metabolite(s) that showed a significant decrease in abundance that was unique to 
a particular substrate. It also had to be detectable on the plain surfaces (control 
sample) indicating its presence within the cells when it is in a ‘resting’ state and 
showing depletion when the substrate properties are changed, i.e, cultured on 
hydrogel surfaces.  
 
d) Other factors out with metabolite mass detection and behaviour such as 
commercial availability and current research done on each compound, which may 
give an inclination on the likelihood to affect cell behaviour (supporting the 
hypothesis), were also taken into consideration. 
 
Using the aforementioned criteria, the metabolites cholesterol sulphate (CS), 1-
octadecanoyl-sn-glycero-3-phosphate (GP18:0) and sphinganine were singled out for 
further investigation (Figure 4-2).  
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Figure 4-1 Simplified schematic illustrating metabolite selection process. Metabolite 
chosen for further investigation were LC-MS metabolites that had been putatively identified as 
being involved in lipid metabolism. Selections were whittled down based on a number of 
defined criterion inclusive of measured abundances singled out by cluster analysis and 
statistical significance as determined from the volcano plots. 
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Figure 4-2 Average peak intensities of metabolites isolated for further investigation. 
Metabolites were chosen from those identified as being involved with lipid metabolism. An 
initial condition for selection was that each metabolite showed considerable depletion on a 
singular substrate compared to the remaining three biomaterials suggesting it may play a 
functional role that occurs uniquely in cells cultured on that particular substrate. Error bars 
denote standard deviations from the mean; n = 3 replicates; * notes statistical significance to 
the total population where p < 0.05, ** where p < 0.01 and *** where p < 0.001 calculated using 
one way ANOVA. 
 
4.3.2 Metabolite cytotoxicity and screening for differentiation 
The metabolites were serially diluted 1 in 10 with DMEM culture media over the 
concentration range 1nM to 100μM. MSCs were then cultured in increasing 
concentrations of each metabolite and the cells observed over two weeks for any visible 
adverse effects. Cell counts were carried out after 1, 7 and 14 days in culture. Cells were 
fixed, permeabilised and their nuclei stained with DAPI. Cells were counted by 
observation under a fluorescence microscope. Numbers were then averaged (n = 5 
replicates) and standard deviations calculated. 
Cells were tolerant of cholesterol sulphate and GP18:0 for 2 weeks up to 10 μM where 
no significant change from the totalled average cell number was noted. A drop in the cell 
populations at 1 μM after 7 days was noted when cells were cultured with GP18:0. 
However, cell populations were observed to be stable for the duration in culture. Cells 
cultured with sphinganine showed less tolerance to this compound as sphinganine was 
found to be toxic at the 10 and 100 μM (Figure 4-3). Subsequent experiments were 
therefore performed using the range 1 nM – 10 μM for cholesterol sulphate and GP18:0 
and 1 nM – 1 μM for sphinganine. 
Chapter IV – Identifying endogenous small molecules from the metabolome that drive 
differentiation 
 
 
 
110 
 
 
Figure 4-3 Cytotoxicity profiles of the metabolites cholesterol sulphate, GP18:0 and 
sphinganine. Mesenchymal stem cells were cultured with increasing concentrations of 
endogenous metabolite for a two week period. Cell nuclei were stained with DAPI and counted 
after 1, 7 and 14 days in culture to ascertain populations of adherent cells. Cells were shown to 
be to cholesterol sulphate and GP18:0 up to 10 μM, while tolerance to sphinganine was 
observed up to 1 μM. Dashed line represents the average number of cells over the total 
population; Error bars denote standard deviations from the mean; n = 5 replicates; * notes 
statistical significance to the total population where p < 0.05 calculated using unpaired 
student t-test. 
 
Having determined cell tolerance levels to each of the chosen metabolites, MSCs were 
then cultured with these increasing concentrations of sphinganine, GP18:0 and 
cholesterol sulphate for a total of 3 weeks. Cell samples were then analysed for 
expression of differentiation biomarkers using a qRT-PCR screen. Cell samples were 
assessed for the production of nestin as indication of neuronal differentiation, Glut-4 for 
adipose differentiation, type II collagen and osteopontin for chondrogenic and osteogenic 
development respectively. Gene expression was compared to non-supplemented media 
sample set as well as being assessed for a dose dependent up-regulation in average 
gene expression (Figure 4-4). 
Cholesterol sulphate showed strong induction of the osteogenic biomarker osteopontin. 
The same dose dependent up-regulation was not observed for nestin, GLUT-4 and type 
II collagen, suggesting that cholesterol sulphate is an osteoinductive metabolite. 
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Incubation of MSCs with GP18:0 showed a dose dependent increase in osteopontin but 
also for gene expression of type II collagen, a marker of chondrogenic development. 
Both genes showed a 6-fold increase at their optimum when cultured with 0.1 and 1 μM 
concentrations. These observations suggest that GP18:0 plays a role in both 
chondrogenic and osteogenic development of MSCs during differentiation. 
Sphinganine did not show influence on the up-regulation of any of the tested lineages 
when cultured with MSCs. The effect of sphinganine on MSC behaviour was investigated 
in more detail and is discussed at a later point within this chapter. 
 
 
 
Figure 4-4 PCR screening to detect expression of specific differentiation biomarkers. 
Mesenchymal stem cells were cultured with increasing concentrations of cholesterol sulphate, 
1-octadecanoyl-sn-glycero-3-phosphate (GP18:0) and sphinganine. Samples were evaluated for 
production of the differentiation markers nestin, Glut-4, type II collagen (COL2A1) and 
osteopontin (OPN). Cells cultured with cholesterol sulphate (A), showed a dose dependent 
increase in OPN expression, while cells cultured with GP18:0 showed up regulation of both OPN 
and COL2A1. Cells cultured with sphinganine (C) did not show up regulation of any of the 
tested lineages. Negative control is held nominally at 1 (dashed line). Error bars denote 
standard error from the mean; n = 4 replicates; * notes statistical significance to the control 
where p < 0.05 for osteopontin; § notes statistical significance to the control where p < 0.05 for 
type II collagen; *** notes statistical significance to the control where p < 0.001 for nestin 
calculated using one way ANOVA. 
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4.3.2.1 Cholesterol sulphate 
Cholesterol sulphate is a metabolite formed from its more ubiquitous precursor 
cholesterol. It is found widely in most tissue types but is particularly noted for its 
abundance in skin where it facilitates the differentiation of keratinocytes (Kuroki et al., 
2000). Cholesterol sulphate is also known to induce phosphorylation of high mobility 
group protein 1(HMG1) via casein protein I (CK-I) (Okano et al., 2001). HMG1 belongs to 
a larger family of high mobility group proteins that are associated with chromatin and play 
important roles in the regulation of gene transcription (Boonyaratanakornkit et al., 1998), 
suggesting an affecting role of cholesterol sulphate in gene expression. 
Although cholesterol sulphate has attracted due interest in research, little is known about 
its ability to influence cell lineage commitment during stem cell differentiation. To confirm 
the results observed in Figure 4-4, MSCs were again cultured with cholesterol sulphate 
and fluorescently stained for osteopontin and osteocalcin expression, after 21 days in 
culture, both were observed to be up regulated (Figure 4-5). Extracellular calcium 
deposits, as evidence of mineralisation were also observed when cells were stained with 
alizarin red (Figure 4-6).  
Although not as potent as the synthetic glucocorticoid dexamethasone, cholesterol 
sulphate, which is also a glucocorticoid (Figure 4-7), demonstrated a strong influence in 
promoting the production of osteogenic markers; dexamethasone is conventionally used 
in the nM concentration in osteoinductive media compared to cholesterol sulphate, which 
was tested at 1 μM).  
While it is known that glucocorticoids play an integral role in the initial differentiation of 
MSCs along the osteogenic lineage (Bellows et al., 1987, Cooper et al., 1999, Mirmalek-
Sani, 2006, Pittenger et al., 1999), over exposure to glucocorticoids can lead to the 
inhibition of osteogenesis (and on a larger scale osteoporosis (Manelli and Giustina, 
2000)). This increase or over exposure in glucocorticoid levels is known to cause a shift 
in function, instead promoting adipogenesis (Bujalska et al., 2008, Justesen et al., 2004, 
Mirmalek-Sani, 2006, Zuk et al., 2001). For this reason, the widespread use of 
dexamethasone as a media supplement for differentiating cells in vitro requires, in 
addition to careful concentration management, the presence of other compounds that 
bias the system towards the desired lineage. Typically, nM concentrations of 
dexamethasone are used for osteogenic differentiation while μM amounts of 
dexamethasone or cortisol has been used for adipogenesis (Bujalska et al., 2008, 
Janderova et al., 2003, Klemm et al., 2001, Zuk et al., 2001). The lack of an exact “cut 
off” point between dexamethasone as an osteo- or adipo- inductive agent can render 
formation of a heterogenous cell population when MSCs are differentiated in vitro. 
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Cholesterol sulphate on the other hand, was used at concentrations at which 
dexamethasone and cortisol are known to induce adipogenesis (1 μM). Analysis of 
cholesterol sulphate effects by qRT-PCR (Figure 4-4A) indicated that at this 
concentration, GLUT-4 expression was negligible (1.2 fold change) compared to OPN 
expression (34 fold increase) suggesting that cholesterol sulphate is less likely to 
produce the heterogeneity effect that can be observed when using dexamethasone in in 
vitro culture. 
 
 
  
 
Figure 4-5 Immunofluorescence images of MSCs cultured in non-supplemented media, 
osteogenic induction media (OIM) and 1 µM cholesterol sulphate (CS). Cells were 
maintained in culture for 3 weeks prior to staining. Cells cultured with cholesterol sulphate 
stained positively for differentiation biomarkers osteopontin and osteocalcin, indicating that 
cholesterol sulphate induced osteogenic development in MSCs. Fluorescence images show actin 
cytoskeleton (red), cell nuclei (blue) and either osteopontin or osteocalcin (green). Scale bar - 
100μm. 
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Figure 4-6 Light microscopy images of cells stained with alizarin red for calcium 
deposition. Cells were cultured without (A) and with 1 μM cholesterol sulphate (B) for three 
weeks and then stained with alizarin red to assess for calcium mineralisation as MSCs 
differentiate into osteoblasts.  Cells in (A) have only their intracellular calcium content stained 
by alizarin red while those in (B) have both intracellular and extracellular (circled) calcium 
deposits stained. Scale bar - 100μm. 
 
 
 
Figure 4-7 Chemical structures of the naturally occurring glucocorticoid cortisol (A), the 
synthetic counterpart dexamethasone (B) and cholesterol sulphate (C). All three 
compounds are cholesterol derivatives, which may account for their common effect in inducing 
differentiation. Cortisol is known to induce both osteogenic and adipogenic effects. 
Dexamethasone also induces osteo- and adipogenic fates in MSCs and is routinely used in 
conjunction with other reagents in in vitro differentiation protocols. Cholesterol sulphate 
however, shows an osteogenic effect on MSCs as the sole inducing agent and was not shown to 
affect adipogenesis. 
 
Analysis using ingenuity pathways (IPA) to integrate metabolomic data with known 
genomic and proteomic activity shows that cholesterol sulphate is implicated in TGF-β 
mediated cell activity.  
The TGF-β family comprises a set of related proteins inclusive of activins, bone 
morphogenic proteins (BMP) and growth differentiating factors (GDF). In broad terms, 
these proteins transmit signals from the cell membrane where they are located to the 
nucleus via the Smad signalling cascade resulting in a number of cell functions inclusive 
of differentiation. A number of steroidal compounds such as cortisol and 
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dehydroepiandrosterone sulfate (DHAS) have been shown to influence the activity of 
TGF-β (Lebrethon et al., 1994) and it may be that the structurally similar cholesterol 
sulphate also acts via this signalling route. Whether this interaction empathically leads to 
differentiation in MSCs however, is a hypothesis that still needs to be confirmed. 
 
 
 
Figure 4-8 Ingenuity interaction pathway depicting direct (unbroken arrow) or indirect 
(broken arrow) molecular interactions for MSCs cultured on 38 kPa F2/S hydrogels. The 
assembled network illustrates the link between cholesterol sulphate (purple dashed outline), 
TGF-β and the wider influencing MAPK, which is activated in response to external stimuli via 
integrin signalling (blue outline). Hubs for detected down regulated metabolites are shown in 
green, up regulated in red and unchanged in gray. CP denotes systems involved in canonical 
pathways 
 
4.3.2.2 1-octadecanoyl-sn-glycero-3-phosphate (GP18:0) 
Lysophosphatidic acids (LPAs) comprise a glycerol phosphate backbone attached to a 
fatty acyl chain. The structures of LPAs differ due to variations in the length and 
saturation of the acyl chain. They are known to act as regulators of the MAPK and ERK 
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pathways (Kim et al., 2005) both of which play central signalling roles in a number of cell 
functions inclusive of differentiation, acting via membrane bound G-protein coupled 
receptors (LPA1 – LPA6 inclusive). 1-octadecanoyl-sn-glycero-3-phosphate (GP18:0), the 
metabolite identified putatively by LC-MS and used within this study belongs to this class 
of compounds. 
The PCR experiments performed prior (Figure 4-4B) had shown a parallel influence of 
GP18:0 on both osteogenic and chondrogenic development of MSCs in vitro. The results 
observed for osteogenesis is in line with previous studies also reporting the 
osteoinductive nature of LPAs (Blackburn and Mansell, 2012, Lapierre et al., 2010, 
Mansell and Blackburn, 2013, Mansell et al., 2011, Sims et al., 2013). Less is known 
about the chondrogenic effect on stem cells, however, there are a number of studies that 
research the effect of LPAs on chondrocyte cells, which is shown to affect their 
proliferation and migratory behaviour (Facchini et al., 2005, Hurst-Kennedy et al., 2009, 
Kim et al., 2005, Koolpe et al., 1998).  
In light of this, further experiments were carried out to confirm chondrogenic potential of 
GP18:0. MSCs were maintained in micromass culture for 10 days with 0.1 μM GP18:0 
and checked for chondrogenic development by fluorescently staining for the early 
biomarker SOX-9 and the subsequently expressed aggrecan protein. Expression of the 
early biomarker SOX-9 was seen for cells cultured with GP18:0 indicative of early 
chondrogenic differentiation but later development indicated by aggrecan expression was 
less abundant compared to MSCs cultured using chondrogenic induction media (Figure 
4-9); however, it was notable compared to control. The results indicate that GP18:0 
potentially plays a role in early signalling for chondrogenesis but perhaps plays a lesser 
role in the subsequent maturation during cell development. It could also indicate 
however, that development is simply delayed compare to the use of chondrogenic 
induction media 
The comparable expression of osteo- and chondroinductive markers instigated by the 
presence of GP18:0 suggests multifunctional roles of the metabolite with regards to 
cellular development. This occurrence highlights a reason for the observed similarity 
observed in the cluster analysis heat maps and PCA analysis generated from the 
metabolomics data set discussed in the previous chapter. While it may very well reflect 
the heterogeneous population, it is also likely from the experiments done with GP18:0 
that metabolites produced during stem cell differentiation play more than a singular 
function leading to different outcomes. In this instance, the interplay between osteo- and 
chondrogenic development is something that finds application for development of the 
osteochondral interface where these two tissue types are intricately linked. 
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Figure 4-9 Immunofluorescence images of MSCs cultured in non-supplemented media 
(negative), chondrogenic induction media (CIM) and 0.1 µM GP18:0. Cells were 
maintained in culture for 10 days prior to staining. (A) Phase contrast images show the 
formation of cell aggregates in chondrogenic inductive media (CIM) which was not extensively 
observed when cells were cultured with GP18:0. Although cell aggregates were not present in 
as high numbers, the distinct rounded cell morphology adopted by chondroblasts were 
observed. Aggrecan expression was also considerably less for cells cultured with GP18:0 and 
could only just be detected by immunofluorescence. (B – D) are graphical representations of 
the images shown in (A) showing aggregate count (B), area covered by biomarker fluorescence 
of SOX-9 (C) and aggrecan (D). Fluorescence images show actin cytoskeleton (red), cell nuclei 
(blue) and either sox-9 or aggrecan (green). Images were taken at 10x magnification; Scale 
bar - 100μm. Phase contrast images were taken at 4x magnification; Scale bar - 200 μm. Error 
bars denote standard deviations from the mean; n > 3; * & ** notes statistical significance 
compared to the negative control where p < 0.05 and 0.01 respectively as calculated using 
unpaired students t-test. 
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4.3.2.3 Sphinganine 
It was postulated that the putatively identified sphinganine may have an important role to 
play with regards to neuronal differentiation, as the primary differentiation route adopted 
on the 2 kPa hydrogel substrate was determined to be as such (Figure 2-10) and 
considerable depletion in relative amounts which was unique to the soft (2 kPa) substrate 
was observed by LC-MS (Figure 4-2). 
However, PCR screening for differentiation lineages showed that sphinganine had no 
positive effect on neuronal development. Analysis of additional neuronal markers β3-
tubulin and glial fibrillary acidic protein (GFAP) also showed the same trend. 
In light of this, the original experimental format from which the metabolite was identified 
was returned to and the effect of sphinganine investigated with MSCs cultured on the soft 
hydrogel substrates. Cells were cultured on the 2kPa hydrogel in the presence and 
absence of 1 μM sphinganine for a 2 week duration. MSCs were then harvested and 
RNA expression of nestin, GFAP and β3-tubulin ascertained at 1 and 2 weeks 
respectively (Figure 4-10B - D). 
Gene expression of all three neuronal markers were observed to be elevated in cell 
samples cultured in the presence of sphinganine (SP+) as compared to the 
unsupplemented hydrogel substrate (SP-). 
These results highlight the extent to which biomaterial properties have an influence in 
guiding cellular activity. The physical and mechanical differences between the planar 
culture plastic surface and the relatively soft hydrogel surface affects the overall cell 
morphology or shape adopted on each surface, which is known to have a profound effect 
on lineage commitment when stem cells are cultured on substrates that induce these 
changes (Bhadriraju et al., 2007, Kilian et al., 2010, McBeath et al., 2004). In addition, 
relative cell elasticity is known to manifest as a consequence of substrate rigidity 
(Discher et al., 2005, Hoerning et al., 2012) brought about through remodelling of the 
cytoskeleton or actin polymerisation in cohort with rhoGTPase activity (Patel et al., 2012). 
As such, these remodelling activities are known to have profound effects on overall cell 
function, transcription and metabolism (Engler et al., 2006, Hoerning et al., 2012, Patel et 
al., 2012, Tilghman et al., 2012) and as a result, modulate processes that are deemed 
permissible to the cell dependent of its microenvironment. It therefore can be postulated 
that sphinganine is a molecule that acts both as a negative and positive regulator, either 
enhancing or modulating the differentiation process when the conditions are favourable. 
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Figure 4-10 PCR analysis of neuronal development of MSCs cultured with 1 µM 
sphinganine [SP+] and without [SP-]. (A) MSCs were cultured in well plates with increasing 
concentrations of sphinganine and samples were evaluated for production neuronal markers, 
nestin, GFAP & β3-tubulin. Expression levels for all three biomarkers were considerably lower 
than those detected for the negative control. Negative control is held nominally at 1 (dashed 
line). *** notes statistical significance to the control where p < 0.001 for nestin calculated using 
one way ANOVA. The same neuronal markers where again assessed when MSCs were cultured 
on the 2 kPa F2/S hydrogel substrate in the presence and absence of sphinganine (B - D). 
Expression of all biomarkers were observed to have increased over time when treated with 
sphinganine showing the opposite effect from the cells on the relatively stiff culture well plate. 
§ notes statistical significance (p < 0.05) calculated using two way ANOVA in relation to time in 
culture and ** (p < 0.01) in relation to comparisons between treated [SP+] and non-treated 
groups [SP-]. Error bars denote standard deviations; n = 4 replicates. 
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4.4 Summary 
Data mining was carried out to isolate metabolites that showed substantial depletion 
unique to a particular biomaterial compared to the control sample and other hydrogel 
substrates. From this, the metabolites cholesterol sulphate (CS), 1-octadecanoyl-sn-
glycero-3-phosphate (GP18:0) and sphinganine were identified putatively and singled out 
for further scrutiny on the roles they play in influencing targeted differentiation. 
Cholesterol sulphate had shown depletion on the rigid (38 kPa) hydrogel of which the 
primary differentiation lineage was osteogenesis. GP18:0 was observed for the stiff (6 
kPa) substrate, which promoted chondrogenesis and sphinganine from the soft (2 kPa) 
substrate where neurogenesis was observed. 
MSCs cultured with cholesterol sulphate had shown a strong propensity for osteogenic 
development. PCR analysis had shown a dose dependent increase in osteopontin 
production. Immunostaining for both OPN and OCN were positive suggesting that CS 
plays a primary role in directing bone development and formation. GP18:0 is a 
lysophosphatidic acid (LPA), a compound that has been shown in extensive research to 
play a role in the osteogenic development of stem cells. This finding was also supported 
in PCR experiments carried out when MSCs were incubated with GP18:0. Interestingly, 
GP18:0 also showed a dose dependent elevation of the chondrogenic biomarker 
COL2A1. Immunostaining for the chondrogenic biomarkers SOX-9 and aggrecan showed 
high level expression of SOX-9 and to a lesser extent aggrecan. This implies that GP18:0 
likely has an influential role on initial development of chondroblasts.  
MSCs cultured with sphinganine on the culture well plastic showed no increased 
expression of any of the differentiation markers tested for. Instead, nestin expression 
(neurogenic biomarker of which the hypothesis predicted cell line development) was 
observed as actively repressed. However, when cells were then cultured again in the 
presence and absence of sphinganine on the hydrogel surface, the treated group 
showed increased expression of a number of neurogenic markers. 
The result highlights the importance biomaterial influence can have in guiding cellular 
activity and the extent to which they are permissive to cell development.  
Whether these observed effects on stem cell behaviour due to careful manipulation of 
biomaterial mechanics can instigate differentiation in cell lines other than bone marrow 
stem cells and whether the effect is sustained over the longer term are questions that are 
further investigated in the following chapter. 
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5.1 Introduction 
The principal function of biomaterial design is to replicate in vitro the innate physical 
characteristics of tissue types in vivo. The idea being that they are well designed to 
support adhesion, migration, proliferation and differentiation as close possible to the ideal 
environment for the desired function. 
The Fmoc-F2/S hydrogel biomaterials were observed in particular to have a high 
propensity to support initial differentiation of mesenchymal stem cells into chondrocytes, 
which may also be due in part to the cell morphology adopted on the biomaterial which 
supports chondrocyte development (Kilian et al., 2010, McBeath et al., 2004). As such, 
this lineage was focussed on for further investigation. This section pools together the 
practices explored in the previous chapters and focuses on a particular discipline in order 
to understand how biomaterial properties affects cellular development during 
differentiation 
 
5.1.1 Cartilage: structure, function & limitations 
Cartilage is a viscoelastic connective tissue that is found mainly in load bearing joints in 
mammals. It is classed broadly into 3 categories: 1) elastic cartilage, found mainly in the 
external ear and epiglottis. 2) fibrocartilage, which comprises the pubic symphisis, tendon 
and ligaments and 3) hyaline cartilage, present at the sternum-rib interface, nucleus 
pulposus of intervertebral discs and at the articulating ends of long bones where it is 
referred to as articular cartilage. Hyaline cartilage is the most widespread of all three 
cartilage forms. 
The dry weight of cartilage consists of collagen, proteoglycans and chondrocytes (as the 
singular cell type present within cartilage tissue). From the articular surface to the bone 
interface, cartilage tissue exists in a number of distinct zonal regions; these are typified 
by the differences in their cell and extracellular matrix morphology and organisation 
(Hunziker et al., 1997, Hunziker et al., 2002, Hwang et al., 1992). 
The superficial tangential zone is that closest to the synovial fluid in the joint and 
therefore at the forefront of changes in mechanistic dynamics. Although, comprising a 
relative small spatial claim to cartilage (10 – 20%), it houses the largest population of 
chondrocytes. Chondrocytes within this region are flatter and stiffer compared to those 
located in the inner zones (Darling et al., 2006, Shieh and Athanasiou, 2006).  Collagen 
content in this zone is highest and proteoglycan content is lowest (Responte et al., 2007) 
imparting more tensile strength to this zone. The arrangement of collagen fibrils in this 
zone is almost exclusively perpendicular to the bone rather than parallel as is observed 
in the remaining zones.  
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The middle or radial zone has the most spatial occupation of articular cartilage. The 
chondrocyte population is sparse and the orientation of collagen fibrils and the 
chondrocytes themselves run parallel. Chondrocytes within this region are highly active 
compared to the superficial zone (Wong et al., 1996). 
The deep zone is located closest to subchondral bone and earmarks the transition of 
cartilage tissue into bone. Within this zone chondrocytes begin to undergo hypertrophy, 
signifying terminal differentiation in cell development. Cell activity in this zone is markedly 
altered as the cells have increased alkaline phosphatase activity and begin to deposit 
calcium resulting in a calcified layer. 
 
 
 
Figure 5-1 Depiction of the structure of hyaline cartilage from the articular end of a 
knee joint. The diagram illustrates the zonal organisation of cartilage tissue from the 
articular surface to the interface with bone tissue.  
 
The fibrillar element of cartilage extracellular matrix comprises the collagen types II, VI, 
IX, X and XI. Of these, the most abundant is type II collagen, it is also specific to hyaline 
cartilage and is therefore considered a primary indication of successful cartilage 
development. Type IX and type XI collagen form cross-links with type II collagen and 
together they form the meshwork of fibres that lend cartilage its tensile strength.  
The proteoglycan content imparts to cartilage the tissues ability to resist compressive 
loads. Whilst cartilage holds a number of proteoglycans and non-collagenous proteins: 
biglycan, decorin, tenascin, cartilage oligomeric matrix protein (COMP) being a few 
examples. The most abundant proteoglycan, however, is aggrecan. Structurally, 
aggrecan constitutes a protein core to which a series of glycosaminoglycans (GAG) are 
attached. The GAG content of aggrecan molecules; keratin sulphate and chondroitin 
sulphate, are negatively charged causing repulsion between the GAG branches and 
allowing interaction with water molecules (Roughley et al., 2006, Urban et al., 2000, 
Walsh and Lotz, 2004).  Aggrecan has no covalent links to the collagen mesh and is 
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stabilised within the fibrillar network due to this interaction with water and the inclination 
of aggrecan molecules to form dense aggregates. 
Type II collagen, structurally, has a high number of hexose groups which facilitate 
interaction with water better than the other collagen types that have been mentioned 
(Trelstad et al., 1976). The high propensity of type II collagen and aggrecan for 
association with water molecules attributes cartilage with its high hydration property. This 
fluid content makes up approximately 80% of the total tissue weight (Temenoff and 
Mikos, 2000) and plays an important role in sustaining tissue integrity and survival. As an 
avascular tissue, nutrient and oxygen exchange occurs mainly via diffusion through the 
fluid phase of cartilage, which is facilitated by the force dynamics experienced by 
cartilage tissue. 
The low chondrocyte population and avascular nature of cartilage poses as an 
impairment to the regeneration of tissue injuries that are beyond a superficial nature 
(Temenoff and Mikos, 2000). Critical defects require the synthesis of large amounts of 
ECM required to bridge the defect, which is not met by chondrocyte populations. 
Furthermore, there is a lack of repopulation by progenitor cells that is usually supplied by 
the vasculature. In addition, the nature of the ECM is such that it can act as an 
impediment to inherent cellular repair by resident chondrocytes (Temenoff and Mikos, 
2000, Responte et al., 2007). For reasons unknown, cartilage that suffers trauma and is 
repaired naturally does not recover the original ECM make up, synthesising fibrocartilage 
which characteristically contains type I collagen, and is thus not typical of hyaline 
cartilage structure (Poole, 1997, Volpato et al., 2013). To this end, a suitable means of 
repairing or replacing damaged cartilage is an area of intense research in tissue 
engineering. 
The unsuitability of allogenic and autogenic implants means that it is preferable to try to 
heal damage to cartilage instead of employing replacement therapies. Cartilage injuries 
can be repaired using tissue grafts. However, this means of regeneration is limited by the 
low number of chondrocyte cells within the graft able to facilitate integration with the 
native tissue (Poole, 1997, Responte et al., 2007). Therefore, the use of scaffolds is 
particularly attractive for engineering cartilage tissue. Cells can be populated as required 
within the scaffold, it also acts as a major support for the cells promoting retention of 
chondrocyte morphology thus discouraging dedifferentiation while encouraging cell 
adhesion and migration (Estes and Guilak, 2011, Ma et al., 2003, vanSusante et al., 
1995). Cell types housed within the constructs themselves can be fully differentiated 
chondrocytes but also includes the use of stem cells encouraged to develop into 
chondrocytes. The use of MSCs within constructs over mature chondrocytes is thought to 
be particularly advantageous as MSCs exhibit the ability to produce cartilage tissue as 
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well as enhance development of the subchondral plate when implanted in vivo used to 
heal osteochondral defects (Vonschroeder et al., 1991). These results suggest that the 
use of MSCs enables continual development of from naïve chondrocyte through to 
terminal differentiation. 
 
5.1.2 Emulating the chondrocyte ECM 
In order to promote differentiation of stem cells and to maintain functional activity of 
chondrocyte cells in vitro, an ability to maintain the chondrocyte morphology is of 
particular importance. Chondrocytes maintained in monolayer culture rapidly 
dedifferentiate, this is triggered by the loss of the rounded morphology typical of 
chondrocyte cells. As the cell spread on adhesion in monolayer, they create type I 
collagen with diminished production of the cartilage specific type II collagen (Solchaga et 
al., 2005, Wang et al., 2005). To abate this, routine culturing of chondrocytes and 
differentiation of MSCs along the chondrogenic lineage employs the use of pellet or 
micromass cultures to preserve the rounded shape of chondrocytes (Cooke et al., 2011, 
Jung et al., 2009, Sekiya et al., 2002, Wang et al., 2005). Although studies have shown  
chondrocytes to have been cultured in vitro in monolayer, it still requires restriction of the 
cell morphology using functionally patterned substrate surfaces (Curran et al., 2005). 
Micromass and pellet culture methods require that the cells are spatially arranged in 
three dimensions, as such, most studies that undertake research with chondrogenesis 
make use of three dimensional constructs, in particular, alginate hydrogels (Jung et al., 
2009, Sekiya et al., 2002). 
Chondrocytes reside within the tissue in structures known as chondrons. Chondrons 
comprise one or more chondrocyte cells and its surrounding pericellular matrix. They are 
known to be stiffer than chondrocytes in isolation (Nguyen et al., 2010) and their 
mechanical properties differ from the ECM of cartilage itself (Alexopoulos et al., 2005). 
The pericellular matrix is distinct from the extracellular matrix in that they are particularly 
high in proteoglycan and type VI collagen content. The exact function of the pericellular 
matrix remains unknown but studies have put forward a number of functions that the 
PCM is involved in. It is thought to play an important role in the cells ability to make 
structural cartilage. Chondrocytes maintained in pellet culture over time tend to produce 
an overabundance of type I collagen leading to the formation of an ECM that is likened to 
fibrocartilage rather than hyaline cartilage (Larson et al., 2002, Vonk et al., 2010). 
Furthermore, studies comparing cell behaviour of singular chondrocytes with chondrons 
observed that chondrons had higher levels of type II collagen content compared to type I 
Chapter V – Mechanically tuned F2/S hydrogels & pericytes for cartilage engineering 
 
 
 
126 
collagen. Also, cross linking of type II collagen fibrils occurs with cultured chondrons but 
was not observed with just chondrocytes in culture (Vonk et al., 2010). 
The high proteoglycan content of the chondron pericellular matrix may act to resist the 
compressive load on cartilage and lessen direct loading onto the cells’ themselves. 
Studies performed on the pericellular matrix using embedded chondrons (either within 
constructs or tissue) shows an elasticity gradient from chondron periphery to the cell-
matrix interface, measuring over a broad modulus range from 20 – 60 kPa suggesting 
that they are readily deformable and therefore viscoelastic (Alexopoulos et al., 2005). In 
support to this, the makeup of the pericellular matrix varies between cartilage regions to 
compensate for the dynamic nature of mechanical loads imposed on the cells. The ability 
of chondrocytes to tailor the pericellular matrix accordingly within cartilage tissue results 
in uniform chondron stiffness through tissue zones (Alexopoulos et al., 2003, Wilusz et 
al., 2012).  Indicating that the mechanical integrity of the chondron is of particular 
importance to the cell niche, imparting both a protective and mechanotransductive role to 
the contained chondrocyte (Guilak et al., 2006, Poole et al., 1992, Poole et al., 1987) 
To promote chondrogenic development of pericyte cells in F2/S hydrogels, it was 
therefore hypothesized that cells should be cultured within a three dimensional construct 
to simulate chondrocyte morphology but also to have the F2/S hydrogels emulate the 
mechanical properties of chondrons specifically over neo-cartilaginous tissue. As has 
been described, cartilage inherently is avascular and therefore is not subject to the level 
of cytokine signalling that occurs in vascular tissue, relying mainly on diffusion as the 
foremost source of nutrients. It is thus postulated that biochemical signalling is 
interpreted mostly through mechanotransductive effects. For this, the elastic modulus of 
F2/S hydrogels was tuned to approximately 20 kPa. This figure is in line with studies that 
show the elastic modulus of free chondrons (cultured in suspension) to be within this 
elasticity range (Nguyen et al., 2010). It also modulates the production of ECM of 
chondrocyte cells cultured within substrates of this stiffness to compensate for the 
imbalance when cultured in softer substrates (Chen et al., 2012).  
 
 
5.1.3 Cell line (moving from MSCs to pericytes) 
Pericytes, also known as Rouget or mural cells, are polymorphic cells that encircle 
endothelial cells associated with micro-vessel and capillary walls (Figure 5-2). Along with 
adventitial cells (located in the tunica adventitia of blood vessels), both are collectively 
referred to as perivascular stem cells (PSCs). These are two distinct populations; 
pericytes are characterised using the surface markers CD146+, CD34- and adventitial 
cell as CD146-, CD34+, which make them readily isolatable by fluorescence activated 
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cell sorting.  They are known to perform a number of functions inclusive of the regulation 
of vasoconstriction and maintaining stability of the vessel walls (Chen, 2012, Diaz-Flores 
et al., 2009). This section, however, will focus on the role they play as progenitor cells. 
Multipotent capabilities of pericyte cells have been shown in a number of studies, 
illustrating their ability to differentiate along osteogenic, chondrogenic, myogenic and 
adipogenic lineages (Brighton et al., 1992, Crisan et al., 2009, Diefenderfer and Brighton, 
2000); characteristics that are traditionally borne by MSCs (Caplan, 1991, Pittenger et 
al., 1999). 
Although most research with the periosteum is associated with the development and 
integration of bone cells (Arnsdorf et al., 2009), studies investigating chondrogenic 
properties have also been done (Gallay et al., 1994). They are also known to be 
particularly adept at healing critical sized defects in bone (Yu et al., 2010), an application 
which is of particular usefulness to potential application of this research project. 
While not all pericytes are MSCs, current identification methods render MSCs 
indistinguishable from pericyte cells (Crisan et al., 2008). This trait, taken with the 
extensive presence of pericytes throughout the vasculature, has led to the idea of 
pericytes being the ancestral origin of the MSC (Corselli et al., 2010, Crisan et al., 2011) 
and questioning whether all MSCs inherently are pericytes (Caplan, 2008). Pericytes 
close association with the vasculature make these cells highly abundant compared to 
other stem cell sources and provides the possibility of vascular stem cells that ‘supply’ 
the various MSC niches around the body (da Silva Meirelles et al., 2006). 
Was it the case that MSCs are inherently pericyte cells, and within the boundaries of 
current research there is nothing to as yet say they are not. This study shows for the first 
time that use of mechanically tuned F2/S hydrogels can influence even more ‘primitive’ 
stem cells with chondrogenic potential. It also shows that the materials are able to coax 
differentiation along the chondrogenic route using more than one cell type, i.e., it is able 
to show enough flexibility to incorporate for the small nuances with regards to 
differentiating stem cells from different sources as occurs when using chemical means. 
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Figure 5-2 Diagram illustrating the pericyte niche. Pericytes originate from the 
vasculature where they encircle the endothelial wall of blood micro-vessels and capillaries 
where they regulate vasoconstriction.  
 
5.1.4 Objectives/Rationale 
Within this chapter, the chondrogenic capabilities of pericytes are explored using the F2/S 
hydrogels tuned to mimic the mechanical properties of chondrons (20 kPa) as this is 
hypothesised to be optimal for chondrogenic development. 
The F2/S biomaterials are designed as such that cells undergo differentiation with little 
influence out with the biomaterial physical properties (elasticity). Although instigating 
differentiation using changes in substrate elasticity has been shown extensively within 
this project, it has not yet been investigated whether cellular interpretation of biomaterial 
properties is transient or whether it is able to sustain cell development over a period of 
time. 
 
5.2 Materials & methods 
5.2.1 Materials 
Materials/Reagents Supplier(s) 
Human pericytes University of Edinburgh, UK 
Fmoc-diphenylalanine University of Strathclyde, UK 
Fmoc-serine Bachem, UK 
Sodium hydroxide Fisher chemicals, UK 
Distilled water Invitrogen, UK 
Alginate Sigma Aldrich, UK 
Calcium chloride BDH Laboratories, UK 
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Dulbeccos modified eagle medium (DMEM) Sigma Aldrich, UK 
Foetal bovine serum (FBS) Sigma Aldrich, UK 
Penicillin streptomycin Sigma Aldrich, UK 
Trypsin Sigma Aldrich, UK 
Dexamethasone Sigma Aldrich, UK 
Ascorbate-2-phosphate Sigma Aldrich, UK 
Transforming growth factor β1 (TGF-β1) Peprotech, UK 
Sodium pyruvate Sigma Aldrich, UK 
Phosphate buffered saline (PBS)
*
 In-house 
Fixative
*
  In-house 
Permeability buffer
*
 In-house 
1% BSA in PBS
*
 In-house 
Vectashield-DAPI Vector laboratories, USA 
Rhodamine-phalloidin Invitrogen, USA 
Primary antibodies 
Abcam, UK & Santa Cruz 
biotechnologies, USA 
Biotinylated secondary antibodies Vector laboratories, USA 
Streptavidin-FITC Vector laboratories, USA 
0.5% Tween 20 in PBS
*
 In-house 
RNeasy micro kit Qiagen, UK 
Trizol Life technologies, UK 
Chloroform Sigma Aldrich, UK 
Glycoblue Ambion, UK 
Isopropanol Sigma Aldrich, UK 
Ethanol VWR Chemicals, France 
RNase free water Qiagen, UK 
Quantitech reverse transcription kit Qiagen, UK 
Quantifast SYBR green PCR kit Qiagen, UK 
 
                                               
*
 Preparation procedures for reagents & buffers made in-house are detailed in the appendix. 
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5.2.2 Hydrogel preparation 
0.0321 g of Fmoc-F2 and 0.0207 g of Fmoc-S powders were weighed, placed into 14 ml 
glass vials and sterilized under UV light for 45 mins prior to use. Powders were then 
suspended in 4 ml of sterile water to a total peptide concentration of 30 mM. To this 
mixture, 240 μl of sterile 0.5 M sodium hydroxide solution was added to give the finished 
peptide solution used for hydrogel fabrication as described in 2.2.3 and for 3D cell 
culture.  
 
5.2.3 Cell culture 
Human adipose derived pericyte cells were kindly provided by Dr Christopher West at the 
Scottish Centre for Regenerative Medicine, University of Edinburgh. UK. The cells were 
transferred on dry ice as cryopreserved cell pellets and stored in liquid nitrogen until 
ready for use. 
 
5.2.3.1 Cultivation of cryopreserved cells 
Prior to cell seeding, culture well flasks were first filled with culture medium and 
incubated at 37°C for 30 minutes. Following this, pericyte cells were thawed in a water 
bath set to 37°C for 1½ minutes or until the suspension was completely thawed. The cell 
suspension was transferred to a clean centrifuge tube and an equal amount of culture 
media added. The cells were then centrifuged for 5 minutes at 1400 rpm to sediment 
cells and remove the supernatant; which generally contains DMSO. 
Cells were resuspended in an appropriate amount of culture media and aliquots 
transferred to the prepped culture flasks. Cells were then maintained at 37°C, 5% CO2 
and sub-cultured when 90% confluent. 
 
5.2.3.2 Micromass culture 
Pericytes were differentiated into chondrocytes using supplemented DMEM and the 
micromass culture technique as described in 4.2.3. 
 
5.2.3.3 3D culture in F2/S and alginate hydrogels 
F2/S 
Prior to use, F2/S peptide solutions were placed into an incubator for 30 – 45 minutes to 
allow the solution to reach physiological temperature. The peptide solutions were then 
mixed gently with a pipette tip to create a homogenous solution. Detached cells, which 
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had been centrifuged to form a pellet, were then resuspended in the appropriate amount 
of the F2/S peptide solution. 
400 μl of the cell suspension mixture was then added to 500 μl of DMEM culture media 
(unsupplemented). The well plate was then incubated at 37°C for one hour to allow the 
gels to cure. After this, the media was replaced with fresh medium and twice more after 2 
and 24 hours. Cells were then maintained in culture as previously described until ready 
for harvest.  
 
Alginate 
A 1.2% (w/v) alginate solution was made by dissolving 0.360 g of alginate powder 
(Sigma) slowly in 30 ml of phosphate buffered saline containing a magnetic stirrer. The 
solution was then autoclaved at 120°C for 20 minutes. 
Pericytes were tripsinised from the culture well flasks where they were expanded as 
described in 2.2.2, pelleted by centrifugation and resuspended in the alginate solution. 
Alginate beads were made by pipetting 100 μl of the alginate solution into a 100mM 
calcium chloride solution. Hydrogels were allowed to cure at room temperature for 5 
minutes before removing the calcium chloride solution. Hydrogels were then washed 
twice with PBS solution and 500 μl of culture media added to each well. 
 
5.2.4 Cell staining & imaging 
Immunocytochemistry and microscopic analysis were carried out as detailed in 2.2.5 and 
2.2.6. Details of the primary, secondary and tertiary antibodies used for this chapter are 
given in Table 5-1. F2/S substrates investigated using confocal microscopy was imaged 
using a LSM510 META confocal laser-scanning microscope (Carl Zeiss, Jena, 
Germany). Images were collected and optimised for brightness and contrast using the 
associated software (LSM510). Images were collected at 1024 by 1024 resolution and 
compiled in 3 x 3 image tiles. 
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Table 5-1 Biomarkers used for detection of cellular differentiation 
Differentiation 
lineage 
Biomarker Primary antibody 
Secondary 
antibody 
Fluorophore  
Chondrogenesis 
SOX-9 
Mouse 
monoclonal IgG 
Biotinylated anti 
mouse 
Streptavidin 
conjugated FITC 
COL2A1 
Aggrecan 
Cytoskeleton F-actin   
Phalloidin 
conjugated 
rhodamine 
Nucleus    DAPI 
 
5.2.5 Cell viability (Live/Dead assay) 
Culture media surrounding the biomaterials were aspirated to waste and washed once 
with warm PBS solution. A working solution containing both Syto 10 and ethidium 
homodimer-2 dyes was made in PBS (1:500 v/v). 500 μl of the dye solution was added to 
the hydrogels and the samples incubated in the dark at room temperature for 15 minutes. 
Following this, the hydrogels were then fixed at room temperature with 4% formaldehyde 
solution for at least 15 minutes before viewing under a microscope. 
 
5.2.6 RNA extraction and reverse transcription 
F2/S hydrogels were transferred from culture well plates into clean eppendorf tubes 
containing 0.5 ml of trizol reagent. Samples were then incubated at room temperature for 
approximately 10 minutes or until the hydrogels had fully degraded. 
Alginate hydrogels were ground finely in 0.5 ml trizol using a mortar and pestle, as they 
did not degrade when incubated in trizol as occurred with the F2/S hydrogels. Samples 
were then transferred into clean eppendorfs for RNA extraction. 
Reverse transcription of all samples was carried out using the QuantiTect reverse 
transcription kit (Qiagen) as per the manufacturer’s instructions and the resultant cDNA 
samples were then stored at -20°C or used immediately for qRT-PCR experiments. 
 
5.2.7 QRT-PCR 
Samples intended for qRT-PCR analyses were handled as described in 2.2.8. Details of 
the PCR primers used within this chapter are given in Table 5-2. 
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Table 5-2 PCR primers designed for human genes 
Gene   
SOX-9 
Forward 5’-AGA CAG CCC CCT ATC GAC TT-3’ 
Reverse 5’-CGG CAG GTA CTG GTC AAA CT-3’ 
Aggrecan (ACAN) 
Forward 5’-TAC ACT GGC GAG CAC TGT AAC-3’ 
Reverse 5’-CAG TGG CCC TGG TAC TTG TT-3’ 
Collagen type II 
(COL2A1) 
Forward 5’-GTG AAC CTG GTG TCT CTG GTC-3’ 
Reverse 5’-TTT CCA GGT TTT CCA GCT TC-3’  
Collagen type X 
(COL10A1) 
Forward 5’-CAC CTT CTG CAC TGC TCA TC-3’ 
Reverse 5’-GGC AGC ATA TTC TCA GAT GGA-3’ 
RUNX-2 
Forward 5’-GGT CAG ATG CAG GCG GCC-3’ 
Reverse 5’-TAC GTG TGG TAG CGC GTC-3’  
Osteopontin (OPN) 
Forward 5’-AGC TGG ATG ACC AGA GTG CT- 3’ 
Reverse 5’-TGA AAT TCA TGG CTG TGG AA -3’ 
Osteocalcin (OCN) 
Forward 5’-CAG CGA GGT AGT GAA GAG ACC-3’ 
Reverse 5’-TCT GGA GTT TAT TTG GGA GCA G-3’ 
GAPDH 
Forward 5’-ACC CAG AAG ACT GTG GAT GG-3’ 
Reverse 5’-TTC TAG ACG GCA GGT CAG GT-3’ 
 
5.2.8 Metabolomics 
Samples intended for metabolomic analyses were handled as described in 3.2.4.  
Pellets obtained from the metabolite extraction assay were resuspended in 0.2 ml of 
0.01% sodium dodecyl sulfate (SDS) solution. Samples were then placed on a heating 
block (55°C) for 10 minutes to dissolve proteins and subsequently centrifuged at 13000 g 
for 10 minutes to sediment any insoluble material. The supernatant was transferred into 
clean eppendorf tubes and used for protein assay. 
Relative amounts of protein used to normalise LC-MS data were determined using the 
Bio-Rad microassay procedure according to the manufacturers protocol. 
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5.3 Results & discussion 
5.3.1 Pericyte differentiation 
Pericytes were induced to develop into naive chondrocytes in micromass culture with 
chondrogenic inductive media. Samples were maintained in culture for two weeks then 
fluorescently stained with antibodies to SOX-9, type II collagen and aggrecan to assess 
for chondrogenic development. 
At 2 weeks, the number of spread cells had decreased as they adopted the rounded 
morphology of chondrocytes. Cells that were rounded formed aggregates and had begun 
to express type II collagen and aggrecan. The aggregates are still visible under the 
microscope most likely due to preserved cell-cell adhesions with spread cells still on the 
culture well plastic (Figure 5-3). 
The results, in line with other studies, show that pericytes are capable of undergoing 
differentiation along the chondrogenic lineage 
 
 
 
Figure 5-3 Fluorescence images of pericytes cultured in chondrogenic induction media 
(CIM) for 2 weeks. Pericyte cells in micromass culture were maintained in the absence (top 
plane) and presence (bottom plane) of chondrogenic induction media. Cells were stained for 
early chondrogenic biomarker SOX-9 (A & D) and the latterly expressed biomarkers type II 
collagen (B & E) and aggrecan (C & F). Chondrocyte adopt a rounded morphology and begin to 
form aggregates (circled), which then express type II collagen and aggrecan. Undifferentiated 
pericytes maintain their spread morphology and have no discernible expression of SOX-9, type 
II collagen or aggrecan. Scale bars – 100 μm.  
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5.3.2 Cell viability & initial differentiation in F2/S substrates 
Having determined the ability of pericytes to develop into chondrocytes, the next stage 
was to affirm that this cell type is also viable when cultured on the F2/S hydrogel 
biomaterial. This was done using fluorescent detection of syto10 dye (green 
fluorescence) for live cells and ethidium-homodimer-2 (red fluorescence) for dead cells 
(Figure 5-4). 
Cells were cultured both in monolayer (two dimensional) and encapsulated (three 
dimensional) within the hydrogel substrate. Cells were observed as viable both on and 
within the hydrogels. It was also noted that cells had better viability when cultured within 
the hydrogel as very little or no red fluorescence was observed when cells were cultured 
in this manner compared to when cultured in monolayer.  
 
 
 
Figure 5-4 Viability of pericyte cells cultured on and within 20 kPa F2/S hydrogels. Cells 
cultured in monolayer and encapsulated within the hydrogels were assessed using live (green) 
dead (red) viability staining. Fluorescence staining was carried out after 24, 72 & 168 hours in 
culture. Pericytes exhibited good viability both on and within F2/S hydrogels. Cell viability was 
improved when cultured within the hydrogels as no dead cells were observed in the hydrogels. 
The cells also formed aggregates when encapsulated within the hydrogels, indicative of 
chondrocyte morphology. Scale bars – 100 μm 
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Cells were cultured for 1 week in F2/S hydrogels and cell behaviour assessed for 
differentiation along the chondrogenic lineage. Cells were quantified for expression of 
RUNX-2, SOX-9 and type II collagen. These were compared against pericytes that were 
maintained in an undifferentiated state on culture well plastic. Cells cultured within the 
hydrogels in general, showed increased expression of all three protein markers (Figure 
5-5), indicating development into chondrocytes. 
 
 
 
Figure 5-5 QRT-PCR analysis for gene expression of pericyte cells cultured within 20 kPa 
F2/S hydrogels. Cells were assessed for the production of chondrogenic biomarkers RUNX-2, 
SOX-9 & type II collagen (COL2A1) after one week in culture. Cells showed an increased 
production of all three biomarkers when cultured within F2/S hydrogels compared to pericytes 
maintained on plain substrates (control). Error bars denote standard error from the mean; n = 
6 replicates; * notes statistical significance to the control where p < 0.05 as calculated using 
unpaired student t-test. 
 
5.3.3 Assessing long term development of pericytes into mature 
chondrocytes 
To ascertain biomaterial performance, pericytes differentiated using the F2/S substrate 
were compared against chondrocyte development in alginate hydrogels. This section 
monitors the development of pericytes from initial phenotypic change through to maturity 
by profiling the gene expression of a number of biomarkers known to be associated with 
the formation of cartilaginous tissue. To determine the sole effect of F2/S, differentiation 
capabilities were also assessed in the presence and absence of chondrogenic induction 
media.  
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5.3.3.1 Early development: SOX-9 
Initial differentiation of stem cells into chondrocytes is characterised by the expression of 
the transcription factor SOX-9, both in progenitor cells as well as in differentiated 
chondrocytes (Ng et al., 1997, Zhao et al., 1997). It plays an essential role in the 
expression of its co-expressed transcription factors SOX-5 and SOX-6 (Akiyama et al., 
2002) and in the latterly expressed, and cartilage specific, type II collagen (Bell & 
Lefebvre). Inhibition of SOX-9 activity has been shown to lead to the lack of both 
cartilage and bone formation in chick embryo limb buds (Akiyama et al., 2002) 
highlighting SOX-9 as a crucial element in chondrogenesis. 
SOX-9 expression for pericytes cultured in all substrate types was observed as up 
regulated with the exception of pericytes maintained on the flat culture well surface 
(plain) as the defined control set (Figure 5-6). Expression increased steadily over the 
initial time points and had begun to plateau after 1 week in culture (168 hrs). Pericytes 
cultured within the F2/S hydrogels supplemented with induction media (F2/S+), however, 
showed the most rapid up-regulation of SOX-9 with its peak occurring after 3 days (72 
hrs) in culture, earlier than F2/S- and the alginate substrates. Continuous production of 
SOX-9 over the time in culture also suggests the sustained presence of a functional 
chondrocyte population as it is also considered integral to maintaining homeostasis, 
suppressing cell apoptosis (Akiyama et al., 2002, Henry et al., 2012) and inhibiting 
vascularisation of mature cartilage tissue (Hattori et al., 2010). 
Although SOX-9 production is induced by dexamethasone, expression was also 
observed in substrates that were cultured in the absence of induction media (F2/S- and 
ALG-). This up regulation is thought to be due to the cells being held spatially within a 
three dimensional matrix, facilitating the formation of a typical chondrocyte phenotype 
which is an important factor in being able to encourage chondrogenic development in 
vitro (Johnstone et al., 1998, McBeath et al., 2004, Muraglia et al., 2003).  
Cells cultured in alginate hydrogels without chondrogenic induction media (ALG-) had 
shown good production of SOX-9 but did not show up regulation of any of the remaining 
chondrogenic biomarkers tested for in later development. For this reason, it was 
concluded that subsequent chondrocyte development did not occur within this sample set 
and ALG- was excluded from further analyses. ALG- however, is included in all the 
acquired gene expression profiles analysed by PCR for completeness. 
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Figure 5-6 Gene expression profile of SOX-9 by pericyte cells cultured within hydrogel 
biomaterials undergoing chondrogenesis. Cells were assessed for the production of the 
early chondrogenic biomarker on plain substrate (control) and in F2/S and alginate (ALG) 
hydrogels over 5 weeks in culture. Cells cultured within the hydrogels were assessed for 
development in the presence (+) and absence (-) of chondrogenic induction media. Error bars 
denote standard error from the mean; n = 4 replicates; * notes statistical significance between 
substrates where p < 0.05, ** p < 0.01 & *** p < 0.001 calculated using one way ANOVA.  
 
5.3.3.2 Structural development: ACAN & COL2A1 
Monitoring production of the two main components of hyaline cartilage assessed 
structural properties of neo-cartilagenous development in the F2/S hydrogel biomaterials. 
Cartilage extracellular matrix comprises a high collagen content of which type II collagen 
is the most abundant and specific to hyaline cartilage. Along with type II collagen, 
aggrecan also forms the major constituents of cartilage structure (Responte et al., 2007). 
Their expression by differentiating pericytes therefore provides a good indication of how 
the cells have developed structurally. 
Time dependent increase in type II collagen and aggrecan (ACAN) were observed in the 
supplemented alginate substrate (ALG+) and in both supplemented (+) and non-
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supplemented (-) F2/S hydrogels (Figure 5-7). Up-regulation of COL2A1 and ACAN were 
both highest in the F2/S hydrogels with COL2A1 production in F2/S+ observed as 
significantly higher than F2/S-. In all cases, production of COL2A1 and ACAN had 
reached saturation by 1 week. The expression of one in respect to another, however, 
varied between substrate types (Figure 5-8). COL2A1 production in alginate hydrogels 
(ALG+) was observed to be relatively low compared to aggrecan expression 
(approximately 1.5 fold increase at its peak compared to 2.6 for aggrecan) while F2/S+ 
showed the opposite effect; having on average 2.6x higher concentrations of COL2A1 
compared to aggrecan. F2/S in the absence of induction media however showed no 
difference between COL2A1 and aggrecan production (0.89x). The implications of 
balancing the abundance of COL2A1 and ACAN in developing cartilage tissue are 
something that has not drawn much attention in cartilage developmental research. Albeit, 
it is likely that the interplay between these two have important consequences on the 
relative compressive resistance and flexibility of cartilage (Hwang et al., 1992, Responte 
et al., 2007, Wong and Carter, 2003).  
Expression of ACAN, like COL2A1, is also promoted by SOX-9 (Han and Lefebvre, 2008, 
Sekiya, 2000) via the coupled activation by SOX5 and SOX6. While SOX-9 is expressed 
relatively early in chondrogenic development and expressed continually until 
hypertrophy, SOX5 and SOX-6 are expressed at a later stage aiding maturation of 
chondrocytes through significant expression of ACAN and COL2A1 (Han and Lefebvre, 
2008). The differential expression between these two proteins in the alginate and F2/S 
hydrogels with and without induction may be due to the nature of the enhancing effect 
SOX-5 and SOX-6 has on their relative expression pattern. 
Confocal microscopy was carried out for pericytes cultured within the F2/S- hydrogel after 
five weeks to confirm visually the results obtained by qRT-PCR. The constant level of 
expression seen after one week in culture by qRT-PCR analysis is thought to stem from 
having a relatively stable cell population. However, constant production of extracellular 
COL2A1 and ACAN should have sequestered over time and be well represented 
throughout the hydrogel. The F2/S- hydrogel was investigated particularly as it is the 
main focus biomaterial for inducing phenotypic change in pericyte cells solely using 
biomaterial mechanics. Hydrogels were stained for the presence of COL2A1 and ACAN 
had shown good presence throughout the F2/S biomaterials (Figure 5-9) indicating that 
pericytes had undergone differentiation in response to biomaterial properties as the sole 
effector. Cells in the alginate and F2/S+ hydrogel were not imaged by confocal 
microscopy as the chondrogenic capabilities of pericytes using inductive media had been 
demonstrated earlier (Figure 5-3). 
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Figure 5-7 Gene expression profile of A) type II collagen (COL2A1) and B) aggrecan 
(ACAN) by pericyte cells cultured within hydrogel biomaterials undergoing 
chondrogenesis. Cells were assessed for the production of the chondrogenic biomarkers on 
plain substrate (control) and in F2/S and alginate (ALG) hydrogels over 5 weeks in culture. 
Cells cultured within the hydrogels were assessed for development in the presence (+) and 
absence (-) of chondrogenic induction media. Error bars denote standard error from the mean; 
n = 4 replicates; * notes statistical significance between substrates where p < 0.05, ** p < 0.01 & 
*** p < 0.001 calculated using one way ANOVA.  
Chapter V – Mechanically tuned F2/S hydrogels & pericytes for cartilage engineering 
 
 
 
141 
 
 
 
Figure 5-8 Gene expression ratios of type II collagen (COL2A1) and aggrecan (ACAN) by 
pericyte cells cultured within hydrogel biomaterials undergoing chondrogenesis. Cells 
were assessed for production relative to one another over 5 weeks in culture and found that 
cells behaved differently within each substrate type. Cells cultured in alginate hydrogels (ALG+) 
exhibited higher ACAN content while those in F2/S+ showed the opposite effect with COL2A1 
content observed as the more abundant. No difference in COL2A1 abundance relative to ACAN 
was noted in F2/S- hydrogels. Error bars denote standard error from the mean; n = 4 replicates; 
* notes statistical significance between substrates where p < 0.05, ** p < 0.01 & *** p < 0.001 
calculated using one way ANOVA.  
 
Chapter V – Mechanically tuned F2/S hydrogels & pericytes for cartilage engineering 
 
 
 
142 
 
 
Figure 5-9 Confocal microscopy images of pericyte cells cultured within 20 kPa F2/S 
hydrogels. Cells cultured within the hydrogels were assessed for aggrecan production (A) and 
type II collagen production (B) after five weeks in culture as indication of cellular 
differentiation into chondrocytes. Cell nuclei were stained with DAPI, shown in blue and each 
biomarker with FITC, shown in green. Scale bar – 50 μm. 
 
5.3.3.3 Maturity: COL10A1 
Type X collagen (COL10A1) typically is expressed specifically in non-mitotic hypertrophic 
chondrocytes in vivo (Schmid et al., 1985) and as such is used in some cases as an 
indicator of terminal differentiation of chondrocytes. 
A number of studies investigating stem cell chondrogenesis in vitro, however, have noted 
the widespread expression of type X collagen in culture alongside type II (Cooke et al., 
2011, Cui et al., 2012, Karlsson et al., 2007, Perrier et al., 2011) resulting in a mixed 
chondrocyte phenotype. The relatively early expression of type X collagen for pericytes 
cultured in the alginate and F2/S substrates is also observed within this study (Figure 
5-10) suggesting that a mixed phenotype is also produced in this case. 
Although the production of type X collagen expression form part of a natural cycle in cell 
progression rather than an exacerbation by culture conditions (Gibson et al., 1997), the 
state of differentiation does not remain unaffected by microenvironmental conditions 
(Morimoto et al., 2013, Wang et al., 2010). The observed early expression of type X 
collagen, in some part, is thought to occur due to an over exposure to transforming 
growth factor-β1 (TGF-β1) (Cooke et al., 2011, Perrier et al., 2011). A phenomenon that 
is also echoed in this study as cells cultured in the presence of chondrogenic induction 
media containing TGF-β1 (ALG+ and F2/S+) showed higher expression of type X 
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collagen compared to F2/S-, which sustained higher type II collagen levels in the 
extracellular matrix over a longer period (Figure 5-11). 
Comparisons between the F2/S substrates showed that differences between the 
pericytes cultured in the F2/S- and F2/S+ hydrogels occurred mainly with respect to 
collagen reproduction. Both type II and type X collagen where higher in F2/S substrates 
supplemented with chondrogenic media. This increase was also noted as being 
preceded by higher expression of SOX-9 in F2/S+, which promotes the formation of type 
II collagen (Bell et al., 1997, Lefebvre et al., 1997). The presence of induction media, 
however, had no discernible effect on aggrecan expression suggesting induction media 
may not intensify GAG formation (Figure 5-7B). 
While type II collagen production is induced by SOX-9 activity, type X, however, is 
induced by the activation of RUNX-2 expression in the cells (Higashikawa et al., 2009). If 
the F2/S hydrogels also instigate the expression of RUNX-2 during early stage 
differentiation, it therefore goes some way to explaining the premature expression of type 
X collagen in the culture system. The presence of RUNX-2 however, would also suggest 
that the F2/S biomaterials go some way to promoting osteogenic development of the 
pericytes in culture. To test this, samples were checked using qRT-PCR analysis for the 
osteogenic markers RUNX-2, OPN and OCN in each of the substrates. All three 
biomarkers were found to be present and elevated in both F2/S substrates compared to 
the plain substrate (Figure 5-12A). Assessment of total osteogenic or chondrogenic 
activity within each of the substrates showed that the F2/S substrates had, in general, 
higher chondrogenic activity (2.76x and 2.85x in F2/S- and F2/S+ respectively) compared 
to overall osteogenic activity (Figure 5-12B). 
The development of osteoblasts and premature expression of type X collagen in the F2/S 
substrates could to some extent be improved by the use of a co-culture system. 
Experiments performed by Cooke et al had shown that chondrogenic differentiation of 
MSCs with a lessened COL10A1 production could be achieved by using a bilaminar cell 
pellet culture system (MSC pellet encased in juvenile chondrocytes). Cui et al also 
showed that culturing MSCs with meniscal cells at varying ratios in general, performed 
better at minimising COL10A1 expression than when MSC were cultured alone. These 
two systems described by Cooke and Cui, invariably make use of TGF-β to induce 
differentiation. Pericytes cultured in the F2/S hydrogels in the absence of TGF-β already 
exhibited less COL10A1 expression compared to its TGF-β supplemented counterpart 
(Figure 5-11), but it is worth of note that the chondrogenic development of pericytes in 
F2/S may well be further enhanced with the use of co-culture. 
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Figure 5-10 Gene expression profile of type X collagen (COL10A1) by pericyte cells 
cultured within hydrogel biomaterials undergoing chondrogenesis. Cells were assessed 
for the production of the chondrogenic biomarker on plain substrate (control) and in F2/S and 
alginate (ALG) hydrogels over 5 weeks in culture. Cells cultured within the hydrogels were 
assessed for development in the presence (+) and absence (-) of chondrogenic induction media. 
Error bars denote standard error from the mean; n = 4 replicates; * notes statistical 
significance between substrates where p < 0.05, ** p < 0.01 & *** p < 0.001 calculated using one 
way ANOVA.  
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Figure 5-11 Gene expression ratios of type II collagen (COL2A1) and type X collagen 
(COL10A1) by pericyte cells cultured within hydrogel biomaterials undergoing 
chondrogenesis. Cells were assessed for production relative to one another over 5 weeks in 
culture to ascertain the phenotypic variance of differentiating pericytes. Cells cultured in the 
presence of chondrogenic induction media (ALG+ and F2/S+) showed higher amounts of 
COL10A1 relative to COL2A1 expression. F2/S-, however, showed higher COL2A1 expression 
relative to COL10A1.  Error bars denote standard error from the mean; n = 4 replicates; * notes 
statistical significance between substrates where p < 0.05, ** p < 0.01 & *** p < 0.001 calculated 
using one way ANOVA.  
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Figure 5-12 Assessing osteogenic development of pericytes within F2/S hydrogels. A – 
Cells cultured in F2/S hydrogel in the absence (-) and presence (+) of chondrogenic induction 
media were assessed for production of osteogenic biomarkers RUNX-2, osteopontin (OPN) and 
osteocalcin (OCN). Expression levels were elevated for all three compared to cells cultured on 
the plain substrate (held nominally at 1) indicating that the pericytes are also induced to 
undergo osteogenesis. B – The extent to which osteogenic development occurs was compared to 
that observed for chondrogenesis. Values were obtained by measuring fold changes from the 
plain substrate as a control and averaging the value obtained for all tested genes within each 
lineage, i.e., osteogenesis measured combined average fold change for RUNX-2, OPN and OCN 
and chondrogenesis from SOX-9, COL2A1, ACAN and COL10A1 expression. On average, 
chondrogenic development of pericytes was 3 fold higher than levels observed for osteogenic 
development. Error bars denote standard error from the mean; n > 6 replicates; * notes 
statistical significance between substrates where p < 0.05 and ** p < 0.01 compared to plain 
substrate, § where p < 0.05 compared to F2/S- using one way ANOVA in A. Statistical 
significance between F2/S substrates are indicated with ** where p < 0.01 and *** where p < 
0.001 calculated using unpaired students t-test in B.  
 
5.3.4 Metabolite expression profiling of in vitro chondrogenesis 
5.3.4.1 Protein expression profiles  
Cell pellets obtained from metabolite extraction assay used in metabolomics experiments 
were used to assess the total amount of protein present in each sample set. These were 
calculated as fold change from the originating biomaterial (labelled as ‘zero sample’), 
which was used as a baseline for measurement. Calculated fold change was then used 
to normalise identified metabolite peak abundance as detected by LC-MS.  
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Protein concentrations within hydrogel substrates begin to increase within 24 hours of 
seeding and increase continually over the 5 weeks in cultures. Cells at 5 weeks showed 
a 4 to 5 fold increase in protein abundance with the highest detected in the F2/S+ sample 
set (5.06x). Pericytes maintained on culture well plastic showed modest increase over 
time compared to the hydrogel biomaterials. Cells were observed as showing a 2-fold 
increase in protein content as they expand in culture (Figure 5-13). 
The comparable protein amounts between the alginate and F2/S hydrogels infer that the 
effect seen in gene expression by PCR analysis is not due to differences in cell 
population but may be due to differences in activity levels adopted in alginate and F2/S 
hydrogels.  
 
 
 
Figure 5-13 Protein content analysis for pericyte cells cultured within F2/S and alginate 
hydrogels in the presence (+) and absence (-) of chondrogenic induction media. Fold 
change in protein content was normalised against the zero time point, set nominally at 1 
(dashed line). Samples at time zero are defined as biomaterials that did not house any cell 
population. Negative control set is annotated as ‘Plain’; these are pericytes that are maintained 
normally on planar culture well plastic. Inset is a representative graph of BSA standards used 
to measure protein abundance in each sample. Error bars denote standard deviation; n = 4 
replicates. 
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5.3.4.2 Assessing chondrocyte metabolome 
To assess the chondrocyte metabolome, comparisons were made between pericytes 
cultured on the plain substrate (culture well plastic) as a negative control against 
pericytes cultured in F2/S hydrogels with and without added chondrogenic induction 
media. The cells cultured within the F2/S biomaterials did not show a gradual time 
dependent change towards maturity as originally hypothesised, instead they developed a 
mixed phenotype expressing both COL2A1 and COL10A1 biomarkers in parallel. This 
observation however is not unlike the chondrocyte niche, which contains both types of 
collagens at any one point in time, albeit with zonal organisation. As such, the 
metabolome expression is therefore likely to give an averaged visual representation of 
what metabolic processes occur within cartilage tissue as a generalised whole. 
Calculations were performed using data acquired over the latter half of the experimental 
duration (168 – 840 hrs), which were averaged and normalised for total metabolic 
activity. Samples were treated in this manner because observation from qRT-PCR 
analyses and protein expression analysis had shown that cell activity post 168 hrs had 
plateaued for all substrates (Figure 5-6, Figure 5-7, Figure 5-10 and Figure 5-13) 
indicating stable activity. To confirm this statistically, PCA analysis was carried out on 
each data subset (Figure 5-14). 
Principal component plots show that the pericytes cultured on the plain and F2/S 
substrates adopted distinct overall behaviours, with cells cultured in the presence (F2/S+) 
and absence (F2/S-) of inductive media forming a close but distinguishing relationship 
from one another. Replicate samples assessed for cells cultured on the F2/S hydrogels 
from 168 – 840 hrs had clustered together tightly indicating similar or otherwise stable 
metabolic behaviour over this time in culture. Pericytes maintained on culture well plastic, 
however, had shown a number of outliers divergent from the general sample cluster. 
These outliers were determined as the four replicate samples obtained at 168 hrs in 
culture indicating that cell behaviour was relatively different at this time point. Sample 
replicates obtained afterwards, however, (336 – 840 hrs) were clustered closely 
indicating similarity. From this, samples averaged for further analysis were 168 – 840 hrs 
for F2/S (n =16) and 336 – 840 hrs for the plain substrate (n = 12). By pooling the 
samples together into a single averaged time point, statistical confidence and analysis is 
further improved by the representation from a larger sample population. 
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Figure 5-14 Principal component analysis of pericytes cultured on plain and F2/S 
substrates in the presence (+) and absence (-) of chondrogenic induction media between 
1 and 5 weeks. The plot shows differences between cells on all three substrates with the F2/S 
being particularly distinct from the plain substrate. While cell activity over the assessed 
duration was observed to be constant for the F2/S substrates, cell on the plain substrate had 
some outlier points (arrows) which were samples measured at 1 week, indicating that cell 
behaviour was dissimilar from the cohort at this time point. 
 
The time points up to five weeks in culture (840 hrs) represent a steady state metabolism 
adopted by cells on each substrate. To compare total activity states, metabolite 
abundance measured by LC-MS were approximated from each total ion chromatogram 
and represented as fold change relative to the plain substrate. Metabolite abundance 
was found to be approximately two fold for cells cultured in the F2/S- hydrogels compared 
to the plain substrate with the F2/S+ slightly higher (2.68x), representing a general 
increase in metabolite abundance and population from pericytes cultured in F2/S 
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hydrogels (Figure 5-15). The results also confirm and illustrate the difference in 
behaviour noted at the transcriptional level, which filters down to cell metabolism aiding 
changing phenotype. Both sets, however, do not confer necessarily direct correlation as 
is often noted in studies that integrate gene expression with cell behaviour due to non-
gene dependent activity.  As it is assumed that non-differentiating pericytes adopt a 
quiescent metabolic state, then the cells in the F2/S hydrogels can be considered 
relatively active in comparison, even though it is noted that these cells have achieved 
their own ‘steady state’ over time. This higher steady state, however, is suggestive of 
continuous turn over activity taken on by cells cultured in the F2/S substrate that are not 
observed in cells on the plain substrate, such as the expression of SOX-9 and RUNX-2 
leading to the deposition of collagens II, X and aggrecan into the ECM.  
 
 
 
Figure 5-15 Averaged peak intensities of identified metabolite masses detected in 
pericytes cultured on plain and F2/S hydrogel substrates in the absence (-) and presence 
(+) of chondrogenic induction media. Cells cultured in both F2/S hydrogel substrates show 
an increase in metabolite peak intensities compared to the plain substrate with the highest 
amount of change occurring on the media supplemented substrate (F2/S+). Error bars denote 
standard deviation from the mean; n ≥ 12 replicates; * notes statistical significance between 
substrates where p < 0.05 calculated using one way ANOVA. 
 
Cluster analysis performed for all three substrate showed that, on the whole, the 
metabolite profiles of both F2/S substrates were inadvertently similar with higher 
abundances detected on the F2/S+ substrate (Figure 5-16A). Metabolite masses were 
mapped to known metabolic pathways to ascertain which cell processes experienced the 
most change compared to the plain substrate. Most of these pathways were primarily 
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concerned with amino acid metabolism but metabolites involved in energy generating 
processes such as the TCA cycle had also shown significant change (Figure 5-16B). 
Interestingly, the pathway showing the most significant change - arginine & proline 
metabolism, is responsible for driving the synthesis of polyamines from ornithine (Pegg, 
2009). Polyamines, while ubiquitous with regards to influencing a number of cell 
functions inclusive of proliferation and differentiation (Childs et al., 2003, Igarashi and 
Kashiwagi, 2010), also have particular effect in driving the continued development of 
chondrocytes (Facchini et al., 2012). 
 
 
 
Figure 5-16 Pathway analysis for general chondrogenic activity. Identified metabolites 
from pericytes cultured in F2/S hydrogels in the presence (+) and absence (-) of induction 
media were compared against pericytes cultured on plain surfaces as a control and their 
activity assessed using hierarchical cluster analysis (A). Metabolites were then mapped to 
known metabolic pathways (B) and differences in cell activity from the plain substrate 
ascertained. Pathways showing the most significant change were primarily involved in amino 
acid metabolism inclusive of nitrogen metabolism but also processes involved in energy 
generation such as the TCA cycle are noted to be significantly different from the control sample 
indicative of a more active cell phenotype in the F2/S substrates. Dashed in (B) indicates 
statistically significant the threshold, where p < 0.05 as calculated using node centrality 
statistics in metaboanalyst. 
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There are, however, several pockets where there are distinct differences between the 
F2/S- and F2/S+ substrates. These may point toward cell activity that is responsible for 
the observed differences in chondrogenic phenotype between F2/S- and F2/S+ such as 
the elevated expression of COL10A1 over COL2A1 in F2/S+ as exacerbated by the use 
of induction media (Figure 5-11). To assess these further and isolate a pathway(s) that 
may be affected, discriminatory analysis was done using excel to calculate the ratio of 
detected metabolite in F2/S- relative to F2/S+. These were subsequently depicted as a 
scatter plot in order to isolate where these distinctions occur. A threshold value of 2 was 
set as a cut off point for metabolite selection (Figure 5-17A) and all metabolites showing 
greater than two-fold difference were then used for pathway analysis. From a total of 734 
identified masses, 172 were isolated as showing a higher than two-fold difference 
between both substrates (23.4%). Masses mapped to metabolic pathways, showed that 
the majority of these differences are also predominantly centred around amino acid 
metabolic pathways observed in Figure 5-16 with the exception of a few such as tyrosine 
metabolism and arginine & proline metabolism for which activity had no significant 
change. Metabolites involved in generating energy, such as those involved in the TCA 
cycle, which showed significant activity when compared to pericytes maintained on the 
plain surface, did not show any distinction between F2/S- and F2/S+ as both were 
considered to be particularly active.  
As an initial phase, the prerequisite for inducing stem cell differentiation into 
chondrocytes is the detection of cell type specific behaviour that is uncharacteristic of its 
predecessor. Confirming the production of the chondrogenic markers COL2A1, aggrecan 
and low or negligible expression COL10A1 and COL1A1 primarily do this (Yamasaki et 
al., 2001). Studies generally look into accomplishing these requisites but rarely look into 
the consequences that small discrepancies in expression levels may have on the quality 
of cartilaginous development. While there is a degree of overlap in metabolic cell 
processes as ascertained through the metabolome of pericytes cultured in F2/S- and 
F2/S+ substrates (likely correlating with parallel positive expression of chondrocyte 
markers), features of distinctive cell processes are adopted through the use of induction 
media not observed with the biomaterial only (Figure 5-17A). These differences, although 
sufficient to positively drive chondrogenesis, reflect the more subtle nuances regarding 
the imbalance in phenotype expression. In this case, the distinct difference observed in 
collagen expression but not reflected in GAG production (Figure 5-7 and Figure 5-10).  
The results obtained in this chapter suggest that directed differentiation of pericytes into 
mature chondrocytes is better achieved using F2/S biomaterial instruction solely over co-
use with induction media as it supports lessened expression of COL10A1 in 
chondrocytes (Figure 5-11).  
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Figure 5-17 Pathway analysis for F2/S- vs. F2/S+ activity. Ratios of identified metabolites 
from pericytes cultured in F2/S hydrogels in the presence (+) and absence (-) of induction 
media depicted in a scatter plot to ascertain differences between the two (A). Metabolites that 
measured above or below the defined threshold (two fold difference as indicated by the dashed 
line) were isolated and mapped to known metabolic pathways (B). Pathways where the most 
significant changes occurred were primarily associated with amino acid metabolism. 
Interestingly, some pathways (†), while significantly different from the plain substrate remain 
unchanged between F2/S substrates indicating selectivity in cell behaviour due to the presence 
or absence of induction media. Dashed in (B) indicates statistically significant the threshold, 
where p < 0.05 as calculated using node centrality statistics in metaboanalyst. 
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5.4 Summary 
This chapter has explored the use of finely tuned F2/S hydrogels (~ 20 kPa) as a means 
of directing pericyte differentiation into mature chondrocytes and whether the biomaterial 
was able to sustain this over an extended period of time in cell culture. 
Cell lines were moved from bone marrow MSCs to pericytes to show that mechanical 
stimulus is able to influence more primitive cell lines with chondrogenic potential. 
Pericytes, like MSCs, were shown to have good viability when cultured using F2/S 
biomaterials as well as having an ability to undergo differentiation into chondrogenic 
phenotypes through material and chemical instruction (Figure 5-3, Figure 5-4 and Figure 
5-5). 
Cells were maintained in culture with F2/S in the presence and absence of chondrogenic 
media for a period of five weeks. Over this time, cells were checked for expression levels 
of chondrocyte biomarkers SOX-9, aggrecan, COL2A1 and COL10A1. Expression levels 
of all proteins inclusive of the mentioned markers were observed to increase over time 
with levels reaching saturation by 1 week in culture as cell attained not only a constant 
transcription level but also constant metabolic turn over (Figure 5-6, Figure 5-7, Figure 
5-10, Figure 5-13 and Figure 5-14). Chondrogenic development of pericytes in F2/S 
substrates, however, did not show gene expression patterns of mature chondrocytes as 
typified by cells in vivo (high COL2A1 and negligible COL10A1 levels) but expression of 
COL10A1 at very early time points (24hrs) suggest that the cultures adopted a mixed 
phenotype of mature and hypertrophic chondrocytes, which is often observed in in vitro 
systems (Karlsson et al., 2007, Mwale et al., 2006, Perrier et al., 2011). This is thought to 
occur, in part, due to the indication of some osteogenic activity that occurred in the 
culture system confirmed by positive detection of the bone marker RUNX-2 (known to 
promote COL10A1 expression) and others (Figure 5-12). COL10A1 expression is also an 
effect that may further be exacerbated by the presence of induction media, of which 
some of its constituents promote rapid chondrocyte maturation (Figure 5-11 (Cooke et 
al., 2011, Perrier et al., 2011)). This is also likely the case here as the extent to which 
osteogenesis and chondrogenesis occurs in both F2/S- and F2/S+ was not affected 
despite the F2/S+ system showing higher levels of COL10A1 (Figure 5-12). 
Both cell systems, one just the biomaterial (F2/S-) and the other in conjunction with 
differentiating media (F2/S+) are sufficient enough to allow chondrogenic development. 
The alternate routes instigate subtle differences in how the cells process these cues, 
which are reflected in their metabolome (Figure 5-17); they adapt generally similar 
patterns with very fine divergence likely to account for the differences that manifest in 
their resultant phenotypes. 
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The assessment is intended as an exploratory analysis of total pericyte behaviour when 
differentiating in response to chondrogenic induction media or free from biased chemical 
interference. As such, the data was analysed as a whole. It is worthy of note however, 
that for purposes of looking into cell activity in more intricate detail, the selection process 
could be further refined by using strict isolation criteria in addition to setting a threshold 
such as coupling the defined threshold with statistical confidence between measured 
abundance levels of F2/S - and F2/S +. 
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This project investigated the influence that short chain peptide hydrogel material (F2/S) 
properties, specifically matrix stiffness, had on guiding stem cell differentiation. While 
employing some established methodologies for doing so (immunocytochemistry and 
qRT-PCR for example), the project also investigated whether adopted changes in 
phenotype during early stages of differentiation can be tracked by looking into the 
presence and relative amounts of small molecules that the cell produces as a whole (the 
metabolome). Perceiving cell phenotype in this way was considered particularly 
favourable as firstly, the use of matrix rigidity as the sole effector of differentiation allows 
detection and measurements of metabolites to be a reflection of innate cellular 
chemistries unbiased by the presence or use of molecules supplemented in media to 
induce differentiation. And secondly, based on the first principle, a broad reaching 
metabolomics study was able to give enough information to identify metabolites that are 
lesser known to have a role in promoting different stem cell phenotypes. 
While the above points were illustrated in this project, this chapter goes on to scrutinise 
some of the more intricate outcomes observed in this project by way of design and 
obtained results. It also explores a number of ideas that may go towards resolving some 
of the questions raised as a result by way of further study. 
 
6.1 Differentiation resulting from interplay between matrix 
mechanics and adopted morphology 
Adopting a cell lineage requires a certain degree of pattern distinction or geometric 
constraint with regards to distinguishing between cell types with similar native tissue 
mechanics (Lee, 2013). The use of self-assembled peptide F2/S hydrogels in this project 
will inevitably have a surface topography, which unfortunately was not optimised for 
exact patterning and dimensions (personal communication with V. Jayawarna). 
Assessments of the cytoskeletal properties of MSCs cultured on each of the hydrogels 
show that their organisation are much more akin to cells that are cultured in 
encapsulation (Figure 2-6, (Huebsch et al., 2010, Parekh et al., 2011, Sugawara et al., 
2013)) as opposed to onto a flat surface. These suggest that the cells cultured on the 
F2/S surface are constrained in a pseudo three dimensional construct placing restriction 
on how the cells are spread creating a morphology that is different from cells that are 
otherwise unrestricted on smoother surfaces or those with smaller dimension (nano) 
topography as is typically adopted by most two dimensional cultured cells.  
Surface embedding of the cells invariably means that they are subject to geometrical 
constraints as dictated by the substrate. The spatial restriction experienced in this sense 
is likely to define the overall morphology of the cell but the effects of the substrate 
Chapter VI - Discussion 
 
 
 
158 
stiffness is still something that is very much influential over cell behaviour as observed 
from the different lineages adapted on each hydrogel (Chapter 2, (Chen et al., 2012, 
Discher et al., 2005, Evans et al., 2009, Saha et al., 2008)). This also goes some way to 
explain why, although observed in other studies, culturing MSCs on F2/S hydrogels that 
bear similar mechanical strength with native muscle tissue did not show any myogenic 
development (Figure 2-7 - Figure 2-9, (Engler et al., 2004b, Engler et al., 2006, Tse and 
Engler, 2011)).  
Topographical detail for aiding myoblast development is known to be of particular 
importance, especially with regards to aiding fusion and striation (Choi et al., 2012a, Lu 
and Leng, 2009). It is therefore plausible that loss of this detail displaces myogenesis for 
chondrocyte development, a lineage that is more favourable with both adopted 
morphology and substrate elasticity (Chapter 2, (Allen et al., 2012, Glowacki et al., 1983, 
Guo et al., 1989, Im, 2005, Jung et al., 2009, Trickey et al., 2004, vanSusante et al., 
1995, Gao et al., 2010)). In the same vein, adopting a three-dimensional osteocytic 
morphology in a mechanically relevant (38 kPa) matrix also primarily resulted in 
osteogenic development. 
It is well documented that cell shape has a profound effect in guiding lineage adoption 
when stem cells differentiate (Kilian et al., 2010, McBeath et al., 2004, Peng et al., 2011). 
While the mechanics of the F2/S substrates have a clear influence on MSC behaviour 
(Chapter 2), the irregularity of the substrate topography (particularly for two dimensional 
cell culture) very much goes someway to affecting cell behaviour, given that interplay 
between matrix mechanics and substrate patterning both play an important role when 
regulating differentiation (Guilak et al., 2009, Higuchi et al., 2013). This interplay, most 
likely accounts for the observed cell heterogeneity on each of the F2/S substrates (Figure 
2-7 - Figure 2-9).  
By using precision imprinting of topographies on soft substrate surfaces, Lee et al were 
able to show that the manner in which a cell was spatially restricted had an effect on 
whether neuro- or adipogenic development was observed (Lee, 2013). The study has 
interesting connotations in the sense that cells observed on the soft and stiff F2/S 
substrates using fluorescence live/dead microscopy showed that cells on the soft F2/S 
hydrogels were better at forming elongated cell morphologies than those on the stiff 
substrate (Figure 6-1). An occurrence that is likely due to the lessened cross links formed 
in the soft F2/S hydrogel allowing the cells to spread better. Adipogenesis of MSCs is 
evident across all three substrates, a consequence that may be due to the maintained 
rounded morphology on each of the substrates.  Differences in elasticity, however, also 
encourage the formation of neuronal cells (2 kPa), chondroblasts (6 kPa) and osteoblasts 
(38 kPa).  
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In order to reduce this heterogenic effect, further characterisation of the physical 
characteristics of the F2/S surface is required. Pliability of the F2/S peptide solutions 
means that better definition of the surface features could be achieved through precise 
control of the mould used to create the hydrogel surface prior to cell seeding. This is 
likely to provide better control of differentiation outcomes using two dimensional culture 
methods. The use of bipotential media as done in other studies (Fu et al., 2010, 
Guvendiren and Burdick, 2012, Kilian et al., 2010, McBeath et al., 2004) for regulating 
heterogeneity may also be a point for consideration as matrix mechanics is thought to 
have an influence over differentiation lineage that outweighs chemical induction (Engler 
et al., 2006). It is noted, however, that this approach would likely restrict differentiation 
potential and as such could have invariably masked the observed neurogenic and 
chondrogenic effects. 
 
 
Figure 6-1 Fluorescence live/dead images of MSCs cultured on 2 and 6 kPa F2/S 
hydrogels. Cells cultured on the 2 kPa substrate (A) had shown a number of cells which had 
adopted an elongated morphology alongside cells with rounded morphology (shape is outlined 
using dashed ellipses and circles). Cells on the 6 kPa substrate (B) on the other hand, were 
primarily rounded with few elongated cells. Live cells are shown in green and dead in red; scale 
bar – 100 μm. 
 
6.2 F2/S as a biomaterial for in vivo application 
Commercially available scaffolds used in tissue engineering are generally animal derived 
products (Badylak, 2004, Badylak, 2007). While their uses have attained a measure of 
success, these classes of materials are not wholly ideal due to setbacks such as patient 
rejection, non-reproducible characteristics and contamination. For this reason, the use of 
self-assembled peptide scaffolds are particularly attractive prospects as they are able to 
overcome the limitations of batch variability, reducing unpredictable outcomes on 
implantation. 
A B
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The F2/S hydrogels are a well-placed candidate for regenerative medicine as their 
peptide scaffolds inherently make them biocompatible, their tunable mechanics enable 
influence over stem cell differentiation (Chapter 2 and Chapter 5); in particular guiding 
chondrogenic development and have been shown to be relatively stable long-term in 
culture (Chapter 5). 
The ability of hydrogels to undergo phase shifts from liquid to gel during fabrication is 
also of added advantage. It potentially allows for delivery to injury sites via microinjection 
techniques allowing the hydrogel to mould to the shape of the void or injury (Firth et al., 
2006, Nisbet et al., 2010, Williams et al., 2011). An area of regenerative medicine where 
this may find important application is with matrix assisted autologous chondrocyte 
implantation (MACI). Using this technique, chondrocytes are typically harvested from 
healthy cartilage, expanded in vitro within the implantation scaffold and transplanted back 
into the injury site of the patient (Demoor et al., 2012, Dunkin and Lattermann, 2013, 
Ochs et al., 2011). The use of F2/S biomaterials as an instruction for stem cell 
differentiation eliminates the need for creating a second injury site to source 
chondrocytes for autogenic implantation as well as being able to repopulate the defect 
with a sizeable number of chondrocytes to allow sufficient healing to occur. 
The use of Fmoc derived peptide moieties in in vivo engineering is something that has 
recently found use in a number of applications. For example, drug delivery for the 
reduction of intraocular pressure after glaucoma surgery procedures (Xu et al., 2010) and 
the development of skeletal muscle in zebrafish (Williams et al., 2011). While in vitro 
experiments do not necessarily predict in vivo outcomes, these examples suggest that 
the use of F2/S hydrogels for correcting cartilage defects have good potential as an in 
vivo regenerative scaffold. However, studies assessing their compatibility as in vivo 
scaffolds are yet to be explored.  
 
6.3 Incentives for monitoring metabolism as an indication of 
phenotype 
Studying the metabolic activity of cells has of recent given insight into cell behaviour with 
regards to their plasticity (Yanes et al., 2010) and self-renewal properties (McMurray et 
al., 2011) for example. While this thesis has shown that distinct metabolic behaviours of 
stem cells are adopted as they undergo differentiation can be illustrated in the cells 
overall metabolome, it also highlights a number of facets that are open to consideration 
when researching cell behaviour. 
The first lies in noting the distinctions that the microenvironment type used to persuade 
differentiation has on cell activity. Differentiation of MSCs in vitro can be achieved using 
Chapter VI - Discussion 
 
 
 
161 
a number of methodologies. Of these, the most commonly used is the supplementation 
of culture media with a number of small molecules known to instigate stem cell 
differentiation along a number of cell lineages (Lin et al., 2005, Pittenger et al., 1999, 
Sekiya et al., 2002). Alternatively, the use of co-culture methods, substrate detailing via 
surface topography, functionalisation and tailored mechanics have all proved to be 
instrumental in directing stem cell fate (McMurray et al., 2011, McNamara et al., 2011, 
Yim et al., 2010). While altered differentiation states can be achieved through each of 
these means (as a sole instructor or in combination), looking into the broad range 
metabolic processes that occur highlight these routes have, for the most part, 
overlapping behaviours resulting in a common outcome. It is also noted, however, that 
alternate methods do indeed have subtle discrepancies between each other (Chapter 5) 
that may in part be responsible for minute differences in phenotype, which are not 
necessarily detected using physical characteristics such as cell shape or the up-
regulation of a specific biomarker. Rather, the difference may show up when the ‘positive’ 
points are compared in relation to one another (Chapter 5). It is likely that different 
modes of enforcing differentiation can cause a slight bias of one process over another, 
exaggerating or lessening expression of one or a class of molecules. This is something 
that in turn can have an effect on overall cell function and tissue efficacy. Being able to 
pinpoint where these exaggerations or moderations occur has potential in influencing 
how biomaterials are refined and designed for cell culture. 
Secondly, scrutinising the metabolome enables correlations to be made between smaller 
building blocks as the constituent parts of a tertiary whole. A good example of this is the 
observed increase in leucine concentrations from cells cultured on the 38 kPa F2/S 
substrate (Chapter 3, (McNamara et al., 2011)) and the role SLRPs play in driving 
osteogenic development in tissues (Bianco et al., 1990, Kimoto et al., 1994, Xu et al., 
1998, Young et al., 2003). Then again, it could be that a leucine rich environment also 
contributes in alternate ways other than promoting SLRP synthesis towards promoting 
osteogenesis and it would be of worth researching in what manner this identified amino 
acid has an effect on bone formation in vitro. 
Thirdly, a common problem with the use of established induction media cocktails is the 
production of a heterogeneous cell population. Compounds such as dexamethasone, 
which is used extensively in most induction media types, is able to instigate the formation 
of cells into a number of different lineages (Mirmalek-Sani, 2006, Pittenger et al., 1999, 
Zuk et al., 2001) and as a result, total cell populations are not without a degree of 
‘contamination’. While the screening of large drug libraries continually recycle this 
process allowing the discovery of new compounds that affect differentiation (Johnson et 
al., 2012, Ding and Schultz, 2004), the use of the cellular metabolome to isolate innate 
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compounds that may play a role in cell differentiation has the potential to generate a new 
class of compounds which have less of a heterogenic effect when directing cellular 
differentiation as observed with the use of cholesterol sulphate for osteogenic induction 
of MSCs (Chapter 4).  
These innate compounds also have the potential to be candidate metabolites that act as 
biomarkers of differentiation at the metabolic level in the same sense that COL2A1 acts 
as a marker for chondrogenesis, increasing confidence in attaining a desired phenotype. 
A crude example here would be the use of GP18:0 for monitoring chondrogenesis 
(Figure 6-2). Depletion of GP18:0 was also noted in pericytes undergoing 
chondrogenesis in F2/S substrates, a result that is complementary to that observed in 
MSCs (Chapter 3). The term crude is used as it is noted that GP18:0 also instigated 
osteogenic development (Chapter 4), that is, it is not specific to a single lineage. The 
observed trend, however, does to not necessarily render it negligible as a biomarker 
candidate. To develop this further, however, a number of optimisation experiments would 
be required to enhance detection specificity, precision and accuracy when measuring 
from cell extracts. In particular distinguishing features of metabolite expression between 
differentiated cell types can be ascertained through quantitation and comparison with 
mature cell types. 
 
 
 
Figure 6-2 Average peak intensities of GP18:0 detected in pericytes cultured on plain 
and in 20 kPa F2/S substrates with (+) and without (-) chondrogenic induction media as 
detected using LC-MS. Peak intensities are shown as fold change relative to the plain 
substrate. GP18:0 shows a time dependent decrease for F2/S substrates. Levels of GP18:0 were 
also observed to drop much faster for cells cultured in the presence of induction media (F2/S+). 
Error bar denote standard deviations from the mean; n = 4; * notes statistical significance 
compared to the plain substrate where p < 0.05 and *** where p < 0.001 as calculated using 
unpaired students t-test 
 
Lastly, while this project focuses on metabolites with known masses and to an extent 
function, it is restricted based on known and identified functions held in bioinformatic 
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databases. Metabolite identification by LC-MS, inclusive of this study, generates a host of 
detected masses labelled as unknown that may or may not be compounds having an 
active or passive role in cell kinetics. This study however is confined to compounds that 
have prior knowledge to their involvement in human metabolic processes. The breadth of 
unbiased detection experiments reaches beyond this and allows a search for novel 
compounds of interest to be made. To do this, considerable concern would have to be 
given to experimental design and confirmatory experiments but this project illustrates that 
it is a useful starting platform for broadening the inventory of endogenous cell metabolite 
systems (Chapter 3). 
The aforementioned examples illustrate that a metabolomics based study is not only a 
confirmatory process but also a hypothesis-generating platform that can beg far more 
questions than give answers. Nonetheless, dependent on the desired objective, it can be 
viewed inevitably as being part of the process and not necessarily the conclusion.  
 
6.4 Transdifferentiation effects 
While MSCs are defined by their ability to differentiate into mesoderm cell types 
(Dominici et al., 2006), a number of studies have reported their ability to transgress this 
characterisation, exhibiting an ability to form cells of other germ lines (transdifferentiate). 
One such in particular is the formation of neuronal cell types (Sanchez-Ramos et al., 
2000, Woodbury et al., 2002, Woodbury et al., 2000). Findings within this study echoed 
this sentiment when MSCs were cultured on relatively soft (2 kPa) F2/S hydrogel 
substrates, as ascertained through observed increase in nestin, β3-tubulin and GFAP 
transcription (Chapter 2 & 4).  Observation of this effect seems to require a very precise 
mode of cell culture, studies showing MSCs which have been successfully cultivated into 
neuronal cells routinely make use of co-culture with mature neuronal cells (Sanchez-
Ramos et al., 2000, Wislet-Gendebien et al., 2005, Zhao et al., 2002) or through fine 
tuning of the substrate mechanics (Engler et al., 2006, Saha et al., 2008, Teixeira et al., 
2009). While attempted differentiation of MSCs into neuronal cells was not successful 
using supplemented media (Chapter 4 and appendix), experiments by Woodbury et al for 
example, have been able to demonstrate in vitro differentiation of MSC into neuronal 
cells on culture well plastic (Woodbury et al., 2000). While MSCs cultured in the study 
performed by Woodbury et al were positive for the neuronal phenotypic markers; nestin, 
neuron specific enolase and NeuN, they were not shown to have any excitable activity. A 
characteristic that has only been shown thus far using co-culture with mature neurons 
(Wislet-Gendebien et al., 2005). 
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Conversely, actively blocking generated tension causes the observation of adipogenesis 
over neurogenesis in studies using relatively hard surfaces (Kilian et al., 2010, McBeath 
et al., 2004) while those using softer substrates are seemingly still permissible to 
neuronal development (Engler et al., 2006, Lee, 2013). An indication that substrate 
mechanics play a vital role in creating this distinction. A single molecule (sphinganine) 
isolated from the metabolome of MSCs cultured on 2 kPa F2/S hydrogels showed 
enhanced productivity of the tested neurogenic biomarkers when the cells were cultured 
on this substrate but all were actively repressed when cells were placed on culture well 
plastic (Chapter 4), suggesting active inhibition of neurogenesis on stiff substrates. The 
results call into question what cell process(es) are permissive when the cells are cultured 
on compliant/non-compliant surfaces thereby having a direct effect on what lineages are 
adopted on differentiation.  
The observation of adipogenesis on harder substrates on the other hand, is a more 
common occurrence than neuronal development (Kilian et al., 2010, McBeath et al., 
2004). Low contractile states in MSCs that result in adipogenesis either through blocking 
cytoskeletal contractility (Engler et al., 2006, Guvendiren and Burdick, 2012) or culturing 
on relatively soft substrates (Lee, 2013, Fu et al., 2010) suggests that adipocyte 
development is amenable across a stiffness gradient (Guvendiren and Burdick, 2012) 
and is often observed when other influential factors are biased in its favour. Adipocyte 
distribution in vivo is coupled quite naturally with tissues that span a range of elastic 
moduli much broader than the ECM coupled with peripheral nerves for example, which 
has a more uniform association with the viscoelastic epineurium that surrounds neurons 
(Luque et al., 1983, Salonen et al., 1985). The exacting nature of the surrounding 
epineurium may go some way to explaining why, when making use of compliant soft 
substrates in vitro, neuronal development is consequently observed. 
 
6.5 Mesenchymal & perivascular stem cells 
While MSCs over the last few years have been a focus of much research with stem cells, 
a number of factors make them restrictive to use, such as low population numbers on 
extraction, hampering the demands made for progressing tissue engineering ex vivo. For 
this reason, there is a lot of interest in being able to diversify the means by which stem 
cells are sourced, which are also able to meet research demands. As such, a number of 
studies that have reported the acquisition of stem cells from a number of sources other 
than bone marrow such as the pancreas, muscle and kidneys (da Silva Meirelles et al., 
2006), giving hope to the creed that stem cells can be sourced in better populations than 
the bone marrow can give. Pericytes, as one half of the perivascular stem cells, are one 
Chapter VI - Discussion 
 
 
 
165 
such source currently under scrutiny as they are innately associated with the vasculature 
and are therefore more extensively available than bone marrow derived stem cells.  
Due to the lack of a wholly defined MSC phenotype, the discovery of a number of stem 
cell types sourced from locations other than the bone marrow means that due 
consideration must be given to how each of these cells behave with regards to one 
another and whether fabricated biomaterial substrates are able to influence them in a 
similar fashion resulting in a more or less uniform outcome.  
This thesis explored such an idea starting with the more established MSCs and 
ascertaining whether differentiation based on substrate mechanics is a translatable 
quality by testing the theory using pericytes (Chapter 2 and Chapter 5). Furthermore, 
information obtained from MSCs suggests that these interpretation patterns, at least at 
the metabolic level, are something that is conveyable across both cell lines. Singular 
metabolites for influencing differentiation lineages as determined from MSCs in chapter 4 
were also tested using pericytes giving the same positive outcomes (Figure 6-3). The 
results show that these compounds have a prevalent effect, suggesting common 
interpretation by both MSCs and pericytes, a particularly important point with regards to 
regulating how cells are differentiated in vitro.   
 
 
Figure 6-3 Immunofluorescence images of pericytes cultured in non-supplemented 
media (A & D), osteo- and chondrogenic induction media (B & E) and with 1 μM and 0.1 
μM cholesterol sulphate and GP18:0 respectively (C & F). Cells were assessed for osteogenic 
development by staining for the production of osteocalcin (A – C) and chondrogenic 
development by staining for COL2A1 production (D – E). Cells stained positively for each test 
metabolite confirming the results seen previously using MSCs. Fluorescence images show actin 
cytoskeleton (red), cell nuclei (blue) and either osteocalcin or COL2A1 (green). Scale bar – 200 
μm. 
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With the ever-broadening options of stem cell sourcing and means of directing 
differentiation in vitro, it is important that the biomaterial is able to cater for its intent 
across cell lines. The use of materials with tuned substrate elasticity seems to have a 
better influence over attaining a cellular phenotype closer to the desired outcome than 
when compared to using current induction media protocols (Chapter 5).  A question that 
is of particular importance, however, which is not researched in this thesis is the 
comparative plasticity of both bone marrow derived MSCs and pericyte cells. As 
pericytes are considered a predecessor of MSCs, it could be postulated that they will 
exhibit better differentiation potential than MSCs themselves. This, however, is 
something that has not been tested in this thesis and would warrant further research. 
 
6.6 Conclusions 
This thesis in context, firstly illustrates the use of biomaterial mechanics as a sole 
controlling influence on stem cell differentiation. While this line of research has been 
used in a number of other studies, the F2/S substrates comprise the use of peptide 
moieties over synthetic substrates making them a better suited candidate for use in 
wound healing applications such as autologous chondrocyte implantation. 
Secondly, the project also illustrates how metabolomics, as a powerful tool, is able to 
highlight phenotypical divergence through the identification and profiling of small 
molecules that are lesser known to play a role in altering cell states. Being able to 
influence differentiation using alternate substrate mechanics alone has enabled 
metabolic processes carried out exclusively by the cells to be profiled using an unbiased 
metabolomics design.  By investigating cell behaviour in this manner, deciphering 
individual components that drive or support cell differentiation allows identification of 
classes of molecules that contribute to development of altered or adaptive cell states. 
 
Further research 
Questions and particular areas of interest that have arisen during the course of this 
project that may be of advantage to investigate further have been addressed throughout 
this thesis as they occurred. These points however, are summarised below. 
 
Optimisation studies to improve desired outcomes and lessen ambiguity. 
 Fabrication process of the F2/S substrate for two-dimensional culture as a means 
to reduce the observed heterogeneity of cell types formed on MSC differentiation. 
 The use of co-culture system to further direct MSC differentiation along a singular 
lineage as well as to enhance better phenotype development. 
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New concept and development studies to improve currently used methodologies. 
 The use of metabolomics in stem cell research as an aid in assessing cell 
behaviour and development, monitoring metabolic output as an indicator of 
efficacy. 
 The use of a metabolite profile to as a means of identifying and designing 
differentiation specific small molecules that are able to reduce or eliminate cross 
contamination when directing differentiation in vitro. 
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APPENDIX 
     Appendix 
 
 
  
I. Buffers made in-house 
 
a) Phosphate buffered saline (PBS) 
Single phosphate buffered saline tablets (Sigma-Aldrich, UK) were diluted to 250ml in 
distilled water as per manufacturers’ instructions. PBS solutions were then autoclaved at 
200°C for 20 minutes and stored at room temperature 
 
b) Fixative 
Fixative solutions constituted 10% formaldehyde-40 (Sigma-Aldrich, UK) in PBS. 
Solutions were typically made using 10 ml formaldehyde added to 90 ml PBS. Solutions 
were stored at 4°C until ready for use. 
 
c) Permeability buffer 
Permeability buffers constituted 10.3 g sucrose, 0.292 g sodium chloride, 0.06 g 
magnesium chloride and 0.476 g HEPES dissolved in 100 ml of PBS solution using a 
magnetic stirrer. The solution pH was then adjusted to 7.2 and 0.5 ml of triton X added. . 
Solutions were stored at 4°C until ready for use. 
All reagents were purchased from Sigma-Aldrich, UK. 
 
d) 1% BSA in PBS 
1 gram of BSA (Sigma-Aldrich, UK) was dissolved in 100 ml PBS. Solutions were stored 
at 4°C for the short term or at -20°C for longer periods (> 2 weeks). 
 
e) 0.5% Tween-20 
0.5 ml of Tween-20 (Sigma-Aldrich, UK) was diluted in 100 ml PBS. Solutions were 
stored at 4°C until ready for use.  
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II. Statistics calculated using two-way ANOVA followed by Bonferroni multiple 
comparison post-tests for measured protein abundances in MSCs cultured on 
plain, 2 kPa F2/S, 6 kPa F2/S and 38 kPa F2/S substrates. 
Statistically significant comparisons are denoted with an asterix where the calculated p 
value is < 0.05, *; <0.01, ** and < 0.001 ***. 
 
Source of variation 
Substrate ** 
Time * 
Interaction between both variables  
 
Day 1 
  Plain 2 kPa 6 kPa 38 kPa 
Plain -    
2 kPa  -   
6 kPa   -  
38 kPa    - 
 
Day 2 
  Plain 2 kPa 6 kPa 38 kPa 
Plain -    
2 kPa  -   
6 kPa   -  
38 kPa    - 
 
Day 3 
  Plain 2 kPa 6 kPa 38 kPa 
Plain -    
2 kPa  -   
6 kPa   -  
38 kPa    - 
 
Day 5 
  Plain 2 kPa 6 kPa 38 kPa 
Plain -    
2 kPa  -   
6 kPa   -  
38 kPa    - 
 
Day 7 
  Plain 2 kPa 6 kPa 38 kPa 
Plain -  * * 
2 kPa  -   
6 kPa *  -  
38 kPa *   - 
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III. Metabolic pathway; Steroid biosynthesis  
 
 
 
KEGG metabolic pathway shows synthesis of the glucorticoids cholesterol sulphate and 
cortisol (circled). Both compounds are derivatives of cholesterol and have been 
implicated in osteogenic development. Cortisol, known mainly for its involvement in early 
development (Cooper et al., 1999, Manelli and Giustina, 2000), and cholesterol sulphate 
in in vitro osteogenesis of MSCs and pericytes (Chapter 4 and chapter 6). 
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IV. DMSO controls 
 
 
 
The above graph shows the results obtained from PCR experiments done with MSCs 
incubated with serially diluted concentrations of DMSO. 
DMSO was used to create solutions of the test items used in Chapter 4 - cholesterol 
sulphate, GP18:0 and sphinganine. Each test compound was made with a starting 
concentration of 100 μM containing 0.2% DMSO in the final volume. To ensure that 
DMSO concentrations had no bias on MSC differentiation, cells were cultured with 
equivalent levels of DMSO in the media only and transcription levels of OPN,GLUT-4 and 
COL2A1 ascertained. It was concluded that the DMSO levels were low enough not to 
cause any discernible effects. 
Error bars denote standard errors; n = 4 replicates.  
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V. Statistics calculated using one-way ANOVA followed by Bonferroni multiple 
comparison post-tests for SOX-9 gene expression by pericyte cells cultured up to 
5 weeks in different substrates. 
Statistically significant comparisons are denoted with an asterix where the calculated p 
value is < 0.05, *; <0.01, ** and < 0.001 ***. 
 
 
SOX-9: 1 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
 
SOX-9: 24 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
 
SOX-9: 72 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       *** 
ALG-   -     *** 
ALG+     - ***   
F2/S-     *** - *** 
F2/S+ ***     *** - 
 
 
SOX-9: 168 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
     Appendix 
 
 
  
SOX-9: 336 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       ** 
ALG-   -     * 
ALG+     -     
F2/S-       - * 
F2/S+ ** *   * - 
 
SOX-9: 672 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       ** 
ALG-   -     ** 
ALG+     -   ** 
F2/S-       - ** 
F2/S+ ** ** ** ** - 
 
SOX-9: 840 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       * 
ALG-   -       
ALG+     - * * 
F2/S-     * -   
F2/S+ *   *   - 
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VI. Statistics calculated using one-way ANOVA followed by Bonferroni multiple 
comparison post-tests for type II collagen (COL2A1) gene expression by pericyte 
cells cultured up to 5 weeks in different substrates. 
Statistically significant comparisons are denoted with an asterix where the calculated p 
value is < 0.05, *; <0.01, ** and < 0.001 ***. 
 
COL2A1: 1 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
COL2A1: 24 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -     *   
ALG-   -   *   
ALG+     - *   
F2/S- * * * -   
F2/S+         - 
 
 
COL2A1: 72 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
 
COL2A1: 168 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       ** 
ALG-   -     ** 
ALG+     -   ** 
F2/S-       - * 
F2/S+ ** ** ** * - 
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COL2A1: 336 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       * 
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+ *       - 
 
COL2A1: 672 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       *** 
ALG-   -     *** 
ALG+     -   *** 
F2/S-       - *** 
F2/S+ *** *** *** *** - 
 
COL2A1: 840 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -     * *** 
ALG-   -   * *** 
ALG+     - * *** 
F2/S- * * * - *** 
F2/S+ *** *** *** *** - 
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VII. Statistics calculated using one-way ANOVA followed by Bonferroni multiple 
comparison post-tests for aggrecan (ACAN) gene expression by pericyte cells 
cultured up to 5 weeks in different substrates. 
Statistically significant comparisons are denoted with an asterix where the calculated p 
value is < 0.05, *; <0.01, ** and < 0.001 ***. 
 
Aggrecan: 1 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
 
Aggrecan: 24 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -     *   
ALG-   -   *   
ALG+     - *   
F2/S- * * * -   
F2/S+         - 
 
 
Aggrecan: 72 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -     ** ** 
ALG-   -   * ** 
ALG+     - ** ** 
F2/S- ** * ** -   
F2/S+ ** ** **   - 
 
 
Aggrecan: 168 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -     * * 
ALG-   -   * * 
ALG+     - ** * 
F2/S- * * ** -   
F2/S+ * * *   - 
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Aggrecan: 336 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
Aggrecan: 672 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
Aggrecan: 840 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
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VIII. Statistics calculated using one-way ANOVA followed by Bonferroni multiple 
comparison post-tests for type X collagen (COL10A1) gene expression by pericyte 
cells cultured up to 5 weeks in different substrates. 
Statistically significant comparisons are denoted with an asterix where the calculated p 
value is < 0.05, *; <0.01, ** and < 0.001 ***. 
 
COL10A1: 1 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
 
COL10A1: 24 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -     *   
ALG-   -   *   
ALG+     - *   
F2/S- * * * -   
F2/S+         - 
 
 
COL10A1: 72 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       *** 
ALG-   -     ** 
ALG+     -   *** 
F2/S-       - ** 
F2/S+ *** ** *** ** - 
 
 
COL10A1: 168 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       *** 
ALG-   -     *** 
ALG+     - * *** 
F2/S-     * - ** 
F2/S+ *** *** *** ** - 
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COL10A1: 336 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       *** 
ALG-   -       
ALG+     -   *** 
F2/S-       - *** 
F2/S+ ***   *** *** - 
 
COL10A1: 672 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -       * 
ALG-   -     * 
ALG+     -   * 
F2/S-       - * 
F2/S+ * * * * - 
 
COL10A1: 840 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
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IX. Statistics calculated using one-way ANOVA followed by Bonferroni multiple 
comparison post-tests for measured protein abundances in pericytes cultured on 
plain substrates, 20 kPa F2/S and alginate hydrogels with and without 
chondrogenic induction media. 
Statistically significant comparisons are denoted with an asterix where the calculated p 
value is < 0.05, *; <0.01, ** and < 0.001 ***. 
 1 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
24 hr in culture 
  Plain ALG- ALG+ F2/S- F2/S+ 
Plain -         
ALG-   -       
ALG+     -     
F2/S-       -   
F2/S+         - 
 
72 hr in culture 
 Plain ALG- ALG+ F2/S- F2/S+ 
Plain -   *** *** 
ALG-  -  *** *** 
ALG+   - *** *** 
F2/S- *** *** *** -  
F2/S+ *** *** ***  - 
 
168 hr in culture 
 Plain ALG- ALG+ F2/S- F2/S+ 
Plain - *** *** *** *** 
ALG- *** -    
ALG+ ***  -   
F2/S- ***   -  
F2/S+ ***    - 
 
336 hr in culture 
 Plain ALG- ALG+ F2/S- F2/S+ 
Plain - *** *** *** *** 
ALG- *** -  * *** 
ALG+ ***  - * ** 
F2/S- *** * * - ** 
F2/S+ *** *** ** ** - 
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672 hr in culture 
 Plain ALG- ALG+ F2/S- F2/S+ 
Plain - *** *** *** *** 
ALG- *** -   ** 
ALG+ ***  -  ** 
F2/S- ***   -  
F2/S+ *** ** **  - 
 
840 hr in culture 
 Plain ALG- ALG+ F2/S- F2/S+ 
Plain - *** *** *** *** 
ALG- *** -   ** 
ALG+ ***  -   
F2/S- ***   -  
F2/S+ *** **   - 
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X. Assessing neurogenesis of MSCs 
 
 
 
 
MSCs were cultured on glass cover slips for 7 and 21 days in the absence (top row) and 
presence (bottom row) of 60 μM retinoic acid to induce neurogenesis (Yim et al., 2007). 
Cells were subsequently stained for the early biomarker nestin at 7 days and β3-tubulin 
at 21 days. Cells stained positively for nestin indicating initial stage neurogenesis, but 
were negative for the latterly expressed β3-tubulin showing that development of MSCs 
did not progress to formation of mature neuronal cells. Cell nuclei are shown in blue and 
biomarkers nestin or β3-tubulin in green; scale bar 100 µm. 
 
 
 
 
Nestin - Control
Nestin
β3-tubulin - Control
β3-tubulin
